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Author: Siân V. Owen 
In the past 30 years, Salmonella bloodstream infections have become a significant 
health problem in sub-Saharan Africa and are responsible for the deaths of ~390,000 
people each year. The disease is largely caused by a recently described sequence 
type of Salmonella Typhimurium: ST313. Comparative genomic analysis showed that 
the ST313 lineage is closely-related to the ancestral gastroenteritis-associated 
Typhimurium sequence type ST19, but carries a distinct prophage repertoire. I 
hypothesised that prophages contribute to the biology of this clinically-relevant ST. 
In this thesis I show that the African ST313 representative strain D23580 contains 5 
full length prophages. Prophage BTP1 and BTP5 are undescribed, novel prophages 
specific to African ST313 strains, whilst Gifsy-2, ST64B and Gifsy-1 are well-
characterised prophages found in other strains of S. Typhimurium. Of the five 
prophages, only BTP1 and BTP5 showed evidence for functional phage production, 
and mutations responsible for the inactivation of Gifsy-2, ST64B and Gifsy-1 were 
identified. The BTP1 prophage spontaneously induced at a prolific rate, estimated to 
result in the phage-mediated lysis of approximately 0.2% of the lysogenic cell 
population. A GFP reporter system was developed to visualise the spontaneous 
induction of the BTP1 prophage at the single-cell level.  Though the BTP5 phage 
could not be studied using traditional plaque assay methodology, there was evidence 
that the BTP5 prophage was capable of forming viable BTP5 phage that could 
lysogenise naïve hosts. 
I analysed the genomes of recently discovered ST313 isolates from the UK and show 
that ST313 in the UK represents a distinct population of antibiotic susceptible strains 
associated with gastrointestinal infection. Additionally, analysis of the UK-ST313 
genomes indicated that the BTP1 and BTP5 prophages were acquired independently 
by the two African ST313 lineages, showing convergent evolution to acquire and 
conserve the BTP1 and BTP5 prophages.  
Finally I present evidence that the prophages, in particular BTP5, effect the global 
gene expression of ST313, and the ST313-td gene of BTP1 mediates lysogenic 
conversion by functioning as a superinfection immunity factor against infection by 
Salmonella phage P22. 
The implications of these findings for understanding the pathogen in terms of 
ecological niche, host range and invasiveness in humans is discussed. 
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1.1 The genus Salmonella; a short history 
Salmonella is a genus of Gram-negative, rod-shaped bacteria belonging to the 
Enterobacteriaceae family, and more broadly to the class Gammaproteobacteria 
(Garrity et al., 2007). Like other members of the Enterobacteriaceae, Salmonella 
typically inhabit the intestinal tracts of vertebrates, however the ecology of Salmonella 
in the natural environment is not well-studied. In contrast, due to their ability to cause 
disease, particularly in higher mammals, the history of the study of the genus 
Salmonella is intertwined with that of mankind. Clinical descriptions suggestive of 
Salmonella disease can be found in Greek, Roman and ancient Chinese scriptures 
(Cunha, 2004) suggesting that Salmonella disease has plagued humanity throughout 
history. Indeed it has been suggested that Alexander the Great died from Typhoid 
fever (Cunha, 2004). More recently, DNA-based studies of archaeological material 
have implicated Salmonella in a variety of historical events, such as the fall of the 
Aztec civilisation in the 1500s (Vågene et al., 2017), and the ancient cause of death 
of a young woman in Trondheim, Norway in approximately 1200 (Zhou et al., 2017). 
The first clinical descriptions of infections likely to be caused by Salmonella were 
made from the 1600s onwards and were known as either ‘typhus’ or ‘typhoid’. Thomas 
Willis first accurately differentiated the two diseases in 1643 by identifying 
characteristic typhoid ulcers in the ilium (Cunha, 2004). However, confusion between 
typhus, caused by infection by members of the genus Rickettsia, and typhoid fever, 
caused by specific serovars of Salmonella, prevailed up until the late 1800s. The 
diagnostic challenge associated with invasive Salmonella disease persists to this day 
due to the non-specific nature of the clinical syndrome associated with blood stream 
Salmonella infection. Salmonella bacteria themselves were first observed in the 
1880s, by Karl Eberth, who reported ‘rod-shaped’ organisms in the spleens of typhoid 
patients. Salmonella were first cultured by Georg Gaffky from patients in Germany in 
1884 (Ellermeier and Slauch, 2006) and by Theobald Smith at the Bureau of Animal 
Industry in the USA. It was Smith, who proposed the name Salmonella in 1900, in 
honour of his mentor, American veterinarian Daniel E. Salmon. Theobald Smith was 
endeavouring to identify the cause of swine fever or hog cholera when he isolated 
what become known as Salmonella serovar Choleraesuis from a diseased pig 
(although the swine fever was later found to be caused by a virus). Salmonella was 
officially adopted as the genus name in 1934, when taxonomy was revised such that 
the genus Bacterium was abandoned and the genus Bacillus condensed to include 
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only spore-forming bacteria (The Salmonella Subcommittee of the Nomenclature 
Committee of the International Society for Microbiology, 1934).  
1.2 Contemporary Salmonella phylogeny, taxonomy and 
typing 
The genus Salmonella currently contains two recognised species, S. enterica and S. 
bongori. Salmonella enterica is subdivided into six subspecies (Tindall et al., 2005) 
(Figure 1.1): 
 subsp. I enterica 
 subsp. II salamae 
 subsp. IIIa arizonae 
 subsp. IIIb diarizonae 
 subsp. IV houtenae 
 subsp. VI indica 
 
The peculiarity in the numbering of the sub-species is the result of S. bongori 
previously being classed as S. enterica subsp. V, and recognition that arizonae and 
diarizonae should form separate subspecies. The species and subspecies can be 
distinguished from one another based on biochemical reactions (biotyping) (Malorny 
et al., 2011).  
Salmonella is closely-related to other genera in the Enterobacteriaceae such as 
Escherichia, Shigella and Citrobacter with which there is extensive genetic synteny 
and phenotypic similarities (Battistuzzi et al., 2004; Desai et al., 2013). Salmonella 
has been estimated to have diverged from a last common ancestor with Escherichia 
and Shigella around 100 million years ago (Doolittle et al., 1996). A defining difference 
between Salmonella and Escherichia is the presence of pathogenicity islands (known 
as SPIs for Salmonella pathogenicity islands) in the Salmonella genome. The SPIs 
encode secretion systems and translocatable effector genes which are critical for the 
intracellular lifestyle of Salmonella. S. bongori, which is predominantly associated with 
the infection of cold-blooded animals, contains only a limited repertoire of SPIs, and 
shares a more recent common ancestor with Escherichia than S. enterica. 
Consequently, S. bongori can be thought of as an evolutionary intermediate between 
Salmonella and E. coli, and the acquisition of various SPIs and modulation of 
metabolic function are thought to reflect the distinct niche adaption of S. bongori and 
S. enterica (Fookes et al., 2011). 
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Figure 1.1 Infographical representation of the taxonomic structure of genus 
Salmonella. The relative size of black circles representing serovars illustrates that 
the vast majority of known serovars are rarely isolated, whilst a minority are commonly 
isolated. For example, in the USA in 2013, just 20 serovars were responsible for 70% 
of all laboratory-confirmed Salmonella infections (Centers for Disease Control and 
Prevention (CDC), 2016). The majority of sequence types associated with disease in 
mammals belong to subspecies I, enterica.
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Below the level of subspecies, Salmonella are delineated or typed based on a method 
known as serotyping. The method of serotyping was developed by Fritz Kauffmann in 
the 1930s based on the work of Phillip Bruce White, and the ensuing taxonomic 
scheme was designated ‘The Kauffmann-White Schema’ (The Salmonella 
Subcommittee of the Nomenclature Committee of the International Society for 
Microbiology, 1934). The scheme represented a typing method for Salmonella based 
on the agglutination of serum in response to the diverse antigenic properties of the 
Salmonella cell surface (known as serology) (Kauffmann., 1940). Though serum 
agglutination had been used since 1896 to characterise Salmonella isolates (Widal, 
1896), Kauffmann’s approach represented the first standardisation of the method, and 
meant that Salmonella typing could be reproduced independently in different 
laboratories. 
In the intermediate years before the introduction of the Kauffmann-White Scheme, 
numerous reports had been published describing typhoid-like bacilli in different 
animals, or in humans that showed characteristics distinct to the typical typhus 
bacillus (collectively known as paratyphoid bacilli), and the naming system calf-, 
mouse-, swine-, etc., typhus, had been commonly used (Tenbroeck, 1920). 
Consequently, a vast array of names, often incorporating the original host animal, are 
present in the early Salmonella literature but now considered to be synonyms. For 
example, Bacillus typhimurium, Bacterium aertrycke, S. pestis caviae and S. 
psittacosis are all considered synonymic for Salmonella Typhimurium (Weisbroth, 
1979). The modern-day iteration of the Kauffman-White scheme is known as the 
White-Kauffman-Le Minor, in recognition of the contribution of Léon Le Minor, who 
described the majority of the known Salmonella serovars. Though the scheme has 
been updated several times in recent history, to allow for the description of an ever 
increasing number of serovars, the basis of the scheme remains unchanged since its 
inception by Franz Kauffman in the 1930s (The Salmonella Subcommittee of the 
Nomenclature Committee of the International Society for Microbiology, 1934; Grimont 
and Weill, 2007). 
The serotyping scheme relies on the use of a set of standardised rabbit sera that has 
been raised against well-characterised Salmonella strains. Depending on the 
agglutination reaction to each test serum, bacteria are given an antigenic formula. 
The Salmonella antigens that contribute to serotyping are located on either 
lipopolysaccharide molecules (LPS), known as ’O’ antigens, or the flagella- ‘H’ 
antigens (Grimont and Weill, 2007). The ‘H’ antigens are encoded by the fliC and fljB 
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genes which represent the motile phase 1 and phase 2 of Salmonella respectively. 
The formula is written in the format ‘O’ antigen(s): ‘H’ antigen phase 1 : H antigen 
phase 2 (Grimont and Weill, 2007). The latest volume of the White-Kauffmann-Le 
Minor scheme describes over 2,500 serovars of Salmonella. Historically, new 
serovars have been named after the cities in which they are first described, though 
as the number of serovars has increased, convention has been revised such that new 
serovars are given numerical antigenic formulae only (Grimont and Weill, 2007). 
Approximately 60% of all the recognised Salmonella serovars belong to subspecies I 
(enterica) (Grimont and Weill, 2007), which is also the most important subspecies in 
relation to human health. However, the distribution of infections by the ~1,500 
serovars of subsp. enterica is highly geometric and the majority of infections tend to 
be caused by only a handful of the most common serovars. For example, in the USA 
in 2013, just 20 serovars were responsible for 70% of all laboratory-confirmed 
Salmonella infections (Centers for Disease Control and Prevention (CDC), 2016). The 
vast majority of the >2,500 Salmonella serovars are extremely rare in the clinical 
setting. 
Serotyping was initially designed as a pragmatic typing tool to aid distinction between 
Salmonella serovars in diagnostic and public health microbiology, rather than to 
inform phylogeny. A combination of the diversity of the genus Salmonella, the general 
phenotypic uniformity within serovars and technological limitations have meant that 
until recently, serovar-driven taxonomy has prevailed (Brenner et al., 2000). Disease 
surveillance and diagnostic guidelines have consequently also been built on serology, 
which can be unhelpful when serovars are associated with multiple clinical syndromes 
(Herikstad et al., 2002). Recent re-evaluation of Salmonella phylogeny using genetic 
methods has shown surprisingly high consistency between serology and phylogeny, 
with a few notable discrepancies such as the serovars S. Paratyphi B, S. Java, S. 
Paratyphi C and S. Choleraesuis, where serotyping does not accurately represent 
evolutionary relationships (Achtman et al., 2012). 
1.2.1 Use of nomenclature in this thesis 
To avoid confusion between species, subspecies and serovar names, it has 
become conventional to abbreviate the full taxonomic names of Salmonella simply 
to genus name and serovar (Grimont and Weill, 2007). For example, “Salmonella 
enterica subsp. enterica serovar Typhimurium” is conventionally abbreviated to 
“Salmonella Typhimurium”, or “S. Typhimurium”. For brevity, this convention will be 
adopted throughout this thesis. 
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Salmonella strains can be further differentiated into a number of ‘phage types’ based 
on their susceptibility to killing by a specific set of bacteriophages (viruses that infect 
bacteria) (Rabsch, 2007). Phage-typing correlates well with serology, because like 
the antibodies in serum, phages also recognise receptors on the bacterial surface. 
Phage typing has been used to type Salmonella at the sub-serovar level since the 
1940s (Felix and Callow, 1943; Lilleengen, 1948) and the Anderson phage typing 
scheme has been used to classify S. Typhimurium strains in labs worldwide since 
1966 (Rabsch et al., 2011). Phage typing has been utilised particularly effectively for 
epidemiological surveillance, where it is expected that strains isolated from cases 
associated with a point source outbreak will have the same phage type (Baggesen et 
al., 2010). 
Though serology and phage typing have played important roles in Salmonella disease 
epidemiology, a common drawback of these approaches is that they rely on 
morphological properties of Salmonella which may not reflect real evolutionary 
relationships. Pulse field gel electrophoresis (PFGE) is an early way of typing 
Salmonella based on properties of the genome (Goering, 2010). PFGE is a method 
of high resolution separation of DNA molecules in a gel matrix by the application of 
an electric field of alternating direction. Genomic DNA is digested with the XbaI 
restriction enzyme and separated such that the pattern of DNA molecules of varying 
lengths (known as the DNA fingerprint) reflects the number and location of XbaI-
restriction sites in the genome. PFGE has been applied to the global surveillance of 
food borne disease by pathogens such as Salmonella, Shigella and E. coli, as 
pioneered by the PulseNet organisation. However, more discriminatory genome-
based methodologies have now largely replaced PFGE-typing for Salmonella 
(Swaminathan et al., 2001). 
Multi-Locus Sequence Typing (MLST) is a method that has been employed to 
supplement, or replace, traditional Salmonella typing methods such as serology and 
phage typing or PFGE (Achtman et al., 2012). Different MLST schemes have been 
established for many bacterial phyla, but in Salmonella the original scheme uses the 
DNA sequences (or alleles) of seven highly conserved so-called ‘housekeeping’ loci. 
The genes used in the Salmonella MLST scheme are: thrA, purE, sucA, hisD, aroC, 
hemD and dnaN (Maiden et al., 2013). The sequence of each loci is determined for a 
given isolate. Traditionally this is accomplished by targeted PCR amplification and 
Sanger sequencing, but increasingly MLST typing is carried out in silico using whole 
genome sequence data. Each known allelic variant is assigned a number, and each 
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new combination of the 7 alleles is given a numerical ‘type’. As STs are resolved at 
the level of single nucleotides, MLST is highly discriminatory and is more likely than 
serology to recognise evolutionary groupings.  For serovars such as S. Typhimurium, 
which contain a high degree of allelic variation, MLST is used to discriminate isolates 
at the sub-serovar level (Kingsley et al., 2013; Okoro et al., 2012). For example, the 
most common sequence type of S. Typhimurium worldwide causing disease in 
humans is (ST) 19, though more than 100 sequences types of S. Typhimurium have 
currently been defined (EnteroBase: http://enterobase.warwick.ac.uk [Accessed 16 
June 2017]) (Figure 1.2).  
As the cost of whole genome sequencing has plummeted (Muir et al., 2016), typing 
Salmonella using whole-genome based approaches has become increasingly 
common. Since 2014, the UK public health agency, Public Health England, has been 
using whole genome sequencing as a routine typing tool for public health surveillance 
of Salmonella, and adopting in silico MLST as a replacement for traditional serotyping 
(Ashton et al., 2016). More discriminatory schemes have subsequently been applied 
to collections of whole genome sequences, such as core-genome and whole-genome 
MLST (cgMLST, wgMLST) which use the sequence of 3,002 and 21,065 loci 
respectively (EnteroBase: http://enterobase.warwick.ac.uk [Accessed 1 January 
2016]). Lastly, classifying Salmonella based on statistical clustering of whole genome 
phylogenies has become increasingly common, and has recently been used to 
classify global S. Typhi populations (Wong et al., 2016).  
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Figure 1.2 All sequenced S. Typhimurium genomes in the Enterobase genome 
database shown by multi-locus sequence type (MLST). The pie chart shows the 
proportion of all sequenced S. Typhimurium genomes belonging to each MLST 
sequence type. The percent and proportion are shown for the largest 3 sequence 
types. Data obtained from EnteroBase: http://enterobase.warwick.ac.uk [Accessed 
20 June 2017] 
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1.3 Clinical syndromes and host specificities associated with 
Salmonella 
Salmonella causes a huge range of disease in humans, including gastroenteritis, 
sepsis, meningitis, abscess, osteomyelitis and mycotic aneurysms. Such is the 
breadth of disease and the diversity of serovars, clinicians have found it useful to 
consider Salmonella in terms of the two most prominent clinical syndromes 
associated with Salmonella, these being gastroenteritis and invasive 
disease/bloodstream infection. This has led them to associate specific serotypes with 
particular disease types. This crude distinction is not without utility, but neither is it 
without problems. It follows the assumption that isolates belonging to the same 
serovar are homogenous in aspects of disease syndrome and host range. This 
convention existed because certain serovars were associated with a specific host 
range, and with particular infection severities (Jones et al., 2008). Typically there is 
an inverse relationship between the breadth of host range and the severity of infection 
of Salmonella serovars (Figure 1.3). For example, Salmonella serovars with broad 
host ranges tend to be associated with self-limiting gastrointestinal disease, which is 
less severe than the extra-intestinal, often fatal, infections caused by serovars 
restricted to a single host. It has been suggested that this is the result of an 
evolutionary trade-off between niche specialisation and niche versatility (Bäumler and 
Fang, 2013)  
Figure 1.3 The Salmonella host adaption and disease syndrome paradigm.  
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The most prominent example of this is the case of Typhoid fever, a clinical syndrome 
restricted to humans caused by serovars S. Typhi, S. Paratyphi A, and to a lesser 
extent, S. Paratyphi B and C. Consequently these human-restricted pathogens 
associated with invasive (systemic) disease are considered to be ‘typhoidal’ serovars. 
The clinical syndrome caused by these serovars is known as enteric fever or Typhoid 
fever (occasionally the term Paratyphoid fever is used when the causative agent is 
serovar S. Paratyphi A, B or C, though the diseases are thought to be clinically 
indistinguishable) (Crump and Mintz, 2010). Serovars that are considered host-
restricted in other animal hosts include S. Gallinarum, S. Typhisuis and S. Abortusequi 
which cause invasive disease in chicken, pig and horse respectively (Uzzau et al., 
2000). 
This distinction is useful in the context of Typhoid fever. What is less useful is the 
convention of considering the remainder of serovars as being “non-typhoidal” and by 
association not associated with invasive disease. Instead, the majority of serovars are 
associated with a spectrum of host restriction and generalism and clinical disease. 
Certain serovars of Salmonella are described as ‘host-adapted’, and show 
specialisation, though not total restriction, to a specific host. Examples of ‘host-
adapted’ serovars are S. Choleraesuis and S. Dublin, which primarily infect pigs and 
cows respectively, but can also cause invasive disease in humans (Uzzau et al., 
2000). 
At the opposite end of the spectrum, broad-host range “generalist” Salmonella 
serovars tend to cause mild infection in a variety of hosts, manifesting as 
gastroenteritis in humans. Strictly in regard to human health, all Salmonella that are 
not primarily associated with invasive disease in humans (the ‘typhoidal’ Salmonella 
already discussed) are loosely described as ‘non-typhoidal Salmonella’ (NTS).  These 
“non-typhoidal” Salmonella serovars typically have a broad host-range, and the 
majority of human cases are foodborne, often originating from zoonotic reservoirs 
(Mead et al., 1999). NTS are responsible for a significant public health burden 
worldwide and S. Typhimurium and S. Enteritidis are the predominant serovars 
observed in clinical cases in most countries. For example, in England & Wales, 48.7% 
of the isolates referred to the Salmonella Reference Service in 2012 were S. 
Typhimurium or S. Enteritidis (Public Health England data- Salmonella frequency by 
serotype 2000 to 2010). The global burden of non-typhoidal Salmonella caused 
gastroenteritis has been estimated to be 150,000 deaths per year (Majowicz et al., 
2010). 
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Serotyping has historically been a useful tool for dividing the diverse genus 
Salmonella into clinically-relevant groupings. However, this simplified view of 
typhoidal vs non-typhoidal Salmonella disease becomes complicated by host factors 
which also play an important role in Salmonella disease severity and host 
susceptibility. For example, in immunodeficient hosts, non-typhoidal serovars such as  
S. Typhimurium are prominent causes of systemic infection, termed invasive non-
typhoidal Salmonella disease (iNTS) (Gordon, 2011). Specific human genetic variants 
(primary immunodeficiencies) are known to increase susceptibility to Salmonella 
infection (Gilchrist et al., 2015), but immunodeficiency due to an underlying disease 
status (secondary immunodeficiency) such as that associated with human 
immunodeficiency virus (HIV) infection has become increasingly associated with iNTS 
disease. In fact, iNTS was one of the first HIV/AIDS defining illnesses (Feasey et al., 
2012; Gruenewald et al., 1994). Though iNTS disease does not represent a large 
health burden in the developed world where hygiene standards are high and 
prevalence of immunodeficiency is relatively low, in sub Saharan Africa (sSA), iNTS 
is responsible for an estimated 390,000 deaths per year (Ao et al., 2015) (Figure 1.4). 
 
Figure 1.4 Map of the world showing the estimated annual frequency of 
mortality due to iNTS disease by continent. Based on estimates by Ao et al., 2014. 
The numerical estimates of annual deaths per continent are: N. Africa (MidEast) 723, 
Africa 388,555, Asia (Oceania) 2784, SE Asia 94,452, Europe 152,638, Americas 
42,162.  
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1.4 iNTS disease in sub Saharan Africa & S. Typhimurium 
ST313 
Reports of bacteraemia in children caused by non-typhoidal Salmonella in sub 
Saharan Africa (sSA) began to appear in the published literature in the 1960s (Ao et 
al., 2015; Uche et al., 2017). With the subsequent AIDS epidemic, NTS began to be 
frequently isolated from bloodstream infections in adults as well as children, and NTS 
was described as a common HIV-associated pathogen in sSA (Gilks et al., 1990). 
iNTS disease has remained a significant health burden, and is estimated to be 
responsible for around 39% of all community-acquired blood stream infections in sSA 
(Uche et al., 2017). Serovars S. Typhimurium and S. Enteritidis are most frequently 
isolated from iNTS patients (MacLennan and Levine, 2013; Uche et al., 2017), though 
a number of other serovars have been associated with iNTS disease in specific 
locations including S. Isangi (South Africa), S. Concord (Ethiopia), S. Infantis 
(Ethiopia), S. Dublin (Mali), S. Stanleyville (Mali), S. Heidelberg (Malawi) and S. 
Bovismorbificans (Malawi) (Bronowski et al., 2013; Gordon, 2011; Tennant et al., 
2010; Uche et al., 2017; Wain et al., 2013). Recent meta-analysis suggests that S. 
Typhimurium has been responsible for 48% of all reported iNTS disease cases (Uche 
et al., 2017) and for this reason it has been the focus of research into the pathogenicity 
of iNTS disease associated Salmonella. 
Whole genome sequencing of S. Typhimurium isolates collected from patients with 
iNTS disease in Malawi initially identified a novel sequence type (ST), ST313, of S. 
Typhimurium in 2009 (Kingsley et al., 2009) (Figure 1.5A). Subsequent whole 
genome-based study of isolates from across the African sub-continent confirmed the 
existence of two distinct phylogenetic lineages of ST313, and spatio-temporal 
phylogenetic reconstruction estimated that lineage 1 emerged circa 1960 in south 
west Africa, whereas lineage 2 emerged circa 1977 in Malawi (Okoro et al., 2012) 
(Figure 1.5B). Both lineages are associated with antimicrobial resistance (AMR) 
mediated by differing Tn21-like integrons on the virulence plasmid pSLT (Kingsley et 
al., 2009), and it was proposed that clonal replacement of lineage 1 by lineage 2 had 
occurred, driven by the acquisition of chloramphenicol resistance by lineage 2 (Okoro 
et al., 2012). The finished genome of lineage 2 strain D23580 (Accession Number: 
FN424405) isolated from a child in Malawi, published by Kingsley et al., 2009 is now 
generally used as the reference strain for ST313. 
14  
 
Since its description in 2009, numerous publications have reported ST313 S. 
Typhimurium to be a leading cause of iNTS disease in countries across sub-Saharan 
Africa (Summarised in Table 1.1). Most recently, ST313 have been isolated in Brazil 
(Almeida et al., 2017). The strong association between ST313 and iNTS disease 
compared to other sequence types of S. Typhimurium, and other serovars of 
Salmonella, has led to the hypothesis that ST313 S. Typhimurium have adapted to 
cause systemic disease in the sSA human niche.  
Phylogenetic analysis indicates that ST313 is closely-related to ST19- the ‘archetypal’ 
S. Typhimurium sequence type responsible for self-limiting gastroenteritis worldwide, 
and containing well studied strains LT2 and SL1344 (Kingsley et al., 2009).  
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Figure 1.5 Two landmark papers describing the iNTS disease-associated S. 
Typhimurium ST313. A. Figures reproduced from Kingsley et al., 2009. (left) Radial 
phylogeny showing the phylogenetic relationship between 6 strains of ST313 and 
ST19. (right) Radial phylogeny showing the phylogenetic relationship between 
sequence types (ST) of S. Typhimurium. B. Figure reproduced from Okoro et al., 2012 
showing a phylogenetic tree of ST313 and other S. Typhimurium isolates. The tree 
shows that the population structure of ST313 consists of two discrete lineages. 
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Authors Year Associated Country Summary 
Publications describing ST313 disease epidemiology 
Almeida et al. 2017 Brazil 
Antimicrobial-sensitive ST313 
isolates from food, faeces and blood 
in Brazil. 
Kariuki & Onsare 2015 Kenya 
Emergence of ceftriaxone resistant 
ST313 in Kenya 
Keddy et al. 2015 South Africa 
ST313 in S. Africa is associated with 
neonates and HIV+ adults 
Moon et al. 2015 Mozambique 
ST313 is a prevalent cause of iNTS in 
Mozambique 
Kariuki et al. 2015 Kenya 
Identification of an ESBL-producing 
IncHI2 plasmid in ceftriaxone-
resistant ST313 isolates from Kenya 
Feasey et al. 2014 Malawi 
Identification of an ESBL-producing 
IncHI2 plasmid in ceftriaxone and 
ciprofloxacin resistant ST313 isolates 
from Malawi 
Ley et al. 2014 DRC 
ST313 is a prevalent cause of iNTS in 
the DRC 
Leekitcharoenphon et al. 2013 Nigeria, DRC 
ST313 is a prevalent cause of iNTS in 
the DRC and Nigeria 
Paglietti et al. 2013 Zimbabwe 
ST313 is a prevalent cause of iNTS in 
the DRC 
Okoro, et al. 2012 
Malawi, Kenya, Mozambique, 
Uganda, DRC, Nigeria and Mali 
ST313 is a cause of iNTS disease 
across Africa and is composed of 2 
discrete phylogenetic lineages 
Okoro et al. 2012 Malawi 
Recurrence of iNTS disease by 
ST313 in Malawi is mainly 
recrudescence not reinfection 
Boyle et al. 2011 Kenya, Malawi 
ESBL-producing ST313 from Kenya 
and Malawi carry the blaOXA-1 gene 
Kingsley et al. 2009 Kenya, Malawi 
iNTS disease in Kenya and Malawi is 
associated with the novel sequence 
type (ST)313 
Publications reviewing ST313 disease epidemiology 
Wain et al. 2013 - 
Review of iNTS disease epidemiology 
and epidemiological questions 
remaining 
Feasey et al. 2012 - 
Review of the epidemiology and 
clinical features of iNTS disease 
de Jong et al. 2012 - 
Immunology-focused review of iNTS 
disease 
    
    
Table 1.1 The S. Typhimurium ST313 disease epidemiology literature
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Initial genome-based studies proposed that the link between S. Typhimurium ST313 
and iNTS disease in sSA was that, compared with the generalist S. Typhimurium 
ST19, ST313 has adapted to an extra-intestinal/invasive lifestyle via genome 
degradation (Kingsley et al., 2009; Okoro et al., 2015). This deduction was prompted 
by the finding of an accumulation of pseudogenes in pathways associated with 
gastrointestinal colonization, as observed in host-restricted Salmonella serovars such 
as S. Typhi, and in other notable human pathogens such as Yersinia pestis, Shigella 
spp, Mycobacterium leprae and Bordetella pertussis (Cole et al., 2001; McClelland et 
al., 2004; McNally et al., 2016; Parkhill et al., 2001; The et al., 2016; Yang et al., 
2005). Of the 44 novel pseudogenes and deletions found in ST313-representative 
strain D23580, compared to ST19 strain LT2, 26 are also degraded in S. Typhi 
(Kingsley et al., 2009). For example, a 1694 bp deletion containing the allP and allB 
genes was identified in D23580. These genes are involved in allantoin metabolism, a 
pathway that has also been lost in the host-restricted Salmonella serovars S. Typhi, 
S. Paratyphi A and S. Gallinarum. Allantoin is a breakdown product of purines in lower 
mammals, but not produced in humans and avian species, implying that loss of the 
allantoin metabolism pathway could indicate evolution towards a human/avian 
restricted niche (Kingsley et al., 2009).  
As well as genome degradation, Kingsley et al. reported the presence of two novel 
prophages, denoted BTP1 and BTP5 (for Blantyre Prophage) as well as the addition 
of an array of antibiotic resistance genes carried on a Tn21-like integron on the pSLT 
virulence plasmid (Kingsley et al., 2009). Though the structure of the MDR integrons 
differed in ST313 lineage 1 and 2, both lineages were reported to carry the BTP1 and 
BTP5 prophages. Subsequent analysis by Okoro et al. showed that the prophage 
repertoire of ST313 isolates is highly conserved in isolates from both lineages and 
originating from across the African continent (Kingsley et al., 2009). Interestingly, 
other publications characterising iNTS associated S. Bovismorbificans and S. 
Enteritidis and respective gastroenteritis-associated comparator strains showed a 
similar pattern, with the major genetic differences being the plasmid and phage 
elements (Bronowski et al., 2013; Feasey et al., 2016). 
The BTP1 prophage carried by ST313 contains the gtrC gene, which mediates 
acetylation of the O-antigen (Kintz et al., 2015). Consequently, the O-antigen 
morphology of ST313 strains differs from ST19 strains which do not contain the BTP1 
prophage. O-antigen modification systems are commonly carried by temperate 
phages to confer superinfection immunity to the lysogen, and these systems have 
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also been shown to play a role in bacterial virulence (Davies et al., 2013). Despite 
genomic degradation that mirrors that of host-restricted S. Typhi (McClelland et al., 
2004), numerous reports have shown that ST313 are capable of causing infection in 
a number of animal models and implicating a possible avian reservoir; S. Typhimurium 
ST313 causes invasive disease in chickens (Parsons et al., 2013), and several 
studies have reported virulent infection in mice (Herrero-Fresno et al., 2014; Okoro et 
al., 2015; Singletary et al., 2016; J. Yang et al., 2015). Herrero-Fresno et al. (2014) 
and Yang et al. (2015) reported that ST313 were more invasive than ST19 in the 
BALB/c mouse and C57/BL6 mouse respectively, and Singletary et al (2015) reported 
that ST313 disseminated to the mesenteric lymph nodes more rapidly than ST19 in 
the streptomycin-treated mouse. However, Okoro et al. (2015) reported that ST313 
cause less inflammation than ST19 in the streptomycin-treated mouse model, 
whereas Singletary et al (2015) reported no difference in inflammation caused by 
ST313 and ST19 in the same model. ST313 have additionally been reported to 
produce less inflammation than ST19 in the bovine ligated ileal loop infection model 
(Okoro et al., 2015), whereas no differences were observed in the rhesus macaque 
ligated ileal loop infection model (Singletary et al., 2016). Only one genetic 
mechanism has been identified that could explain the reported differences in animal 
infection models. The sseI gene is a pseudogene in ST313 lineage 2 (Kingsley et al., 
2009). A recent study showed that the loss of the functional Salmonella pathogenicity 
island 2 (SPI-2) effector SseI protein facilitates hyperdissemination from the gut to 
systemic sites via migratory dendritic cells (DCs) in the streptomycin pre-treated 
mouse model (Carden et al., 2017). The lack of agreement between various animal 
infection models utilised to study ST313, together with the lack of genetic 
mechanisms, has fuelled debate as to whether ST313 are truly more invasive, or 
whether the association between ST313 and iNTS disease is predominantly due to 
host factors (Lokken et al., 2016).  
1.4.1 A note on the use of the term “invasive” 
 
The term ‘invasive’ was originally applied to iNTS as a clinical term i.e. capable of ‘invading’ 
the blood stream to cause systemic disease. However the term has been widely confused 
with the cellular biology definition of ‘invasive’ i.e. when a bacterium is capable of actively 
invading eukaryotic non-phagocytic cells such as epithelial cells and fibroblasts. The 
distinction between these two definitions is important, because a pathogen which is more 
clinically invasive may not necessarily exhibit greater cellular invasiveness. 
19 
 
As well as animal infection models, numerous cellular models have been used to 
study ST313 pathogenesis. The infection behaviour (including invasion, proliferation 
and cytotoxicity) of ST313 has been studied in various murine and human cells, 
including human epithelial cell lines (HeLa), human macrophage cell lines (THP-1), 
murine macrophage cell lines (J774) and human and mouse primary (bone-marrow 
derived) macrophages (Almeida et al., 2017; Carden et al., 2015; Herrero-Fresno et 
al., 2014; Ramachandran et al., 2015) (Table 1.2). As with animal infection models 
however, no consistent infection phenotype has been reported to distinguish ST313 
from ST19, though some patterns have emerged. Generally, ST313 replicate better 
in murine macrophages than ST19 strains, and illicit less cytotoxicity (Carden et al., 
2015; Herrero-Fresno et al., 2014; Ramachandran et al., 2015). There is conflicting 
data on the ability of ST313 to invade epithelial cells compared to ST19 (Almeida et 
al., 2017; Carden et al., 2015; Herrero-Fresno et al., 2014). The lack of consensus 
between studies may reflect the use of various different bacterial strains to represent 
ST313 and ST19 (Table 1.2). ST313 have also been reported to require a higher 
concentration of complement for serum-mediated bacterial killing than ST19 or S. 
Paratyphi B (Goh and MacLennan, 2013) and to be more resistant to high fluid shear 
forces than ST19, which may indicate adaption toward survival in the blood stream 
(Yang et al., 2016). 
Phenotypes not directly related to infection have also been described (Table 1.2). 
Yang et al. (2015) reported that ST313 was more acid resistant than ST19 strains. 
Ramachandran et al. (2016) showed ST313 form less surface-associated biofilm and 
exhibit less long-term survival under desiccating conditions than ST19. Furthermore, 
ST313 cannot form the biofilm-associated RDAR (red dry and rough) morphology at 
25 °C, and are defective in stationary-phase catalase activity, due to point mutations 
in the bcsG and katE genes respectively (Singletary et al., 2016). It has been 
suggested that, taken together, these phenotypes may support the hypothesis that 
ST313 has lost an adaption to an environmental niche that is extant in ST19. Finally, 
ST313 has been shown to have altered motility compared to ST19. Yang et al. (2015) 
reported that ST313 strains  showed higher swimming motility than ST19, whereas 
Ramachandran et al. (2015) reported reduced motility in ST313 strains compared to 
ST19, and Carden et al. (2015) showed reduced flagellin expression in ST313 
compared to ST19 (Carden et al., 2015; Ramachandran et al., 2015; J. Yang et al., 
2015).  
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Despite considerable research into the effects of core genome degradation, along 
with in vivo and in vitro phenotypes that differentiate ST313 from other clades of S. 
Typhimurium, a mechanism that would confer an enhanced ability of S. Typhimurium 
ST313 to cause systemic disease has not yet been described. It is therefore clear that 
our understanding of S. Typhimurium ST313 pathogenesis, and its association with 
iNTS disease is incomplete.  
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Authors Year Key Strains used Phenotypes described 
Publications describing ST313 phenotypes 
Almeida et al. 2017 
Brazilian ST313 & 
ST19 isolates, SL1344 
Brazilian ST313 isolates are heterologous in invasion 
of epithelial cells (HeLa) and replication in mouse 
macrophages (J774) 
Owen et al. 2017 D23580 Chapter 3 
Carden et al. 2017 D23580, SL1344 
The pseudogenisation of sseI in lineage 2 ST313 
facilitates hyperdissemination from the gut to 
systemic sites via migratory DCs in the streptomycin 
pre-treated mouse model (C57BL/6). 
Yang et al. 2016 D23580, χ33391 
ST313 are more resistant to high fluid shear 
conditions (likely to be encountered in the 
bloodstream) than ST19 
Ramachandran et al. 2016 
D23580, SL1344 + 
Malian ST313 & ST19 
strains 
ST313 form less biofilm than ST19 and are less 
resistant to desiccation 
Singletary et al. 2016 D23580, 14028 
Point mutations in katE and bcsG in ST313 result in 
loss of stationary phase catalase production and 
RDAR morphology formation, linked to environmental 
persistence. No differences between ST313 and 
ST19 in rhesus macaque ligated ileal loop infection 
model but ST313 more rapidly disseminates to the 
mesenteric lymph nodes in the streptomycin pre-
treated mouse. 
Yang et al. 2015 D23580, A130, SL1344 
ST313 are more acid resistant, more motile, and 
more invasive in BALB/c mice than ST19. 
Carden et al. 2015 
D23580, A130, 
SL1344, DT104 
ST313 invade epithelial cells (HeLa) less efficiently 
and are less cytotoxic, and illicit less inflammasome 
activity in primary mouse macrophages. Expression 
of sopE2 and fliC is lower in ST313 than in ST19. 
Kintz et al. 2015 D23580 
ST313 possess a modified O-antigen due to 
acetylation by the BTP1 prophage-encoded gtrC 
gene. 
Okoro et al. 2015 
D23580, A130, 5597 
(Kenya), 5579 (Kenya), 
SL1344 
ST313 have a distinct metabolic profile compared to 
ST19. ST313 illicit less inflammation in streptomycin 
pre-treated mouse and bovine ligated ileal loop 
infection model. 
Ramachandran et al. 2015 
D23580, SL1344 + 
Malian ST313 & ST19 
isolates 
ST313 are less motile than ST19, are more virulent in 
cultured macrophages (THP-1), and primary mouse 
and human macrophage models compared to ST19. 
ST313 are less cytotoxic compared to ST19. 
Herrero-Fresno et al. 2014 
02-03/002 (DRC), 4/74, 
14028 
ST313 possess the st313-td gene, which increases 
replication in murine macrophages (J774) and 
increases invasiveness in mice (C57/BL6) relative to 
ST19, but does not affect invasion of epithelial cells 
(HeLa). 
Parsons et al. 2013 
D23580, Q456, 4/74, 
F98 
ST313 causes invasive infection of chickens that is 
more rapid than ST19. ST313 exhibits lower 
gastrointestinal colonization. 
Goh et al. 2013 D23580, LT2, 
CVD1901 (Paratyphi A) 
ST313 require a higher concentration of complement 
for serum-mediated bacterial killing compared to 
ST19 and Paratyphi A. 
Kingsley et al. 2009 D23580 
ST313 have undergone genome degradation 
analogous to that found in host-restricted Salmonella 
such as S. Typhi or S. Gallinarum. 
Publications reviewing ST313 phenotypes 
Lokken et al. 2016 - 
Review of reported phenotypes of ST313 and host 
factors associated with iNTS disease. 
1Animal passaged derivative of SL1344 
Table 1.2 The S. Typhimurium ST313 phenotypic literature 
22  
 
1.5 An introduction to bacteriophages 
Bacteriophages or ‘phages’ are viruses that infect bacteria. Phages were first 
discovered independently by the British pathologist Frederick William Twort in 1915, 
and the French-Canadian microbiologist Félix d’Hérelle in 1917 (Twort, 1915; 
d’Hérelle, 1917). Both scientists reported a filter-passing agent capable of lysing 
bacteria, that could be transmitted from infected to uninfected cultures of the same 
bacteria, though it was d’Hérelle who coined the term bacteriophage, literally meaning 
“eater of bacteria”. d’Hérelle subsequently began isolating bacteriophages against 
gastroinstinal pathogens including E. coli and Shigella species, and was the first to 
isolate phages against S. Typhi and S. Typhimurium (d’Hérelle, 1922). 
Not long after the initial descriptions of bacteriophages by Twort and d’Hérelle, other 
microbiologists reported the appearance of bacteriophage in cultures spontaneously, 
without infection, and without evidence of culture lysis. These bacteriophages could 
subsequently infect and lyse isogenic strains of the same bacterial species, but could 
not infect the strain from which they had originated (Lisbonne and Carrére, 1922; 
Bordet, 1923). The cultures which produced these bacteriophages were termed 
lysogenic- literally meaning ‘generating lysis’ (Lwoff, 1953). More than 25 years before 
the discovery of DNA as a heritable genetic material, Jules Bordet wrote on the 
subject of a bacterial lysogen that “The faculty to produce bacteriophage is inscribed 
in the heredity of the bacterium; it is ‘inserted’ in the normal physiology of the 
bacterium” (Bordet, 1925; Lwoff, 1953). Bordet had foreseen what would later inspire 
a breakthrough in molecular biology; the origin and all characteristics of a phage are 
determined by the nucleic acids that make up its genome, which in the case of 
temperate phages (those originating from a lysogen) can become integrated into the 
genome of the host (Lwoff, 1953). This latent phage state within the heritable material 
of the host was termed a pro-bacteriophage, or more commonly, prophage (Lwoff and 
Gutmann, 1950). All phages can be classed as either temperate, or lytic, depending 
on whether or not they possess the faculty to enter the latent prophage state. 
Despite their early discovery, phages were not confirmed to be true viruses (as 
opposed to another factor, such as a lytic enzyme) until the application of electron 
microscopy, and were first visualised by the German doctor Helmut Ruska in 1940 
(Ruska, 1940). Subsequently, phages became important tools in the development  of 
techniques in molecular biology, and the pioneering experiments of Alfred Hershey 
and Martha Chase in 1952 using phage T2 contributed to the discovery of DNA as a 
heritable genetic material (Hershey and Chase, 1952). Study of temperate phages, in 
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particular phage lambda (λ), underpinned the discovery of important molecular 
biology concepts such as the regulation of gene expression and genetic 
recombination, as well as contributing to the field of genetic engineering (Casjens and 
Hendrix, 2015; Murray, 2006). Due to the depth in which it was studied, much of our 
current understanding of the biology of temperate phages is based on the study of 
phage lambda. 
Based on their morphology and type of nucleic acid carried, phages can be classified 
into broad taxonomic groups (Ackermann, 2006) (Figure 1.6). The heritable genetic 
material carried by phages can take 4 forms: single stranded DNA (ssDNA), double 
stranded DNA (dsDNA), single stranded RNA (ssRNA) and double stranded RNA 
(dsRNA). However, dsDNA phages are by far the most well studied and most 
abundant group. The order of tailed dsDNA phages, Caudovirales, constitutes 96% 
of all known phages (Fokine and Rossmann, 2014) and the vast majority of known 
phages associated with the genus Salmonella belong to one of the three families of 
the Caudovirales; the Myoviridae, Siphoviridae and Podoviridae (Kropinski et al., 
2007). These families are differentiated based on further morphological features. The 
Myoviridae are characterised by a rigid contractile tail. The Siphoviridae have long, 
non-contractile tails and the Podoviridae have short, non-contractile tails. All three 
Caudovirales families contain both temperate and lytic phages. The lifecycle of a 
temperate phage (and a lysogenic cell), is shown in Figure 1.7. Temperate phage 
undergo a more complicated life cycle than that of lytic phage, which are only capable 
of infection leading to cell lysis. The process of lysogeny, particularly how phage enter 
into, and come out of, a latent state has been a topic of intense study for more than 
half a century, though much of the process remains a mystery or understood only in 
well-studied phage systems such as lambda. 
The beginning of both of the lytic and lysogenic phage life cycle is infection. In tailed 
phages, this process is usually mediated by interaction of the phage tail with specific 
receptors on the bacterial surface, a process known as adsorption. Once the phage 
has adsorbed, infection continues with the translocation of the phage nucleic acids 
from the phage capsid, into the bacterial cell. At this point, the lytic and lysogenic life 
cycles diverge. Temperate phages are capable of both lytic and lysogenic infection, 
and the complex molecular process that defines which path is taken is known as the 
lytic-lysogenic decision (Ptashne, 2004). Lysogeny is thought to be favoured in poor 
growth conditions, because phages require cells that are metabolically active to grow 
lytically. The lytic-lysogenic decision in phage lambda is tuned to the metabolism of 
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the cell by the fate of single protein CII, one of the first proteins to be synthesised by 
the incoming phage (Ptashne, 2004). 
 
 
 
Figure 1.6 Schematic representation of the major phage groups. Reproduced 
and adapted from Ackermann, 2006. The structural characteristics of all major phage 
groups are shown. The Caudovirales order of tailed phage are highlighted in blue, as 
the three phage families in this order: Myoviridae, Siphoviridae and Podoviridae are 
the most frequently associated with the Salmonella genus, and therefore most 
relenvant to this thesis. The Myoviridae are characterised by a rigid contractile tail. 
The Siphoviridae have long, non-contractile tails and the Podoviridae have short, non-
contractile tails.  
Caudovirales 
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The CII activator protein is rapidly degraded by host proteases in metabolically-active 
cells, which allows the lytic development of the phage. Inactive cells have low 
protease levels and therefore high levels of CII protein accumulates, driving the 
synthesis of the phage CI repressor and integrase proteins, to block the lytic 
replication of the phage and allow stable integration into the host chromosome.  
During lysogeny, the CI repressor is constitutively expressed, repressing the 
production of all genes required for phage replication (Ptashne, 2004). The prophage 
replicates concomitantly with the host genome unless an induction signal is detected. 
The induction of lambdoid prophages is tuned to the SOS response of the host cell. 
The bacterial SOS response is an ancient gene expression cascade which is activated 
by DNA-damage, and is conserved across the Bacterial kingdom (Baharoglu and 
Mazel, 2014; Erill et al., 2007; Kreuzer, 2013; Michel, 2005). Upon interaction with 
single-stranded DNA, the bacterial RecA protein becomes ‘activated’ (Sassanfar and 
Roberts, 1990). Though the exact molecular basis of RecA protein ‘activation’ is not 
fully understood, in the case of Salmonella phage P22, presence of activated-RecA 
is known to stimulate the autoproteolysis of the P22 repressor protein leading to de-
repression of phage replication genes (Campoy et al., 2006; Ptashne, 2004). 
Consequently, the phage lytic replication pathway proceeds. Specifically, the 
prophage excises from the host chromosome, replicates its DNA, synthesises and 
packages itself inside a protein capsid and tail, and induces cell lysis by the synthesis 
of proteins which hydrolyse the bacterial cell wall. The molecular processes and 
transcription events that control phage infection, and prophage induction are 
summarised in Figure 1.8. 
Though the process of prophage induction has likely evolved to allow prophages to 
efficiently escape from doomed host cells (frequently likened in the literature to rats 
leaving a sinking ship), prophages are unable to prevent the natural accumulation of 
mutations in their genome during generations in lysogeny. Consequently, wild-type 
bacterial strains frequently harbour prophages that have been inactivated by 
mutations. These prophages are known as defective, or cryptic prophages. For 
example, a strain of E. coli K-12 contained 9 defective prophage elements (Wang et 
al., 2010) and in Salmonella, prophage-derived elements have been estimated to 
represent up to 20% of the genome (Casjens, 2003). Frequently, genes encoding 
bacterial virulence factors are encoded on active or defective prophage elements 
(Brüssow et al., 2004).  
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Figure 1.7 The lifecycle of a temperate phage. The processes which lead to each 
cell-state are represented by arrows. The topmost state represents a cell containing 
a remnant prophage. All Salmonella genomes contain remnant phage genes. Phage 
DNA is shown represented in pink
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Figure 1.8 Schematics showing the paradigm of the phage lambda molecular 
genetic switch. Important molecular events governing each outcome is represented. 
Dashed lines indicate transcripts. Important promoters for each stage are shown in 
large bold text. A. During lytic infection N and Q protein antitermination allows late 
gene transcription. B. During lysogenic infection, CII protein activates CI repressor 
synthesis. C. During lysogeny, CI repressor protein is constitutively produced, 
preventing phage replication. Activation of the SOS response leads to the RecA-
dependent inactivation of the repressor protein.
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1.6 Temperate bacteriophages and the evolution of bacterial 
pathogens 
Temperate prophages have long been recognised to carry important virulence factors. 
Before the actual virulence factors were characterised, changes in the virulence of 
bacterial strains upon lysogenisation by prophages was recognised, and was termed 
‘lysogenic conversion’. The earliest reported examples of this phenomenon are 
lysogenic conversion of Corynebacterium diphtheriae by a phage designated β, by 
Victor Freeman (Freeman, 1951), who showed that previously avirulent C. diphtheriae 
strains could cause disease in guinea pigs once lysogenised. Much later, the protein 
toxin tox, carried by the β-phage was characterised and shown to be the cause of 
lysogenic conversion (Holmes, 2000). The gene encoding the C1 neurotoxin, carried 
by the C1 prophage of Clostridium botulinum is a second early example of a 
prophage-encoded gene responsible for the virulence of a notorious pathogen 
(Barksdale and Arden, 1974). Subsequently, many examples of prophage-encoded 
virulence factors, capable of mediating lysogenic conversion, have been described 
(Brüssow et al., 2004) (summarised in Table 1.3). In Salmonella, important prophage-
encoded virulence factors include the sodC gene of Gifsy-2 and the guanine 
nucleotide exchange factor carried by the ɸsopE prophage (Figueroa-Bossi & Bossi, 
1999 ; Mirold et al., 1999). 
Recently it has been recognized that prophages can contribute to bacterial virulence 
and physiology by more complex mechanisms than simply encoding virulence factors. 
For example, prophages that use attachment sites corresponding to important genetic 
loci can act as regulatory switches by integration and excision, such as the Com 
system of Listeria monocytogenes, where controlled prophage excision and 
reintegration is required during infection to promote bacterial escape from 
macrophage phagosomes (Rabinovich et al., 2012). Spontaneous phage induction 
can directly contribute to virulence in a number of other bacterial pathogens (Nanda 
et al., 2015). Prophage induction causes an increase in biofilm formation by releasing 
extracellular DNA in pathogens including Streptococcus pneumoniae and Shewanella 
oneidensis (Carrolo et al., 2010; Gödeke et al., 2011). More recently spontaneous 
prophage induction was shown to modulate Pseudomonas aeruginosa biofilm 
formation by stimulating biogenesis of membrane vesicles (Turnbull et al., 2016). 
Finally, it has been reported that phage-mediated lysis can function as a crude method 
of toxin delivery, facilitating human gingival fibroblast invasion by Aggregatibacter 
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actinomycetemcomitans  (Stevens et al., 2013), and enabling Stx toxin release in 
Shiga toxin-producing E. coli (Shimizu et al., 2009; Xu et al., 2012).  
The contribution of prophages to the evolution of bacterial pathogens is undeniable, 
but the reason for this association remains a topic of debate (Abedon and LeJeune, 
2007). One hypothesis that has widely prevailed in the literature is that the inclusion 
of virulence factors by prophages increases phage fitness indirectly, by increasing the 
fitness of the host cell. Whilst in the latent prophage state, the phage genome is 
replicated vertically with the bacterial chromosome, therefore, the fitness of the 
prophages is tied to that of the host cell. By increasing the success of the pathogen, 
the prophage increases the chance of its own survival.  
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Protein Gene Phage Bacterial host 
Extracellular toxins 
Diphtheria toxin tox β-Phage C. diphtheriae 
Neurotoxin C1 Phage C1 C. botulinum 
Shiga toxins stx1, stx2 H-19B E. coli 
Enterohaemolysin hly2 φFC3208 E. coli 
Cytotoxin ctx φCTX P. aeruginosa 
Enterotoxin see, sel NA Staph. aureus 
Enterotoxin P sep φN315 Staph. aureus 
Enterotoxin A entA φ13 Staph. aureus 
Enterotoxin A sea φMu50A Staph. aureus 
Exfoliative toxin A eta φETA Staph. aureus 
Toxin type A speA T12 Strep. pyogenes 
Toxin type C speC CS112 Strep. pyogenes 
Cholera toxin ctxAB CTXφ V. cholerae 
Leukocidin pvl fPVL Staph. aureus 
Superantigens 
speA1, speA3, speC, speI, s
peH, speM, speL, speK, ssa 
8232.1 Strep. pyogenes 
Cytolethal distending toxin cdt Unnamed E. coli 
Proteins altering antigenicity 
Membrane proteins Mu-like Pnm1 N. meningitidis 
Glucosylation rfb ε34 S. enterica 
Glucosylation gtr P22 S. enterica 
O-antigen acetylase oac Sf6 Sh. flexneri 
Glucosyl transferase gtrII SfII, SfV, SfX Sh. flexneri 
Effector proteins involved in invasion 
Type III effector sopE SopEΦ S. enterica 
Type III effector sseI (gtgB) Gifsy-2 S. enterica 
Type III effector sspH1 Gifsy-3 S. enterica 
Enzymes 
Superoxide dismutase sodC Sp4, 10 E. coli O157 
Superoxide dismutase sodC-I Gifsy-2 S. enterica 
Superoxide dismutase sodC-III Fels-1 S. enterica 
Neuraminidase nanH Fels-1 S. enterica 
Hyaluronidase hylP H4489A Strep. pyogenes 
Leukocidin pvl φPVL Staph. aureus 
Staphylokinase sak φ13 Staph. aureus 
Phospholipase sla 315.4 Strep. pyogenes 
DNase/streptodornase sdn, sda 315.6, 8232.5 Strep. pyogenes 
Serum resistance 
OMPb bor λ E. coli 
OMP eib λ-like E. coli 
Adhesions for bacterial host attachment 
Vir vir MAV1 M. arthritidis 
Phage coat proteins pblA, pblB SM1 Strep. mitis 
Others 
Mitogenic factors mf2, mf3, mf4 370.1, 370.3, 315.3 Strep. pyogenes 
Mitogenic factor toxA Unnamed P. multocida 
Virulence gtgE Gifsy-2 S. enterica 
Antivirulence grvA Gifsy-2, Fels-1 S. enterica 
Table 1.3 Prophage-encoded virulence factors and associated mechanisms of 
action. Adapted from Brüssow et al. (2004). 
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1.7 Aims and hypotheses 
Compelling evidence exists to implicate prophages in the evolution of bacterial 
pathogens. Due to their intrinsic mobility, prophages can rapidly modulate the disease 
phenotype of a bacterial population. It was therefore hypothesised that the prophage 
repertoire of S. Typhimurium ST313 has contributed to the epidemic of invasive non-
typhoidal Salmonella disease in the immunosuppressed human niche that is highly 
prevalent in sub-Saharan Africa. 
The aims of this project were as follows: 
 Functionally characterise the phage biology of each of the prophages found in 
the representative ST313 strain D23580 
 Assess the biological contribution of each of the prophages of D23580, by the 
construction and phenotypic screening of knock-out mutants for each 
prophage 
 Identify specific prophage genes which may modulate the phenotype of ST313 
representative strain D23580 
 Apply the findings from strain D23580 to strains representing the diversity of 
the ST313 population, to make broader conclusions about the contribution of 
prophages to the biology of this clinically-relevant sequence type.  
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Chapter 2 
Materials and Methods 
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2.1 Reagents and chemicals 
A list of chemicals and reagents used in this thesis, along with purchase suppliers can 
be found in Table 2.1. 
2.2 Media and antibiotics 
Recipes for all liquid and solid media used in this thesis are given in Table 2.1. All 
media were made up with water purified by de-ionisation and filtration to a standard 
of 18.2 MΩ/cm (dH2O). All media were sterilised by autoclaving using a standard 
sterilisation cycle of 121°C at 15 psi (100 kPa) above atmospheric pressure for 15 
minutes. InSPI2 media was not sterilized by autoclaving and instead by vacuum-
driven filtration through 0.22 µm SteritopTM filter unit (Millipore). All sugar solutions 
were sterilised by syringe-driven filtration using Millex-GP 0.22 µm (Hydrophilic 
Polyethersulfone 33 mm) filter units and added to media post-autoclave, or before 
vacuum-driven filtration. Once prepared, all solid media was kept at 4°C until use. 
Lysogeny broth (Lennox formulation) (LB) contained 10 g tryptone, 5 g yeast extract 
and 5 g NaCl per litre (pH 7.0). When required, LB was supplemented with the 
following antibiotics: ampicillin (Ap), 100 µg/ml; chloramphenicol (Cm), 25 µg/ml; 
kanamycin (Km), 50 µg/ml; gentamicin (Gm), 20 µg/ml; oxytetracycline (OxyTc), 10 
µg/ml; tetracycline (Tc), 20 µg/ml. Antibiotic stock solutions were made in dH2O, 
Ethanol, Methanol or NaOH as specified in Table 2.1. Stock concentration and final 
concentrations of all antibiotics used are given in Table 2.1. All antibiotic stock 
solutions were aliquoted and stored at -20°C and thawed on ice before use.  
Agar plates were prepared by aliquoting approximately 25 ml of molten LB bacto-agar 
(1.5%) cooled to 50°C into sterile petri dishes. Lids were left ajar under sterile 
conditions to allow the plates to cool and dry for 30 minutes. Agar plates were stored 
in sealed plastic bags at 4°C. Where agar was supplemented with antibiotics, stock 
solutions were added to the agar at 50°C and mixed thoroughly before pouring the 
plates. 
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Table 2.1 Chemicals and reagents used in this thesis, including the supplier 
and catalogue numbers. Reagents are listed in order of use in media, so that media 
recipes can be referenced. The stock and final concentrations (including solvent) are given 
where appropriate. 
Use 
Chemical/ 
Reagent 
Source 
Cat 
number 
Stock conc. 
used 
Final conc. 
used 
LB media  
Tryptone Appleton Woods MN649 N/A 10 g/L 
Bacto-Yeast 
Extract Appleton Woods DM832 N/A 5 g/L 
NaCl Sigma-Aldrich  S3014 N/A 5 g/L 
Bacto-agar Appleton Woods 214010 N/A Various 
            
inSPI2 
media 
MES (pH 
5.8) Sigma-Aldrich  M8250 400 mM 80 mM 
Tricine Sigma-Aldrich  T5817 400 mM 4 mM 
FeCl3 Sigma-Aldrich  236489 100 mM 100 µM  
K2SO4 Sigma-Aldrich  P0772 376 mM 376 µM 
K2HPO4 Sigma-Aldrich  60353 100 mM 0.4 mM 
KH2PO4 Sigma-Aldrich  P8416 100 mM 0.4 mM 
Glucose Sigma-Aldrich  G8270 20% 0.4% 
NH4Cl Sigma-Aldrich  A9434 1.5 M 15 mM 
MgSO4 Sigma-Aldrich  83266 1 M 1 mM 
CaCl2 Sigma-Aldrich  C3306 1 M 0.01 mM 
Na2MoO4 Sigma-Aldrich  737860 100 μM  10 μM  
Na2SeO3 Sigma-Aldrich  S5261 100 μM  10 nM 
H3BO3 Sigma-Aldrich  B6768 4 μM  4 nM 
CoCl2 Sigma-Aldrich  C8661 3 mM 300 nM 
CuSO4 Sigma-Aldrich  C1297 1 mM 100 nM 
MnCl2 
(tetrahydrate) Sigma-Aldrich  529680 8 mM 800 nM 
ZnSO4 Sigma-Aldrich  Z4750 10 μM  1 nM 
            
Green plate 
media 
Tryptone Appleton Woods MN649 N/A 8 g/L 
Bacto-yeast 
extract Appleton Woods DM832 N/A 1 g/L 
NaCl Sigma-Aldrich  S3014 N/A 5 g/L 
Bacto-agar Appleton Woods 214010 N/A 11 g/L 
Methyl Blue Sigma-Aldrich  M6900 N/A 0.1 g/L 
Alizarin 
Yellow Sigma-Aldrich  206709 N/A 0.6 g/L 
Glucose Sigma-Aldrich  G8270 20% 0.7% 
            
M9 Salts 
Na2HPO4 Sigma-Aldrich  S9390 N/A 64 g/L 
K2HPO4 Sigma-Aldrich  60353 N/A 15 g/L 
NaCl Sigma-Aldrich  S3014 N/A 2.5 g/L 
NH4Cl Sigma-Aldrich  A9434 N/A 5 g/L 
            
M9 Media 
M9 salts (5X) N/A N/A 5X 1X 
Glucose Sigma-Aldrich  G8270 20% 0.4% 
MgSO4 Sigma-Aldrich  83266 1 M 2 mM 
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CaCl2 Sigma-Aldrich  C3306 1 M 0.1 mM 
            
Media 
supplement 
Mitomycin C Sigma-Aldrich  M4287 
2 mg/ml 
(H2O) 2 μg/ml 
Kanamycin 
mono-
phosphate Melford K0126 
50 mg/ml 
(H2O) 50 μg/ml 
Tetracycline Sigma-Aldrich  87128 
20 mg/ml 
(Methanol) 20 μg/ml 
Ampicillin 
sodium salt Melford A0104 
100 mg/ml 
(H2O) 100 μg/ml 
Chloramphen
icol Sigma-Aldrich  C0378 
20 mg/ml 
(Ethanol) 20 μg/ml 
Nalidixic acid Sigma-Aldrich  N8878 
50 mg/ml 
(H2O) 50 μg/ml 
Gentamicin 
sulphate Melford G0124 
40 mg/ml 
(H2O) 20 μg/ml 
L-Arabinose Sigma-Aldrich  A3256 20% (H2O) 0.20% 
m-toluic acid Sigma-Aldrich  T36609 
0.5 M 
(NaOH) 1 mM 
 Congo red Sigma-Aldrich C6767 N/A 40 μg/ml 
 H2O2 (30%) Merck Millipore 107209 N/A 20 µl/ml 
            
Protocol 
reagent 
Chloroform Sigma-Aldrich  C2432 N/A N/A 
Isopropanol Sigma-Aldrich  19516 N/A N/A 
Ethanol Sigma-Aldrich  469836 N/A N/A 
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2.3 General bacterial methods 
2.3.1 Bacterial strains and culture conditions 
A list of strains and plasmids used in this study can be found in Table 2.2. Bacteria 
were routinely cultured in glass universal bottles in a volume of 5 ml LB broth 
inoculated from single colonies on LB plates for 16 hours at 37°C with shaking at 220 
rpm (this procedure is referred to in this thesis as ‘overnight culture’). Unless 
otherwise stated, for experiments, overnight cultures were used to sub-inoculate 
1:1000 in 25 ml LB broth in 250 ml sterilize Erlenmeyer flasks and grown at 37°C with 
220 rpm agitation. For growth in minimal media, 1 ml of overnight culture was 
harvested by centrifugation at 12,000 x g at room temperature for 1 minute. Cell 
pellets were washed three times in minimal media and sub-inoculated 1:500 in 25 ml 
of minimal media in 250 ml sterilized Erlenmeyer flasks and grown at 37°C with 220 
rpm agitation. Optical density (OD) measurements were taken using a Jenway 67-
series spectrophotometer at a wavelength of 600 nm. When colony forming unit (CFU) 
counts were required, 10-fold serial dilutions of cultures (up to a factor of 10-8) were 
carried out in sterile LB broth and triplicate 10 µl drops plated on LB agar plates (Miles 
and Misra method). CFU counts are given in units per ml (CFU/ml). Frozen stocks of 
all bacterial strains were kept at -80°C for the duration of the work. To prepare frozen 
stocks, overnight cultures were mixed with sterile (autoclaved) 50% glycerol to a final 
concentration of 20% in a 1.5 ml volume in a sterile 2 ml cryovial tube (i.e. 900 µl 
overnight and 600 µl 50% glycerol). Bacterial colonies were maintained on agar plates 
at 4°C for a maximum of 1 week. 
2.3.2 Motility assays 
0.3% LB agar was made-up and whilst molten, exactly 25 ml of agar were aliquoted 
into petri dishes to ensure minimal variation in agar depth between plates. The plates 
were left to dry at room temperature overnight (16 hours). 3 µl of overnight cultures 
were spotted on to the 0.3% LB agar plates. Care was taken not to pierce the agar 
surface with the pipette tip. Plates were left at room temperature for 30 minutes before 
incubation at 37°C for 5 hours. Motility was assessed by measurement of the diameter 
of migration. All strains were tested independently in triplicate. 
2.3.3 RDAR morphotype assays 
The methodology used to assay RDAR morphology was based a recent publication 
(Singletary et al., 2016). 2 µl of overnight bacterial cultures was spotted onto two sets 
of LB plates without NaCl and supplemented with 40 µg/ml Congo red (Table 2.1). 
Plates were incubated in parallel at 25°C and 37°C for 7 days without inversion. To 
avoid drying of the agar over the prolonged incubation time, plates were incubated 
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within a plastic bag. All experiments were conducted in triplicate. After 7 days colonial 
morphology was photographed using the ImageQuant LAS 4000 imager (GE 
Healthcare). The presence of a filamentous, patterned texture of the colony at 25°C 
indicated RDAR morphology, whereas smooth colony morphology was judged to be 
RDAR negative. RDAR morphology does not form at 37°C therefore this condition 
acted as a negative control.
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Table 2.2 All bacterial strains used in this thesis.  
Bacterial strains Description a References/origin 
S. Typhimurium  
D23580 derivatives 
JH3621 D23580 WT (Kingsley et al., 2009) 
JH3810 ∆BTP1::FRT This study 
JH3798 ∆BTP5:FRT This study 
JH3874 ∆Gifsy-1 (Owen et al., 2017) 
JH3875 ∆Gifsy-2 (Owen et al., 2017) 
JH3877 ∆BTP1 (Owen et al., 2017) 
JH3878 ∆BTP5 (Owen et al., 2017) 
JH3881 ∆BTP1 ∆BTP5 (Owen et al., 2017) 
JH3940 ∆BTP1 ∆BTP5 ∆Gifsy-1 (Owen et al., 2017) 
JH3942 ∆BTP1 ∆BTP5 ∆Gifsy-1 ∆Gifsy-2 (Owen et al., 2017) 
JH3949 ∆Φ (∆BTP1 ∆BTP5 ∆Gifsy-1 ∆Gifsy-2 ∆ST64B)  (Owen et al., 2017) 
JH3983 ∆Gifsy-1, aph-galE496; KmR (Owen et al., 2017) 
JH3984 ∆Gifsy-2, aph-galE496; KmR (Owen et al., 2017) 
JH3986 ∆ST64B (Owen et al., 2017) 
JH3987 
PdinI-gfoA from 14028s (C→T substitution, 
position 2,790,162 in D23580 chromosome) 
(Owen et al., 2017) 
D23580 BTP5::KmR BTP5::KmR (insertion of aph in BTP5); KmR This study 
D23580∆BTP1 
BTP5::KmR 
∆BTP1 BTP5::KmR (insertion of aph in BTP5); 
KmR 
This study 
D23580 ΔrecA 
D23580 with recA gene replaced with nptII from 
pKD13 and subsequently flipped out using the Flp 
recombinase-encoding pCP20 plasmid 
(Owen et al., 2017) 
D23580 ST313-tdSTOP 
D23580 with two stop codons introduced into the 
beginning of the ST313-td gene sequence (total 
change of 4 nucleotides) 
This study 
14028s derivatives 
MA5958 14028s, WT L. Bossi  
MA6684 ∆Gifsy-1 ∆Gifsy-2 bio-106::Tn10 galE496; TcR 
L. Bossi (Campoy et al., 
2006) 
LT2 derivatives 
LT2 LT2, WT 
(Zinder and Lederberg, 
1952) 
MA8508 
Gifsy-1[-] Gifsy-2[-] Fels-2[-] Fels-1[Δ(int-
attR)104::cat] 
L. Bossi (Lemire et al., 
2011) 
LT2 [BTP1] 
LT2 derivative MA8508 lysogenised with phage 
BTP1 
(Owen et al., 2017) 
LT2 [P22] 
LT2 derivative MA8508 lysogenised with phage 
P22 (wildtype) 
(Owen et al., 2017) 
LT2 Δrec 
LT2 derivative MA8508 with recA gene replaced 
with nptII from pKD13 and subsequently flipped 
out using Flp recombinase encoding pCP20 
plasmid 
(Owen et al., 2017) 
4/74 derivative 
 4/74, WT (Rankin and Taylor, 1966) 
JH3864 ∆Gifsy-2 N. Wenner 
JH3865 ∆Gifsy-1 N. Wenner 
JH3866 ∆Gifsy-1 ∆Gifsy-2 N. Wenner 
JH3880 ∆ΦSopE N. Wenner 
E. coli 
S17-1 λpir 
pro thi hsdR recA chromosome::RP4-2 Tc::Mu 
Km::Tn7/λpir; TpR, SmR 
(Simon et al., 1983) 
a Relevant antibiotic resistances are indicated by R: Ap, ampicillin; Gm, gentamicin; Km, kanamycin, OxyTc, oxytetracyline; Sm, 
streptomycin; Tc, tetracycline; Tp, trimethoprim. For clarity purposes, the natural resistances of D23580 and its derivative are not 
indicated. 
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2.3.4 Stationary phase catalase activity assay 
Catalase activity was assayed based on previously described methods (Singletary et 
al., 2016). 20 µl of 20% aqueous H2O2 was added to 1 ml of bacterial overnight culture 
in 1 cm diameter glass test tubes and briefly vortexed to homogenise the suspension. 
Tubes were incubated at room temperature for 5 minutes and subsequently 
photographed and the height of the bubble column measured. Assays were 
conducted in triplicate. 
2.3.5 Antibiotic resistance typing 
Phenotypic antimicrobial susceptibility testing was carried out at Public Health 
England, Collindale for all UK-isolated ST313 strains. The antimicrobial susceptibility 
testing was done using breakpoint concentrations. Briefly, an agar dilution method 
involving Iso-sensitest agar or Muller-Hinton agar was used to determine if isolates 
were sensitive or resistant to a set concentration of individual antimicrobials (Table 
2.3). 
 
 
Antibiotic Concentrations tested 
Ampicillin 8 mg/L 
Chloramphenicol 8 and 16 mg/L 
Colistin 2 mg/L 
Sulphonamide 256 mg/L 
Gentamicin 2 mg/L 
Tobramycin 8 mg/L 
Amikacin 8 mg/L 
Streptomycin 16 mg/L 
Tetracycline 8 mg/L  
Trimethoprim 2 mg/l  
Nalidixic Acid 16 mg/L 
Ciprofloxacin  0.064 and 0.5 mg/L 
Ceftazidime 1 and 2 mg/L 
Cefotaxime 0.5 and 1 mg/L 
Cefoxitin 8 mg/L 
Cefpirome 8 mg/L  
Ertapenem 0.064 and 0.5 mg/L 
Temocillin 128 mg/L. 
  
Table 2.3 Antibiotic concentrations used for antimicrobial resistance typing of 
UK-isolated ST313 strains carried out by PHE (Chapter 4). 
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2.3.6 Microscopy and preparation of samples 
An EVOS FL cell imaging system (Thermo Fisher) fitted with a GFP light cube (470/22 
nm excitation, 525/50 nm emission) was used to visualise cells under transmitted light 
and fluorescent light with an EVOS 40X flurorite coverslip-corrected objective 
(Thermo Fisher, AMEP4699) and an Olympus 100X super-apochromat, coverslip-
corrected oil objective (Thermo Fisher, AMEP4733). 2 µl of cell samples were pipetted 
onto glass microscopy slides and covered with a glass coverslip. Where cell fixing 
was required, cell samples were pelleted by centrifugation at 11,000 Xg for 2 minutes, 
and washed in PBS buffer (Melford, P3203). Cells were further pelleted and 
resuspended in 4% paraformaldehyde PBS for 20 minutes at room temperature. Cells 
were again pelleted and resuspended in PBS ready for microscopy. Where the 100X 
objective was used, a drop of immersion oil (Sigma-Aldrich, 56822) was applied to 
the objective before imaging. 
2.4 Phage and prophage methods 
2.4.1 Phages 
All phages were propagated on the strain D23580 ΔΦ (JH3949; Table 2.2). This strain 
contains no prophages, so lysates produced from phage replication on this strain 
cannot be contaminated by induced native prophages. Phage lysates were clarified 
by centrifugation at 12,000 x g for 2 minutes and syringe filtration through a 0.22 µm 
filter. Lysates were routinely stored at 4°C for the duration of the project. 
2.4.2 Phage enumeration and plaquing 
Phage enumeration and plaque isolation were carried out using the double layer agar 
technique. Where enumeration of spontaneously induced phage in overnight cultures 
was required, 1 ml of overnight culture was passed through a 0.22 µm syringe filter. 
For enumeration, phage lysates or culture supernatants were serially diluted by orders 
of 10 in sterile LB broth. For overnight culture supernatant, dilution up to 10-7 was 
sufficient, whereas for phage lysates, higher dilutions were required (typically up to 
10-10). 4 ml of 0.4% LB agar was seeded with 100 µl of and overnight culture of the 
required indicator strain (approximately 108 CFU) and, once dry, phage dilutions were 
applied to the cell lawn in 10 µl drops. Once dried, plates were incubated overnight at 
37°C. Phage concentrations were calculated as plaque forming units (PFU) per ml of 
lysate or culture supernatant (PFU/ml). 
2.4.3 Isolation of phage lysogens 
Exponential phase cultures of susceptible host strains and phage were mixed and 
plated using the double layer agar technique as described above. Turbid centres from 
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BTP1 or P22 containing plaques were identified using primers for the pid gene, 
pid_Fw and pid_Rev (Table 2.4). Turbid plaque centres that were positive for pid were 
further picked and purified on green indicator plates (Table 2.1) (Maloy, 1990). This 
medium contains glucose as a carbon source, and a pH indicator dye that turns dark 
green at sites where phage infection causes cell lysis and the concomitant release of 
organic acids, while the lysogens remain pale green. Candidate lysogens were picked 
onto fresh green plates and cross streaked against phage to confirm resistance of the 
lysogens to superinfection by the target phage. 
2.4.4 Determination of prophage viability 
Viable phages were detected in the supernatant of D23580 WT after 16 h culture. To 
stimulate chemically mediated prophage induction, mitomycin C (Sigma-Aldrich 
M4287) was added to exponentially growing cultures (OD600 = 0.3) at a final 
concentration of 2 µg/ml. Phages were enumerated using the double layer agar 
technique as described above using specific indicator strains to detect each phage 
(Table 3.2). Prophage viability was defined as the ability to form infective phage 
particles with or without chemical induction. 
To determine the viability of the BTP5 prophage, supernatant from a 16 h culture of 
the D23580 BTP5::KmR strain was passed through a 0.22 µm filter. 100 µl of filtered 
supernatant was added to 100 µl of D23580 ∆BTP5 and incubated for 1 h before 
selection on LB Km. Colonies were screened for insertion of the BTP5::KmR prophage 
using primers BTP5_int_fw, BTP5_int_rv, BTP5_attB_fw and BTP5_attB_rv to detect 
both the presence of internal BTP5 sequence and disruption of the chromosomal 
attachment site. The experiment was repeated using supernatant from one of the 
isolated BTP5::KmR lysogens to confirm the efficiency of lysogenization (number of 
colonies per ml of supernatant) was approximately the same, indicating that no 
resuscitation of the BTP5 prophage had occurred. 
2.4.5 BTP1 burst size and spontaneously-induced population estimation 
Burst size determination was achieved using the single step growth curve protocol 
previously described (Hyman and Abedon, 2009). Briefly, 50 µl of exponentially 
growing D23580 ΔBTP1 cells (OD600 = 0.3) at a density of 108 CFU/ml were mixed 
with 50 µl BTP1 phage at a density of 107 PFU/ml to achieve a multiplicity of infection 
(MOI) of approximately 0.1. After 5 minutes adsorption time at 37°C, 1 µl of the cell-
phage mixture was diluted 1000X by addition of 999 µl sterile LB, in order to minimise 
further adsorption. Free (non-adsorbed) phages were enumerated by plaque assay 
on a susceptible indicator strain as described above. The number of infected cells 
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was calculated as: [(number of cells x MOI) - number of unabsorbed phage]. 
Subsequently, the number of free phage was enumerated by sampling and filtration 
every 10 minutes. The difference between the phage titer pre- and post-burst divided 
by the number of infected cells was determined to be the burst size. The duration of 
time between infection and burst was determined as the latent period. 
The percentage of the population undergoing spontaneous induction was estimated 
as [(100 / average number of cells in 16 h culture) / (average number of phage in 16 
h culture / burst size)]. 
2.4.6 Adsorption assays 
Overnight cultures were used to re-inoculate fresh 25 ml cultures, and cells were 
grown until OD600 2.0 (≈2x108 CFU/ml). Phage suspensions were normalised to a 
concentration of ≈1x108 PFU/ml. 1 ml of cells were mixed with 1 µl phage suspension 
to achieve an MOI of approximately 0.01. A low MOI was used to maximise the 
adsorption efficiency. The cell and phage suspension were incubated with agitation 
for 5 minutes to allow adsorption to occur. The suspension was centrifuged at 7,000 
x g for 5 minutes to pellet cells and adsorbed phage. The titer of free-phage remaining 
in the supernatant was determined by titration and spotting as described in 2.3.2. A 
no-cell control (1 ml of sterile LB medium) was used as negative control. The level of 
reduction of free-phage PFU/ml in the absorbed supernatant vs. the negative control 
indicates the efficiency of adsorption of the phage. Absorption assays were conducted 
in triplicate. 
2.4.7 BTP1 genomic DNA isolation and sequencing 
A pure BTP1 phage stock was produced by picking and resuspending a BTP1 plaque 
in sterile LB and plating on indicator strain D23580 ΔΦ. This process was repeated 
three times to ensure purity and clonality. A high titer BTP1 lysate (~1011) was 
produced by mixing 10 µl of BTP1 plaque suspension with 5 ml of exponential phase 
(OD600= 0.3) D23580 ΔΦ. BTP1 virions were concentrated by polyethylene glycol 
(PEG) precipitation. Briefly, 1 ml of PEG-8000 20% NaCl 2.5 M was added to 4 ml 
BTP1 lysate and incubated on ice for 2 h. Subsequently the mixture was centrifuged 
at 15,000 x g for 1 hour at 4°C and liquid decanted. The pellet was resuspended in 
50 µl molecular grade water and treated with DNase I for 1 hour at 37°C to remove 
any contaminating bacterial DNA. Subsequently the sample was heated to 90°C for 
10 minutes to simultaneously deactivate DNase I and release BTP1 DNA from 
capsids. BTP1 DNA was purified using the Zymo Research Quick-DNATM Universal 
Kit (cat# D4069) as per the “Biological Fluids & Cells” protocol and eluted in 15 µl 
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molecular grade water. Preparation of sequencing libraries and sequencing were 
performed by Tamsin Redgwell and Andy Millard at the Warwick Medical School, 
University of Warwick, UK. Sequencing libraries were prepared using the Illumina 
Nextera XT DNA sample kit per the manufacturer’s protocol (Illumina, USA) with 1 ng 
of input DNA. Sequencing was performed on an Illumina MiSeq instrument using V2 
chemistry (2 x 250 bp). Sequencing reads were quality trimmed using Sickle (Joshi 
and Fass J. N., 2011) and assembled using Spades (Bankevich et al., 2012). The 
assembly was manually reordered to begin at the small terminase. Functional 
annotation was transferred from the D23580 (FN424405) prophage BTP1 sequence 
using Prokka 1.11 (Seemann, 2014). Read data, assembly and functional annotation 
were deposited at the DDBJ/EMBL/GenBank database under the sample accession 
LT714109 (URL: http://www.ebi.ac.uk/ena/data/view/LT714109) and study accession 
PRJEB18919. 
2.4.8 Transmission electron microscopy of phage (TEM) 
To prepare samples for TEM, 10 µl of the culture supernatant from a D23580 
overnight culture was pipetted onto a carbon/Pioloform-coated copper 200-mesh grid, 
and allowed to adhere for 10 minutes. To image phage infections, the supernatant of 
a 16 h D23580 culture containing virions was added to mid-exponential phase S. 
Typhimurium 4/74 (OD600 = 0.3) cells in LB media, and incubated at 37°C for 20 
minutes before TEM sample preparation. The grids were subsequently washed twice 
in distilled water for 2 minutes, negative stained with 2% uranyl acetate for 1 minute 
and examined using a FEI 120 kV Tecnai G2 Spirit BioTWIN transmission electron 
microscope at the EM Unit, University of Liverpool. 
2.5 Molecular genetic techniques 
2.5.1 Primers, plasmids and Sanger sequencing 
All primers and plasmids used in this study are listed in Table 2.4 and 2.5 respectively. 
All primers were purchased from MWG Eurofins (Germany) and were HPSF purified. 
All plasmids used in this study were isolated from E. coli strains using the ISOLATE 
II Plasmid Mini Kit (Bioline) following the manufacturer’s instructions except column 
elution was always carried out in molecular grade H2O. All Sanger sequencing was 
carried out by GATC Biotech AG (Germany) using the LIGHTRUN or SUPREMERUN 
protocols.
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Oligo name Sequence (5’→3’) Purposes 
BTP5_int_fw GAACGATGCGCCAATACCAC Amplification of a 
260bp product in 
BTP5 lysogenic 
strains 
BTP5_int_rv CATGCGTGCCGGTTAATGAG 
BTP5_attB_fw CGGCTGGATTACAGCGTAAA Amplification of a 
167bp if attachment 
site empty. No 
product if occupied 
BTP5_attB_rv AGGCCACTCTTTAGAGTGGC 
NW_1 ACGTGAATTCGCTGGTGCCGACGAACCATG (EcoRI) Amplification of 
attBGifsy-2 from 
MA6684, pNAW16 
construction 
NW_4 AGCTGGATCCAACGTACAGTTCTAATGCG (BamHI) 
NW_26 ACGTGAATTCCAATGATTAAAGAGTGGGC (EcoRI) Amplification of 
attBGifsy-1 from 
MA6684, pNAW15 
construction 
NW_29 ACGTGGATCCAGGATATCTTTAATGGCGC (BamHI) 
NW_52 ACGTGAATTCTAGCAGCGCAGACATCGCC (EcoRI) Amplification of 
attBBTP1 from 4/74, 
pNAW17 construction 
NW_53 ACGTGGATCCGAAGGCTGGCTTTATCTGGC (BamHI) 
NW_54 ACGTGAATTCATCAGGCCATGCGCAAGCG (EcoRI) Amplification of 
attBBTP5 from 4/74, 
pNAW18 construction 
NW_55 ACGTGGATCCCTGGGCTTTGACGATCAC (BamHI) 
NW_61 GCGGGTTATAACGGCGATG 
galE496 sequencing 
NW_82 GAAAAGAATTCTCAGTTCCGTCAAGTTC (BamHI) 
NW_86 
GTCGGGGCGCTCGCCAGGAAGCTACTCTCGCGTAAAAA
AG 
Insertion of KmR in 
STM0777-galE 
intergenic region NW_87 ACTGACATATGAATATCCTCCTTAG 
NW_161 
ACTTCGGAATAGGAACTTCAAGATCCCCTAGGGATAACA
GGGTAATCACGCTGCCGCAAGCACTCAGGGCGC (I-SceI) Construction of pKD4-
I-SceI NW_162 
GCGCCCTGAGTGCTTGCGGCAGCGTGATTACCCTGTTAT
CCCTAGGGGATCTTGAAGTTCCTATTCCGAAGT (I-SceI) 
NW_179 ACGTGAATTCTCGATACGCTGCTCAATGTAG (EcoRI) Amplification of 
attBST64B from LT2, 
pNAW42 construction 
NW_180 ACGTGGATCCAACATTCAGCAGGGTCGGTG (BamHI) 
NW_194 GCCAGAGCTTTGCCAGCCG Modification of PdinI-
gfoA in D23580, 
construction of 
JH3987 
NW_195 GACGGATGGTTAAGTTGCAG 
NW_196 GGTTATGTAGCTTCTCTATGC PdinI-gfoA 
sequencing in JH3987 NW_197 GCAGGATGCTCTGTATACG 
NW_214 
ATTCTCATAATTCCCTCTACATTTAACTACTGTATATAAAC 
ACTAGGGATAACAGGGTAATC (I-SceI) 
Modification of PdinI-
gfoA in D23580, 
construction of 
JH3987 
NW_215 
GCAAAAAGTGCTATTCACCTCTTGAATATTCTTTCTAACA
G GTATCATTTCGAACCCCAGAGTCC 
BTP5_kan_f 
GCGGAATTTCTCCCGGTAGTCGATGCATAATATCGCCCT
CAATGAATTTTGTGTAGGCTGGAGCTGCTTC Insertion of KmR in 
BTP5 BTP5_kan_r 
TGGGACGTTACCTTAGCGGGTTTTATAGTGGCGCTTTGA
CGACACTAAATCATATGAATATCCTCCTTAG 
BTP5_kan_ext_f CTGCTGGCGTCAGGTTCTCA Sequencing of KmR 
insertion in BTP5 BTP5_kan_ext_r GCGTTTGTCCTGCCTTTCAA 
pid_Fw GCCCAAATCGCCGCTTGC Amplification of 380bp 
product in BTP1 
lysogenic strains 
pid_Rev GATTATTGTTGCGTGCCC 
RecA_pKD13_F
w 
GTACGAATTCACTATCCGGTTCAATACCAAGTTGCATGAC
AGGAGTAATAGTGTAGGCTGGAGCTGCTTC Construction of LT2 
ΔrecA RecA_pKD13_R
ev 
GTTTTGCTGAATGGCGGCTTCGTTTTGCCCGCCCCACCA
TCACCTGATGACATATGAATATCCTCCTTAG 
03761_gfp_2_L_
f 
ATTATTGTTCTGTAAACTTAAAGCAATGATCTGGTTGGTA
TAAATGTTCTAGATTTAAGAAGGAG 
Amplification of gfp+ 
gene from pZEP08 
with flanking ends of 
intergenic BTP1 site 
and pKD4 kanamycin 
gfp_kan_2_L_r 
CTAAGGAGGATATTCATATGGCGACCGGCGCTCAGCTG
GA 
gfp_kan_2_R_f 
TCCAGCTGAGCGCCGGTCGCCATATGAATATCCTCCTTA
G 
Table 2.4 All oligonucleotide primers used in this thesis 
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03761_gfp_2_R_
r 
GCCCATCTGGACTATCTCAACTAGTCGATTCATGACATGT
GTCACGTGTAGGCTGGAGCTGCTTC 
Amplification of 
kanamycin reistance 
construct from pKD4 
with flanking ends of 
gfp+ gene from 
pZEP08 and 
intergenic BTP1 site 
03761_gfp_ext_f CTAAGATTGCTATCACACTG Amplification of region 
external to the  gfp-
KmR insertion in 
BTP1 to verify 
insertion 
03761_gfp_ext_r TGATGCCGAGCACGCCCATCT 
late_gfp_2_L_f 
TTCCTAATTCAATAGAGCAAATCCCCTCAATAAAGGGGGT
AGAGCGTTCTAGATTTAAGAAGGAG 
Alternative primer to 
03761_gfp_2_L_f for 
replacement of BTP1 
late genes with gfp-
KmR 
late_gfp_2_R_r 
TAAGATAAATTTACATGGGTGCTTGTCACCCATGTTTTAC
AATATGTGTAGGCTGGAGCTGCTTC 
Alternative primer to 
03761_gfp_2_R_r for 
replacement of BTP1 
late genes with gfp-
KmR 
aacA1_F 
(NW_88) 
CTAAATACATTCAAATATGTATCCGGTCCAACCAGCGGCA
CCAG 
Construction of in 
pPL-Gm : PCR 
Amplification of 
aacC1 of pME4510 by 
overlap extension 
PCR cloning into pPL 
(pJV300) 
aacA1_R 
(NW_89) 
GTAAACTTGGTCTGACAGTTACCAATTAGGTGGCGGTAC
TTGGG 
Late_gfp_ext_f AACACAGTATCCTGGATTTGTTCTA Amplification of region 
external to late genes 
to confirm insertion of 
the gfp-KmR cassette 
Late_gfp_ext_r TGCTTAACAAGGGTAGGTGATGGCC 
waaL_del_fw 
AGATTCATTAAAGAGACTCTGTCTCATCCCAAACCTATTG
TGGAGAAAAGGTGTAGGCTGGAGCTGCTTC Insertion of KmR in 
place of waaL waaL_del_rv 
CCTGATGATGGAAAACGCGCTGATACCGTAATAAGTATC
AGCGCGTTTTTCATATGAATATCCTCCTTAG 
waaL_ext_fw ACAAGCGTATTTGGAAAGATTCATTAAAG Amplication of region 
external to waaL 
deletion 
waaL_ext_rv CTGGTTTGATAAGTGATTGAGTCCTGATG 
BTP1_ko_oligo_f
w 
AATGCGAAGGTCGTAGGTTCGACTCCTATTATCGGCACC
AGTTAAATCAAGTGTAGGCTGGAGCTGCTTC 
Insertion of KmR in 
BTP1 attachment site 
in strain 4/74 
BTP1_ko_oligo_r
v 
TAGATGGTGCCGATAATAGGAGTCGAACCTACGACCTTC
GCATTACGAATCATATGAATATCCTCCTTAG 
BTP1_JP_fw CGTGAACACACCCTTCTCAG External to BTP1 
attachment site. Used 
to confirm absense of 
BTP1 prophage 
BTP1_JP_rv ACTCATGGCGCATGGTAAAC 
snp_BTP1_left_f
w 
AGCGCTTTCTGAACGCCCGA 
Diagnostic PCR of 
closest SNP to BTP1 
between D23580 & 
4/74 in the 40 Kb 
upstream of the 
BTP1 prophage 
snp_BTP1_left_r
v 
CATCACTGTTATAACGGCTG 
snp_BTP1_right_
fw 
ATTGCTGCCGGTTTTGAATG 
Diagnostic PCR of 
closest SNP to BTP1 
between D23580 & 
4/74 in the 40 Kb 
downstream of the 
BTP1 prophage 
snp_BTP1_right_
rv 
AGAATTGGTATCAGCACTCG 
BTP5_KO_fw 
GCAGGCGACTCATAATCGCTTGGTCGCTGGTTCAAGTCC
AGCAGGGGCCAGTGTAGGCTGGAGCTGCTTC 
Insertion of KmR in 
BTP5 attachment site 
in strain 4/74 BTP5_KO_rv 
AATTTGGTGGCCCCTGCTGGACTTGAACCAGCGACCAAG
CGATTATGAGTCATATGAATATCCTCCTTAG 
BTP5_ext_fw CGGCTGGATTACAGCGTAAA External to BTP5 
attachment site. Used BTP5_ext_rv AGGCCACTCTTTAGAGTGGC 
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to confirm absense of 
BTP1 prophage 
snp_BTP5_left_f
w 
CCAGGTGATAACCTCGCGCC 
Diagnostic PCR of 
closest SNP to BTP1 
between D23580 & 
4/74 in the 40 Kb 
downstream of the 
BTP5 prophage 
snp_BTP5_left_r
v 
ATAATGCGGGTAAGTTCGCC 
snp_BTP5_right_
fw 
GGCCGCCTGACGATTATGGC 
Diagnostic PCR of 
closest SNP to BTP1 
between D23580 & 
4/74 in the 40 Kb 
downstream of the 
BTP5 prophage 
snp_BTP5_right_
rv 
GTATCAGTGGCCTGTGATGT 
ST313td_L_bam
_f 
GGCCGGATCCATAATGCGCTCTTGG 
Amplification of 
ST313td gene with 
stop codon mutation 
for construction of 
pEMG::ST313tdSTO
P 
ST313td_L_bam
_r 
AAATGGTTAATTAAATATAGTCCATATCACCCCGCC 
ST313td_R_eco
_f 
GGTGATATGGACTATATTTAATTAACCATTTGATTT 
Amplification of 
ST313td gene with 
stop codon 
mutation for 
construction of 
pEMG::ST313tdST
OP 
ST313td_R_eco
_r 
GGCCCTTAAGTCGAGAATTCGTGGA 
ST313_STOP_s
eq_f 
ATACTCAAGAATTGCCATGC 
for sequencing of 
stop mutations with 
template amplified 
from 
ST313td_ext_f+r 
ST313_STOP??
_f 
GGTGATATGGACTATATTTA 
Diagnostic PCR for 
ST313_stop mutation ST313_STOP??
_r 
AGATTTGTTGTTTGTAGACG 
ST313td_pPLGM
_f 
GTGAGCGGATAACAAGATACTGAGCACAGACGAAATCGT
TAGCGCTT 
For insertion of 
ST313td gene into 
expression plasmid 
pPL-Gm using overlap 
extension PCR 
cloning 
ST313td_pPLG
M_r 
GCCTTTCGTTTTATTTGATGCCTCTAGAtgtgaa
gctactggaagagt 
STnc6030_pPL
_F (NW_295) 
GTGAGCGGATAACAAGATACTGAGCACAGCA
ATATAGTCAACCTGAGAAC 
For insertion of 
STnc6030 asRNA 
into expression 
plasmid pPL-Gm 
using overlap 
extension PCR 
cloning 
STnc6030_pPL
_R (NW_296) 
GCCTTTCGTTTTATTTGATGCCTCTAGACTGC
GTATCTGAAGGGGATTAAG 
STnc6030_T7 
(NW_297) 
TAATACGACTCACTATAGGGCTGCGTATCTG
AAGGGGATTAAG 
For synthesis of 
anti-STnc6030 
riboprobe. Use with  
STnc60_pPLGM_f 
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Table 2.5 All plasmids used in this thesis 
Plasmid Description a Reference 
pEMG Suicide plasmid; KmR 
(Martínez-García and 
de Lorenzo, 2011) 
pKD13 nptII-cassette template plasmid ; KmR 
(Datsenko and 
Wanner, 2000) 
pKD4 aph-cassette template plasmid ; KmR  
(Datsenko and 
Wanner, 2000) 
pKD4-I-SceI 
pKD4 derivative with an I-SceI site cloned 
upstream of aph; KmR 
(Owen et al., 2017) 
pKD46 
λ Red recombination plasmid, arabinose-
inducible; ApR 
(Datsenko and 
Wanner, 2000) 
pKD46 bla::Tn10   pKD46 derivative; OxyTcR 
(Passaris et al., 
2014) 
pCP20 
Plasmid carrying the Flp recombinase to 
remove kanamycin resistance from pKD13 
derived resistance cassette insertions; ApR 
(Cherepanov and 
Wackernagel, 1995) 
pCP20-TcR 
Derivative of plasmid carrying the Flp 
recombinase to remove kanamycin resistance 
from pKD4 derived resistance cassette 
insertions; TcR 
(Kintz et al., 2015) 
pNAW15 Suicide plasmid pEMG::attBGifsy-1; KmR (Owen et al., 2017) 
pNAW16 Suicide plasmid pEMG::attBGifsy-2; KmR (Owen et al., 2017) 
pNAW17 Suicide plasmid pEMG::attBBTP1; KmR (Owen et al., 2017) 
pNAW19 Suicide plasmid pEMG::attBΦSopE; KmR This study 
pNAW18 Suicide plasmid pEMG::attBBTP5; KmR (Owen et al., 2017) 
pNAW42 Suicide plasmid pEMG::attBST64B; KmR (Owen et al., 2017) 
pSIM5-tet 
λ Red recombination plasmid, temperature-
inducible; TcR 
(Koskiniemi et al., 
2011) 
pSW-2 
Plasmid for m-toluate-inducible expression of 
the I-SceI enzyme; GmR 
(Martínez-García and 
de Lorenzo, 2011) 
pZEP08 
Used as template to amplify the gfp+ for 
construction of a prophage induction reporter 
construct 
(Hautefort et al., 
2003) 
pME4510 
Used to amplify aacC1 gene for modification of 
pJV-300; GmR 
(Rist et al., 1998) 
pJV-300 (pPL) 
Modified to encode aacC1 from pME4510 (pPL-
Gm); ApR 
(Sittka et al., 2007) 
pEMG::ST313tdSTOP Suicide plasmid pEMG::ST313tdSTOP; KmR This study 
pPL-Gm 
Derived from pJV-300 but bla gene replaced 
with aacC1 gene from pME4510; GmR 
This study 
pPL-STnc6030 
Expression plasmid; STnc6030 sRNA under the 
control of the PLlacO-1 promoter; GmR 
This study 
pPL-ST313td 
Expression plasmid; ST313-td gene under the 
control of the PLlacO-1 promoter; GmR 
This study 
pPL-ST313tdSTOP 
Expression plasmid; ST313-tdSTOP gene 
under the control of the PLlacO-1 promoter; 
GmR 
This study 
a Relevant antibiotic resistances are indicated by R: Ap, ampicillin; Gm, 
gentamicin; Km, kanamycin, OxyTc, oxytetracyline; Sm, streptomycin; 
Tc, tetracycline; Tp, trimethoprim. 
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2.5.2 Polymerase chain reaction (PCR) & agarose gel electrophoresis 
For cloning and recombineering procedures, PCR reactions were performed with Q5 
High-Fidelity DNA polymerase (New England Biolabs M0491S) according to the 
manufacturer’s instructions. Each dNTP was used at a final concentration 0.2 mM, 
each primer was used at a concentration of 0.5 pmol/µL and 1 unit of enzyme was 
used per reaction of 50 µl. For PCR reactions where amplicons were not required for 
cloning, MyTaqTM Red Mix polymerase mastermix (Bioline) was used according to the 
manufacturer’s instructions. In a typical 20 µL PCR reaction the mastermix was diluted 
2-fold, primers were added to a final concentration of 1 pmol/µL and 1 unit of enzyme 
was used.  
Initial denaturation time in the reaction was dependent on the template DNA used. 
For colony PCR or lysate PCR, initial denaturation proceeded for 10 minutes at 95°C 
and the time was reduced to 2 minutes when extracted and purified DNA was used 
as template. Initial denaturation was followed by 30 cycles of denaturation for 15 
seconds at 95°C, annealing for 30 seconds at a temperature typically 4°C below the 
lowest melting temperature of the primer pair and extension for approximately 15-30 
seconds per kilobase at 72°C. The cycling was followed by a final extension step at 
72°C for 7 minutes. PCR products were held at 4°C when the PCR reaction was 
completed. 
Agarose gels were made using molecular grade Agarose (Bioline). A 50X TAE buffer 
stock solution containing 242 g/L Tris-base, 57.1 ml/L Acetic acid and 100 ml/L 0.5M 
sodium EDTA was used. Gels were made up of TAE buffer (1X, made by diluting 20 
ml of 50X stock in 980 ml of ddH2O), and typically 1.5% agarose. Midori Green 
Advanced DNA Stain (NIPPON Genetics EUROPE GmbH) was added to agarose 
gels to a final concentration of 0.004%. Agarose gels were typically run at a constant 
voltage of 100 V for 30 minutes, or as required for sufficient separation of the DNA 
products. The molecular size of electrophoresed DNA products was estimated by 
comparison with Hyperladder I (Bioline). Separated DNA was visualised under ultra 
violet or blue light. Where it was necessary to extract DNA from agarose gels, the 
band of interest was excised from the gel using a clean scalpel. The gel slice was 
weighed to determine volume of buffer required for solubilisation. DNA products were 
purified from PCR reactions or agarose gel slices using the ISOLATE II PCR and Gel 
Kit (Bioline), following the manufacturer’s instructions except column elution was 
always carried out in molecular grade H2O. 
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2.5.3 Generalised transduction 
Generalized transduction was performed with the highly efficient transducing phage 
P22 HT 105/1 int-201 (Schmieger, 1972). As D23580 is highly resistant to P22 
infection (Kintz et al., 2015), high numbers of P22 transducing particles were 
necessary to obtain transductants in this background. Therefore, 200 µl of stationary 
phase culture of the recipient strains were mixed with 100 µl of the P22 lysates. After 
1 hour of incubation at 37°C, transductants were selected on LB Km agar plates. 
Transductants were grown to stationary phase in LB containing 10 mM EGTA (Sigma-
Aldrich, E3889) and Km. Cultures were streaked on indicator Green Plates and P22-
free colonies were selected for further experiments (Maloy, 1990). 
2.5.4 Preparation of electro-competent cells and electroporation 
Bacterial overnight cultures were diluted 1:1000 and grown in 25 ml LB broth with 
antibiotics where required, until OD600 0.5. Cells were incubated on ice for 10 minutes, 
and then pelleted by centrifugation at 4°C and 7,000 x g for 10 minutes. Cells were 
washed three times in 25 ml ice-cold sterile dH2O, and finally resuspended in 200 µl 
of ice-cold water. Cells were aliquoted into 40 µl volumes for electroporation reactions. 
Cells aliquots were mixed with target DNA (typically 200 ng of DNA was used per 
electroporation of linear dsDNA PCR amplicons, and 20 ng of DNA for electroporation 
of plasmids), and the suspension was incubated on ice for 5 minutes before transfer 
to a pre-chilled 2 mm single-use sterile electroporation cuvette (Geneflow, E6-0060). 
Electroporation was achieved by application of 2.5 kV, 25 µF, 200 Ω current to the 
cuvette using a 1652076 Gene Pulser Laboratory Benchtop Cell Electroporation Unit 
(Bio-Rad). 1 ml of room temperature LB broth was added to the cuvette to recover the 
electroporated cells, and the suspension was transferred to an Eppendorf tube and 
incubated at 37°C for 1 hour (unless the cells contained temperature sensitive 
plasmids, in which case a temperature of 30°C was routinely used). Afterwards, cells 
were pelleted by centrifugation at 12,000 x g for 2 minutes, and resuspended in 100 
µl sterile LB. The resuspension was spread onto an LB plate containing the 
appropriate selectable antibiotic and incubated overnight at 37°C. Cells electroplated 
without DNA were also plated on the selectable antibiotic agar, as a negative control. 
2.5.5 Preparation and transformation of chemically competent E. coli cells 
Bacterial overnight cultures were diluted 1:1000 and grown in 25 ml LB broth with 
antibiotics where required until OD600 0.5. Cells were incubated on ice for 10 minutes, 
and then pelleted by centrifugation at 4°C and 7,000 x g for 10 minutes. The cell pellet 
was resuspended in 40 ml ice-cold 100 mM CaCl2 and incubated on ice for 20 
minutes. Cells were again pelleted by centrifugation at 4°C and 7,000 x g for 10 
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minutes and resuspended in 10 ml ice-cold 100 mM CaCl2. Sterile glycerol was added 
to final concentration of 10%, and the cells were incubated on ice for a further 20 
minutes. The chemically competent cells were aliquoted into 300 µl volumes and 
stored at -80°C until needed. 
For chemical transformation, target DNA was mixed with a thawed aliquot of 50 µl 
chemically competent cells (20 ng of DNA for transformation of plasmids). The 
suspension was incubated on ice for 20 minutes. The cells were heat shocked for 90 
seconds at 42°C in a pre-heated water bath, followed by incubation on ice for a further 
2 minutes. 700 µl of LB broth was added and the cells were incubated at 37°C for 1 
hour (unless the cells contained temperature sensitive plasmids, in which case a 
temperature of 30°C was routinely used). Cells were pelleted by centrifugation at 
12,000 x g for 2 minutes, and resuspended in 100 µl sterile LB. The resuspension 
was spread onto an LB plate containing the appropriate selectable antibiotic and 
incubated overnight at 37°C. Cells transformed without DNA were also plated on the 
selectable antibiotic agar, as a negative control. 
2.5.6 Plasmid construction by restriction/ligation 
Construction of plasmids by restriction digest and ligation was achieved by using the 
EcoRI and BamHI restriction enzymes (Thermo Fisher). Plasmid inserts were 
amplified using primers designed with overhangs corresponding to the EcoRI and 
BamHI restriction sites. All amplicons were digested with restriction enzymes in 
parallel to the pEMG plasmid vector. DNA restriction was carried out as double 
digestion reactions according the manufacturer’s instructions, using the universal 
Tango buffer 1X (Thermo Fisher). Cut DNA was purified using the ISOLATE II PCR 
and Gel Kit (Bioline). 50 ng of plasmid and 3-fold molar excess of the insert were 
ligated using T4 DNA ligase (New England Biolabs) at room temperature for 16 hours 
according to manufacturer’s instructions. Ligated DNA was directly transformed into 
chemically competent E. coli S17-1 λpir cells. Cells harbouring the pEMG variant 
plasmids were selected by plating on LB agar containing Km. 
2.5.7 Plasmid construction by overlap-extension PCR cloning 
Construction of plasmids by overlap-extension PCR cloning was based on methods 
previously described (Bryksin and Matsumura, 2010). The pJV-300 plasmid (Sittka et 
al., 2007) was initially modified to encode gentamicin resistance (pPL-Gm) by overlap-
extension PCR cloning. Chimeric primers containing pJV300 plasmid sequence at the 
5′ ends and insert sequence at the 3′ ends were first used to PCR-amplify gentamicin 
resistance locus from the pME4510 plasmid. The amplified gene was used as a mega-
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primer in a second PCR with the circular pJV300 template to amplify the entire 
plasmid but replacing the ampicillin resistance locus with the gentamicin resistance 
locus. For this reaction, 30 ng of the template plasmids were mixed with 150-300 ng 
of the insert and Q5 buffer, dNTPs, Q5 DNA polymerase (New England Biolabs) and 
water were added to a final volume of 50 µl. PCR reactions were carried out as 
follows:98°C, 30 sec; 25X(98°C, 10sec; 55°C, 30 sec, 72°C, 3 min); 72°C 5 min. The 
original plasmid template was then destroyed in restriction digests with DpnI in 
Cutsmart buffer (1X) (New England Biolabs) according to the manufacturer’s 
instructions, and the overlap extension PCR products were used to transform E. coli 
DH5α cells. Cells harbouring the new pPL-Gm (pJV300 gentamicin resistant 
derivative) plasmid were selected by plating on LB agar containing gentamicin.  
Subsequently, overlap-extension PCR cloning was used to insert sequence of interest 
into the pPL-Gm plasmid downstream of the PLlacO-1 constitutive promoter. The same 
procedure was followed, except that the chimeric primers used to amplify the insert 
targeted a different region of the pPL-Gm plasmid between the PLlacO-1 promoter and 
the rrnB transcriptional terminator, as described in Table 2.7. To confirm correct 
conformation of plasmid after transformation, primers external to the insertion site 
were used to sequence the inserted fragment (Sanger sequencing). 
2.6 Construction of mutant Salmonella 
2.6.1 Construction of single gene mutants by  Red recombineering 
The pKD4 plasmid was used as the template for all constructs used in  Red 
recombineering procedures. Primers (Table 2.4) were designed to amplify the 
kanamycin resistance gene flanked by the FRT recombinase sites from the pKD4 
plasmid, with flanking ends corresponding to the chromosomal position to be replaced 
with the kanamycin resistance construct. Approximately 1 ng of pKD4 plasmid and 
0.5 pmol/µL of each of the forward and reverse primers were used to amplify the 
kanamycin resistance constructs. The expected size of the construct was verified on 
an agarose gel and the construct cut and purified from the agarose gel ready for 
recombineering. Recombineering procedures were carried out using the  Red 
recombination plasmids pSIM5-tet in the D23580 background and pKD46 in the 
4/74/14028s/LT2 backgrounds (Datsenko and Wanner, 2000; Koskiniemi et al., 
2011). Where the pSIM5-tet plasmid was used, an additional step of incubation at 
42°C for 15 minutes directly after cells had reached OD600 0.4 in order to induce 
recombinase expression. Where pKD46 was used, the LB broth in which the 
competent cells were grown was supplemented with 10 mM L-arabinose to induce 
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recombinase expression. Electro-competent cells of Salmonella carrying pSIM5-tet or 
pKD46 were prepared and transformed with the indicated PCR fragment as described 
in section 2.5.4 (Datta et al., 2006; Yu et al., 2003) and recombinants were selected 
on LB agar plates supplemented with kanamycin. Correct insertion of the kanamycin 
cassette was confirmed by PCR using primers external to the deleted portion of DNA. 
To eliminate the chance of off-target effects from expression of the  recombinase, 
the kanamycin marked mutation was transduced into a clean genetic background 
using P22 transduction as described in section 2.5.3.  
In the case of the galE496 allele a slightly modified procedure was used. The galE496 
allele (premature stop codon TAG on the 326th codon of galE) of MA6684 was 
transferred into D23580 derivative strains by a two-step procedure. An aph (KmR) 
cassette was amplified from pKD4 with primers NW_86 and NW_87 and was inserted 
by  Red recombination into the intergenic region STM0777-galE496 of MA6684. Due 
to the defective O-antigen of the galE mutants, the resulting strain was grown in LB 
supplemented with 0.2% of glucose and 0.02% of galactose for the preparation of a 
P22 lysate (Butela and Lawrence, 2012). The KmR-galE496 module was 
subsequently transduced into D23580 derivative strains and transductants were 
screened by PCR with the primers NW_61 and NW_82 and checked by sequencing 
to confirm the presence of galE496.  
To construct strain D23580 BTP5::KmR, the KmR cassette was first amplified from 
pKD4 with primers BTP5_kan_f and BTP5_kan_r, and then inserted by  Red 
recombination into D23580 pSIM5-tet. The location of the KmR cassette is in a non-
coding position between genes STMMW_32011 and STMMW_32031. Insertion of the 
cassette at the correct location was confirmed by PCR using primers BTP5_kan_ext_f 
and BTP5_kan_ext_r. 
The pCP20-TcR plasmid was used to remove the kanamycin resistance locus where 
needed, and so reduce the effect of polar effects on the genes downstream of the 
deletion. The pCP20-TcR plasmid encodes the yeast FLP recombinase and is 
temperature sensitive for replication and induction of FLP expression. FLP recognises 
the FLP recombinase target sites (FRT sites) which flank the kanamycin resistance 
gene in the recombineering construct. FLP mediates site-specific recombination 
between the two FRT sites resulting in excision of the antibiotic resistance gene, 
leaving behind an 82-85 nt scar sequence (Datsenko and Wanner, 2000). Deletion 
mutants containing the kanamycin construct were made electrocompetent as 
previously described (2.5.4). Electroporation was used to transform cells with 500 ng 
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of pCP20-TcR plasmid. Cells were selected on tetracycline plates, and then passaged 
twice at 37°C to cure the temperature sensitive pCP20-TcR plasmid. Loss of the 
antibiotic resistance cassette and the pCP20 plasmid were screened for by checking 
for the loss of resistance to kanamycin and tetracycline. 
The RecA- stains were obtained from Angela Makumi and Abram Aertsen, KU Leuven, 
Belgium. To construct a RecA- LT2 strain (LT2 derivative MA8508 was used, Table 
2.2), the KmR cassette was first amplified from pKD13 with primers RecA_pKD13_Fw 
and RecA_pKD13_Rev, and then inserted by  Red recombination into MA8508 
pKD46. Kanamycin resistance was subsequently removed using the Flp recombinase 
encoded in the pCP20 plasmid. The same methodology was applied to D23580 to 
obtain the D23580 RecA- strain, but using the pKD46 bla::Tn10 and pCP20-TcR 
plasmids instead as ampicillin resistance in D23580 (Kingsley et al., 2009) prohibits 
the use of the original pKD46 and pCP20 plasmids. 
2.6.2 Construction of single nucleotide substitution mutants  
The functional promoter of the antirepressor gene (gfoA) in Gifsy-1 of S. Typhimurium 
14028s was inserted in place of the corresponding promoter of D23580 (Lemire et al., 
2011). Therefore, a single nucleotide substitution (C→T position 2790162) was 
introduced into the promoter controlling dinI(STMMW_26401)-gfoA (STMMW_26391) 
transcription (PdinI-gfoA) of D23580 by a protocol based on the principle described by 
Blank and Colleagues (Blank et al., 2011). Due to the multidrug resistance phenotype 
of D23580, a plasmid harbouring an I-SceI-KmR module was first constructed: the I-
SceI restriction site was inserted upstream aph (KmR) in pKD4, using the Site-Directed 
Mutagenesis method with primers NW_161 and NW_162 (Laible and Boonrod, 2009). 
The resulting plasmid (pKD4-I-SceI) was used as template to insert an I-SceI-KmR 
module into PdinI-gfoA by  Red recombination, using primers NW_214 and NW_215. 
This module was transduced into a clean D23580 background and the resulting strain, 
D23580 I-SceI-KmR-dinI-gfoA, was transformed with pSIM5-tet for a second  Red 
recombination. The functional PdinI-gfoA of S. Typhimurium 14028s was PCR-amplified 
using the primers NW_194 and NW_195 and the resulting fragment (319 bp) was 
electroporated into D23580 I-SceI-KmR-dinI-gfoA carrying pSIM5-tet. To select the 
recombinants, new electro-competent cells were directly prepared after the 
electroporation, and bacteria were transformed with pSW-2. After selection on LB 
agar containing Gm and m-toluate, colonies were screened by PCR with primers 
NW_196 and NW_197 and the resulting PCR fragments were sequenced to confirm 
the mutation. Two passages in LB were used to eliminate pSW-2.  
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2.6.3 Construction of mutant Salmonella by suicide plasmid-mediated genome 
editing 
This genome editing protocol was adapted for Salmonella Typhimurium, according to 
the method previously described by Martínez-García and collegues (Martínez-García 
and de Lorenzo, 2011). To construct the different suicide plasmids, the DNA 
fragments (700-800 bp) flanking chromosome regions of interest were PCR amplified, 
fused by overlap extension PCR and inserted into the pEMG suicide plasmid, or by 
restriction ligation using restriction sites incorporated into the insert amplicon. In 
pEMG, the inserts are flanked by two I-SceI restriction sites. The pEMG derivative 
suicide plasmids were mobilized from E. coli S17-1 λpir to S. Typhimurium by 
conjugation. S. Typhimurium transconjugant clones that had integrated the suicide 
plasmid by a homologous recombination were selected on solid minimal medium M9 
supplemented with 0.2 % of glucose, 50 µg/ml of kanamycin and 20 µg/ml 
chormaphenicol. This medium is counter-selective for the S17-1λpir donor strain, 
which is auxotrophic for proline and thiamine. The merodiploid state of the resulting 
Salmonella transconjugants was resolved using the pSW-2 plasmid, encoding the I-
SceI endonuclease. To improve the transformation yield of Salmonella with pSW-2, 
this plasmid was purified from S. Typhimurium 4/74 pSW-2 or S. Typhimurium 
D23580 pSW-2 and was then introduced into the strains of interest by electroporation. 
Transformants were selected on LB agar medium supplemented with 20 µg/ml 
gentamicin and 1 mM of m-toluate. In this condition I-SceI is expressed, provoking 
cleavages of the chromosome at the inserted I-SceI sites. The presence of double 
strand DNA breaks stimulates the RecABCD dependent DNA repair allowing 
homologous recombination events. The recombination can lead either to the 
restoration of the wild type status or to the generation of the mutant. Colonies were 
screened for kanamycin resistance and sensitive clones were tested by specific PCR. 
Due to the instability of its replication origin, pSW-2 was cured from the resulting 
strains by two passages in LB in the absence of gentamicin. 
In the case of the D23580ST313-tdSTOP strain in which four nucleotides were replaced at 
the 5’ end of the ST313-td coding sequence to introduce 2 x stop codons, a two-step 
procedure was used. First, the Site-Directed Mutagenesis method (Laible and 
Boonrod, 2009) with primers ST313td_L_bam_f / ST313td_L_bam_r and 
ST313td_R_eco_f / ST313td_R_eco_r where used to amplify an EcoRI, BamHI 
restriction site containing insert for the pEMG suicide plasmid. The plasmid 
(pEMG::ST313tdSTOP) was then used to introduce the stop codons into the D2580 
genome using the suicide plasmid methodology described above. 
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2.6.4 Construction of GFP reporter strains for prophage induction 
In order to act as a marker of prophage induction, a promoter-less gfp gene was 
designed to be inserted into a non-coding region of the late genes of prophage BTP1. 
In order to insert the gfp+ gene into the chromosome, a construct was designed based 
on the gfp+ gene of plasmid pZEP08 (Hautefort et al., 2003), and the FRT-site-flanked 
kanamycin gene of the pKD4 plasmid. Primers (Table 2.4) were designed such that 
the orientation of the kanamycin gene was opposite to that of the gfp+, in order to 
minimise the likelihood of polar effects from the kanamycin resistance gene 
transcription. Primers 03761_gfp_2_L_f and gfp_kan_2_L_r were used to amplify the 
gfp+ gene using pZEP08 DNA as template, and primers 03761_gfp_2_R_r and 
gfp_kan_2_R_f were used to amplify the kanamycin resistance loci. A third overlap 
extension PCR reaction was used to fuse both fragments together. The construct was 
extracted from agarose gel and electroporated into  Red electrocompetent cells. The 
kanamycin gene was subsequently removed using the pCP20-TcR gene as has been 
described.  
Subsequently, secondary mutations were designed which, rather than insert the 
construct within the prophage chromosome, the prophage lysis genes were deleted, 
and replaced with the gfp+ construct. In the latter case, the same protocol was 
followed, except that the flanking ends of the construct corresponded to either side of 
the lysis genes targeted for deletion. In this case, primers late_gfp_2_L_f and 
gfp_kan_2_L_r were used to amplify the gfp+ portion of the construct and primers 
late_gfp_2_R_r and gfp_kan_2_R_f were used to amplify the kanamycin resistance 
portion. The same approach was taken for prophage P22, except the flanking ends of 
the primers were modified to correspond to the P22 lysis genes (Table 2.4).  
Detection of florescent cells which had become induced for prophage replication was 
achieved using microscopy of induced and uninduced cultures. An EVOS FL cell 
imaging system (Thermo Fisher) fitted with a GFP light cube was used to detect and 
photograph florescent cells (2.3.6). 
2.7 Construction of expression plasmids 
Plasmids to overexpress the ST313-td gene and STnc6030 asRNA were constructed 
using the overlap extension PCR cloning method described earlier in 2.5.7. The 
primers used to amplify the ST313-td insert were ST313td_pPLGM_f and 
ST313td_pPLGM_r, and the primers used to amplify the STnc6030 insert were 
STnc6030_pPL_F (NW_295) and STnc6030_pPL_R (NW_296) (Table 2.4). 
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2.8 Genetic deletion of prophages 
2.8.1 Prophage deletion via unoccupied attachment site transduction 
The method developed for initial deletion of prophages is described in Figure 2.1. A 
KmR resistance cassette was inserted into the prophage attachment site in strain 4/74 
using lambda red method already described (2.6.1). Salmonella generalised 
transducing phage P22 HT105/1 int-201 was used to transduce a KmR resistance 
cassette into strain D23580 by selecting on LB kanamycin plates, thereby selecting 
for loss of the prophage. Transfer of co-located SNPs was screened by PCR. 
Transductant colonies with D23580 SNP genotypes in the flanking regions of the 
prophage (relative to 4/74) were selected for using colony PCR using annealing 
temperatures shown in Table 2.6. The kanamycin resistance cassette was 
recombined out of the chromosome to leave an 82bp scar using the pCP20-TcR 
plasmid as described (2.6.1). The mutation was confirmed by Sanger sequencing 
over the prophage attachment sites and over left and right SNP loci (primers indicated 
in Table 2.4). Resulting strains were denoted D23580 ΔBTP1::FRT and D23580 
ΔBTP5::FRT to distinguish them from the deletion strain generated by the scarless 
approach (described subsequently). These strains were used for experiments 
described in Chapter 6.2. 
 
Table 2.6 Annealing temperatures used to assay SNPs proximal to prophage 
attachment sites. Three temperatures in the discriminatory range for each primer 
pair are specified. 
 
  Temp 1 Temp 2 Temp 3 
BTP1_L 59.2°C 61.2°C 63.2°C 
BTP1_R 67.0°C 68.5°C 69.6°C 
BTP5_L 68.5°C 69.6°C 70.1°C 
BTP5_R 63.2°C 65.2°C 68.5°C 
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Figure 2.1 Schematic representation of method developed to create whole-
prophage deletions by transduction of unoccupied attachment sites. A. 
Kanamycin cassette is first introduced into strain 4/74 in the BTP1 attachment site 
using lambda red recombineering (Datsenko & Wanner, 2000) B. The kanamycin 
cassette is then transduced from strain 4/74 into D23580 using phage P22 HT105/1 
int-201. As the kanamycin cassette is located within an empty attachment site, 
transductants had lost BTP1. C. Any SNPs either side of BTP1 that may have been 
introduced by the transduction from 4/74 were removed by repeated transduction into 
a clean D23580 background and selecting for polar kanamycin transducing fragments 
using PCR as described in 2.8.1. 
C 
A 
B 
SNPs between 4/74 donor 
and D23580 recipient 
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2.8.2 Scarless prophage curing 
The prophages of S. Typhimurium D23580 and 4/74 were subsequently cured using 
the scarless genome editing technique described in 2.6.3. The phage attachment site 
(attB) of Gifsy-1D23580, Gifsy-2D23580, BTP1, BTP5 and ST64BD23580 were PCR amplified 
from S. Typhimurium prophage-cured strains or naturally naive strains with the 
appropriate primers (Table 2.4) and cloned into the suicide plasmid pEMG, as 
summarized in Table 2.7. E. coli S17-1 pir was used as host strain for the resulting 
suicide plasmids pNAW15 (attBGifsy-1), pNAW16 (attBGifsy-2), pNAW17 (attBBTP1), 
pNAW18 (attBBTP5), pNAW42 (attBST64B) and pNAW19 (attBΦsopE, for 4/74 only). The 
suicide plasmids were mobilized from S17-1 pir into the recipient S. Typhimurium 
strains by conjugation and deletion of the prophages using the suicide plasmids was 
carried out as described in 2.6.3. The scarless phage deletion technique was used to 
generate strains D23580 ΔBTP1, D23580 ΔGifsy-2, D23580 ΔST64B, D23580 
ΔGifsy-1, D23580 ΔBTP5, D23580 ΔBTP1ΔBTP5 and D23580 ΔΦ (Table 2.2). These 
strains were used in experiments described in Chapter 3.2, 5.3, 6.3 and 6.4.
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  Table 2.7 Details of the construction of plasmids used in this thesis 
Cloning technique Template 
plasmid 
Insert Insert Primers Forward / Reverse Template DNA 
Restriction 
sites used 
Resulting plasmid 
construct 
Restriction/ligation pEMG 
attBGifsy-2 
(BTP2) 
NW_1 / 
MA6684 
EcoRI / pNAW16 
NW_4 BamHI (pEMG::attBGifsy-2) 
Restriction/ligation pEMG 
attBGifsy-1 
(BTP4) 
NW_26 / 
MA6684 
EcoRI / pNAW15 
NW_29 BamHI (pEMG::attBGifsy-1) 
Restriction/ligation pEMG attBBTP1 
NW_52 / 
4/74 
EcoRI / pNAW17 
NW_53 BamHI (pEMG::attBBTP1) 
Restriction/ligation pEMG attBBTP5 
NW_54 / 
4/74 
EcoRI / pNAW18 
NW_55 BamHI (pEMG::attBBTP5) 
Restriction/ligation pEMG 
attBST64B 
(BTP3) 
NW_179 / 
LT2 
EcoRI / pNAW42 
NW_180 BamHI (pEMG::attBST64B) 
Restriction/ligation pEMG attBΦSopE 
NW_64 / 
NW_65 
D23580 
EcoRI / 
BamHI 
pNAW19 
(pEMG::attBΦSopE) 
Restriction/ligation pEMG 
ST313-
tdSTOP 
ST313td_L_bam_f / 
ST313td_L_bam_r 
D23580 EcoRI / pEMG::ST313tdSTOP 
Restriction/ligation 
PCR cloning 
pEMG 
pPL (pJV-
300) 
ST313-
tdSTOP 
aacC1 (GmR) 
ST313td_R_eco_f / 
ST313td_R_eco_r D23580 
pME4510 
BamHI pEMG::ST313tdSTOP 
pPL-Gm 
NW_88 / N/A 
PCR cloning 
PCR cloning 
pPL (pJV-
300) 
pPL-Gm 
aacC1 (GmR) 
STnc6030 
NW_89 pME4510 
D23580 
N/A 
N/A 
pPL-Gm 
pPL-STnc6030 NW_295 
PCR cloning 
PCR cloning 
pPL-Gm 
pPL-Gm 
STnc6030 
ST313-td 
NW_296 D23580 
D23580 
N/A 
N/A 
pPL-STnc6030 
pPL-ST313td ST313td_pPLGM_f 
PCR cloning 
PCR Cloning 
pPL-Gm 
pPL-Gm 
ST313-td 
ST313-
tdSTOP 
ST313td_pPLGM_r D23580 
D23580 ST313-
tdSTOP 
N/A 
N/A 
pPL-ST313td 
pPL-ST313tdSTOP 
ST313td_pPLGM_f 
PCR Cloning pPL-Gm 
ST313-
tdSTOP 
ST313td_pPLGM_r D23580 ST313-
tdSTOP 
N/A pPL-ST313tdSTOP 
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Table 2.8 RNA-seq conditions as described in Kröger et al., 2013. 
 
Sample description Abbreviation Growth conditions 
Early exponential phase EEP Growth in Lennox broth to OD600 0.1 
Mid exponential phase MEP Growth in Lennox broth to OD600 0.3 
Late exponential phase LEP Growth in Lennox broth to OD600 1.0 
Early stationary phase ESP Growth in Lennox broth to OD600 2.0 
Late stationary phase LSP Growth in Lennox broth to OD600 2.0 + 6 h 
Low temperature 25°C 
Growth in Lennox broth to OD600 0.3 at 25°C (It's growth at low temperature 
(ON culture 37dgr, 200 RPM, Lennox, diluted 1:1000 and grown at 25 dgr 
until OD600 = 0.3) 
Osmotic shock NaCl_S 
Growth in Lennox broth to OD600 0.3; then addition of NaCl to a final 
concentration of 0.3 M for 10 min 
Addition of bile Bile_S 
Growth in Lennox broth to OD600 0.3; then addition of bile to a final 
concentration of 3% for 10 min 
Iron limitation LwFe_S 
Growth in Lennox broth to OD600 0.3; then addition of 2,2’-dipyridyl to a final 
concentration of 0.2 mM for 10 min 
Anaerobic shock No_O2_S 
Growth in Lennox broth to OD600 0.3 (50 ml), then filled into 50 ml closed 
centrifuge tube and incubated without agitation for 30 min at 37°C (Falcon 
tube) 
Anaerobic growth No_O2 
Static growth in Lennox broth to OD600 0.3 in a completely filled and closed 
50 ml centrifuge tube (Falcon tube) 
Aerobic shock O2_S 
Static growth in Lennox broth to OD600 0.3 in a completely filled and closed 
50 ml centrifuge tube (Falcon tube); then 15 min aerobic growth (baffled 
flask, 250 rpm) 
SPI2 non-inducing conditions noSPI2 Growth in PCN medium to OD600 0.3 (pH 7.4, 25 mM Pi) 
SPI2 inducing conditions inSPI2 Growth in PCN medium to OD600 0.3 (pH 5.8, 0.4 mM Pi) 
Oxidative stress H2O2_S 
PCN to OD600 0.3, then addition of H2O2 to final concentration of 1 mM 
H2O2 for 12 min 
Nitric oxide NOs 
Growth in PCN medium to OD600 0.3 (pH 5.8, 0.4 mM Pi); then addition of 
250 µM Spermine NONOate for 20 min 
RNA from macrophages MAC RNA isolated from macrophages 8 h post infection 
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2.9 RNA-associated methods 
2.9.1 Growth conditions for RNA extraction 
Transcriptomic data for prophage BTP1 (Chapter 5.2) was taken from the complete 
D23580 transcriptome dataset including identification of transcription start sites (TSS) 
using differential RNA-seq (Canals et al., 2018; Hammarlöf et al., 2017), where 
experiment design was based on that used in Kröger et al. (Kröger et al., 2012, 2013).. 
A description of the experimental conditions associated with the data presented in this 
thesis is given in Table 2.8. For analysis of prophage-regulated genes (Chapter 5.3), 
only the conditions ESP, inSPI2 and anaerobic growth were used. 
2.9.2 RNA extraction 
The protocol is essentially as described (Kröger et al., 2013). Four or 5 OD600 units 
were removed from bacterial cultures, and cellular transcription was stopped using 
0.4X culture volume of a 5% phenol (pH 4.3) 95% ethanol “stop” solution (Sigma 
P4557 and E7023, respectively). Cells were stabilised on ice in stop solution for at 
least 30 minutes before cells were harvested at 7,000 x g for 10 minutes at 4°C. At 
this point pellets were either stored at -80°C, or RNA was immediately extracted. To 
isolate RNA, pellets were resuspended in 1 ml of TRIzolTM Reagent (Invitrogen). 400 
µL of chloroform was added and the samples were immediately and thoroughly mixed 
by inversion. Samples were moved to a Phase-lock tube (5 Prime) and the aqueous 
and organic phases were separated by centrifugation at 13,000 rpm for 15 minutes at 
room temperature in a table top centrifuge. The aqueous phase was moved to a new 
1.5 ml tube and the RNA was precipitated using isopropanol for 30 minutes at room 
temperature followed by centrifugation at 21,000 x g for 30 minutes at room 
temperature. The RNA pellet was rinsed with 70% ethanol followed by centrifugation 
at 21,000 x g rpm for 10 minutes at room temperature. The RNA pellet was air-dried 
for 15 minutes and resuspended in DEPC-treated water at 65°C with shaking at 900 
rpm on a Thriller thermoshaker (Peqlab) for 5 minutes with occasional vortexing. RNA 
was kept on ice whenever possible and RNA was stored at -80°C. RNA concentration 
was measured using a nanodrop ND-1000 Spectrophotometer and RNA quality was 
inspected visually using a 2100 Bioanalyser (Agilent). 
2.9.3 cDNA library preparation and RNA-seq 
Strand-specific cDNA library preparation and high throughput cDNA sequencing 
(RNA-seq) of wild-type D23580 and isogenic prophage mutants was performed on 
DNase I digested total RNA by Vertis Biotechnologie AG (Freising, Germany). Strains 
and conditions in which they were grown before RNA extraction are detailed in Table 
5.1. RNA was not depleted for ribosomal RNA. RNA was fragmented by sonication 
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and poly(A)-tails were added to each fragment by poly(A) polymerase. The 5’ end of 
each fragment was de-phosphorylated using tobacco acid pyrophosphatase (TAP). 
An RNA adaptor, containing a 6-10 nucleotide bar-code was ligated to the 5’ end of 
each fragment to allow for identification of each RNA fragment after sequencing. First 
strand cDNA synthesis was performed using oligo(dT) priming and Moloney murine 
leukaemia virus reverse transcriptase (M-MLV RT). The resulting cDNA was amplified 
by PCR to approximately 20-30 ng/µL using a high fidelity DNA polymerase. cDNA 
was purified using the Agencourt AMPure XP kit (Beckman Coulter Genomics) and 
analysed by capillary electrophoresis.  
cDNA prepared by Vertis Biotechnologie AG was sequenced on an Illumina Nextseq 
500 platform using 75 bp read lenghts. The strains and conditions under which they 
were grown before RNA was extracted are detailed in Table 5.1. 
2.9.4 Generating Digoxigenin-labelled riboprobes 
Digoxigenin (Dig)-labelled riboprobes were generated by in vitro transcription using 
T7 RNA polymerase using a Dig Northern Starter kit (Roche). A linear DNA template 
incorporating the antisense sequence to the transcript of interest and a T7 promoter 
sequence was first generated by PCR using primers shown in Table 2.4 and a high 
fidelity enzyme as previously described. The DNA template was purified by gel 
extraction according to the manufacturer’s instructions and 100-200 ng of DNA 
template was used in each in vitro transcription reaction. Linear DNA template was 
combined with 1X labelling mix, which contains unlabelled nucleotides and DIG-11-
UTP, 1X transcription buffer and 40 units of T7 polymerase in a final volume of 20 µL. 
Labelling transcription mixes were incubated at 42°C for 1 hour. 20 U of DNase I was 
added to remove template DNA and the reactions were incubated at 37°C for 15 
minutes. The reaction was stopped by addition of 400 mM EDTA (pH 8.0) and labelled 
riboprobes were stored at -20°C.  
2.9.5 Northern Blotting 
Total RNA after extraction as described in 2.9.2 was separated based on its size by 
electrophoresis through an 8.3 M Urea, 1X TBE (Tris Borate EDTA) 7% 
polyacrylamide gel and a denaturing 20 mM guanidine thiocyanate 1.5% agarose gel. 
Generally 1-10 µg of RNA was mixed with an equal volume of 2X Urea-Blue 
denaturing buffer (0.025% xylene cyanol, 0.025% bromophenol blue and 50% urea) 
and samples were heat-denatured at 90°C for 5 minutes and chilled on ice before 
loading. 4 µl of Low Range ssRNA ladder (NEB) or 5 µl RNA molecular weight marker 
I DIG-labeled (Roche) were treated in the same way as the RNA samples in order to 
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allow approximation of detected transcript length. Samples were run in 1X TBE 
running buffer at a constant voltage of 120V for denaturing polyacrylamide gels or 80 
V (at 4°C) for denaturing agarose gels. 
Separated RNA was transferred from polyacrylamide gels to positively charged nylon 
membranes (Roche, cat. 11 209 272 001) using the Trans-Blot SD Semi-Dry 
Electrophoretic Transfer Cell (BioRad) at a constant amplitude of 125 mA for 30 
minutes at 4°C. For denaturing agarose gels, separated RNA was transferred to 
positively charged nylon membranes using overnight capillary transfer in 20X saline-
sodium citrate (SSC) buffer as described in the DIG Application Manual (Roche).  
RNA was UV-crosslinked to the membranes in a CL-1000 UV-crosslinker (UVP) set 
to 3600 (360,000 µJ/cm2). The membrane was equilibrated in hybridisation buffer for 
1 hour at 68°C in pre-warmed DIG Easy Hyb solution (Roche) in a rotating 
hybridisation oven. 5 µl (approximately 1.25 µg) of riboprobe was heat denatured in 5 
ml of DIG Easy Hyb solution at 68°C for 30 minutes and added to the membrane for 
hybridisation overnight at 68°C in the rotating hybridisation oven. The membrane was 
washed twice for a total of 10 minutes in low stringency wash buffer 1 (2X SSC buffer, 
0.1% SDS) at room temperature with rocking on a see-saw rocker (Stuart) at room 
temperature, followed by 2 washes for a total of 30 minutes in high stringency wash 
buffer 2 (0.1X SSC buffer, 0.1% SDS) with rocking at 68°C. Non-specific sites on the 
membrane were blocked using 1X blocking buffer (casein-based blocking buffer 
supplied by Roche and diluted 10-fold in maleic acid buffer (0.1 M maleic acid, 0.15 
M NaCl adjusted to pH 7.5 using NaOH pellets)) for 30 minutes at room temperature 
with rocking. Alkaline phosphatase conjugated polyclonal anti-digoxigenin 
Fab-fragment was diluted 1:10,000 in 1X blocking buffer and immunological detection 
of the membrane proceeded for 30 minutes at room temperature with rocking. The 
membrane was then washed twice for a total of 30 minutes in wash buffer (maleic 
acid buffer, 0.3% Tween-20). The membrane was incubated for 5 minutes in detection 
buffer (0.1M Tris-HCl, 0.1M NaCl, pH 9.5) and CDP-starTM (Tropix) was used as the 
chemiluminescent substrate. Enzymatic de-phosphorylation of CDP-star by alkaline 
phosphatase results in light emission which was visualised using an ImageQuant Las 
4000 Imager. 
2.10 Methods pertaining to infection models 
2.10.1 Murine macrophage infection assays 
RAW 264.7 (ATCC) murine macrophage cells were maintained in Dulbellcco’s 
Minimal Essential Medium (DMEM) supplemented with 5% fetal bovine serum & L-
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glutamine (2 mM final concentration) without antibiotics, incubated at 37°C in 5% CO2. 
For each infection assay, a total of 106 RAW 264.7 cells were seeded in a six well 
plate and infected with overnight grown, complement-opsonized Salmonella strains 
at a multiplicity of infection of 10:1 (bacteria:macrophage). The plates were 
centrifuged at 500 x g for 5 minutes to maximise the uptake and designated as t = 0. 
Thirty minutes after t = 0, the medium was replaced with medium containing 100 µg/ml 
gentamicin, incubated for one hour to kill the extracellular bacteria and then replaced 
with maintenance medium containing 10 µg/ml gentamicin. After t = 1.5 and t = 15.5 
cells were lysed using ice cold 0.1% triton-X100, and intracellular bacterial counts 
determined after plating the dilutions. All strains were tested independently in 
triplicate. The ratio of the intracellular bacterial population at 15 hours 30 minutes to 
1 hour 30 minutes was designated as fold replication, and was used as the 
determinant of virulence. 
2.10.2 Chicken infection experiments 
Chicken infection experiments were carried out with Lizeth Lacharme, Paul Wigley 
and the Author. All work was conducted in accordance with United Kingdom 
legislation governing experimental animals under project license PPL 40/3652 and 
was approved by the University of Liverpool ethical review process prior to the award 
of the license. All birds were checked a minimum of twice daily to ensure their health 
and welfare. Birds were housed in accommodation meeting UK legislation 
requirements. 1-day old Lohmann Brown Layers were obtained from a commercial 
hatchery, separated into groups on arrival and given ad libitum access to water and a 
laboratory-grade vegetable protein-based pellet diet. Chicks were housed at a 
temperature of 30°C. At 7 days of age chickens were inoculated by oral gavage with 
108 CFU of D23580 wild type or D23580 ∆BTP1::FRT. Birds were killed by cervical 
dislocation at 3 days post infection. The liver, spleen and the caecal contents were 
removed aseptically from each bird and diluted 1:5 (wt/vol.) in sterile 1X PBS. Tissues 
were then homogenized in a Colworth 80 microstomacher. Samples were serially 
diluted and dispensed onto Brilliant Green agar to quantify numbers of Salmonella as 
described previously (Salisbury et al., 2011). Data from caecal content and liver are 
not shown. 
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2.11 Next Generation sequencing of Salmonella isolates 
referred to Public Health England 
2.11.1 Illumina short read sequencing & assembly 
Illumina sequencing of Public Health England (PHE) Salmonella isolates was carried 
out at PHE, Collindale, London, UK as described by Ashton et al., 2016. DNA 
extraction for Illumina sequencing of Salmonella isolates was carried out using a 
modified protocol of the Qiasymphony DSP DNA midi kit (Qiagen). In brief, 0.7 ml of 
an overnight Salmonella culture in a 96 deep well plate was harvested. Bacterial cells 
were pre-lysed in 220 μl of ATL buffer (Qiagen) and 20 μl Proteinase K (Qiagen) and 
incubated with shaking for 30 mins at 56°C. Four microliters of RNase (100 mg/ml; 
Qiagen) was added to the lysed cells and re-incubated for a further 15 minutes at 
37°C. This step increased the purity of the DNA for downstream sequencing. DNA 
from the treated cells was then extracted on the Qiasymphony SP platform (Qiagen) 
and eluted in 100 μl of sterile water. DNA concentration was derived using the GloMax 
system (Promega) and quality (optimal OD260/230 = 1.8 - 2.0) was determined using 
the LabChip DX system (Perkin Elmer). Extracted DNA was prepared using the 
NexteraXT sample preparation method and sequenced with a standard 2x100 base 
pair protocol on a HiSeq 2500 instrument (Illumina, San Diego). Raw FASTQs were 
processed with Trimmomatic (Bolger et al., 2014) and bases with a PHRED score of 
less than 30 removed from the trailing end. 
2.11.2 PacBio sequencing of the U2 UK-ST313 reference strain 
Single molecule sequencing was performed on the PacBio RS II instrument at the 
Centre for Genomic Research, University of Liverpool. DNA was extracted from strain 
U2 using the Zymo Research Quick-DNATM Universal Kit (cat# D4069) as per the 
Biological Fluids & Cells protocol. Extracted DNA was purified with Ampure beads 
(Agencourt) and the quantity and quality was assessed by Nanodrop and Qubit 
assays. In addition, the Fragment analyzer (VH Bio), was used to determine the 
average size of the DNA, using a high sensitivity genomic kit. DNA was sheared to 
approximately 10kb using a Covaris g-tube and spinning at 5400rpm in an Eppendorf 
centrifuge. The size range was checked on the Fragment Analyzer. DNA was treated 
with exonuclease V11 at 37°C for 15 minutes. The ends of the DNA were repaired as 
described by Pacific Biosciences. Samples were incubated for 20 minutes at 37°C 
with damage repair mix supplied in the SMRTbell library kit (Pacific Biosciences). This 
was followed by a 5-minute incubation at 25°C with end-repair mix. DNA was cleaned 
using 1:1 volume ratio of Ampure beads and 70% ethanol washes. DNA was ligated 
to adapters overnight at 25°C. Ligation was terminated by incubation at 65°C for 10 
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minutes followed by exonuclease treatment for 1 hour at 37°C. The SMRTbell library 
was purified with 1:1 volume ratio of Ampure beads. The library was size-selected on 
the Blue Pippin (Sage) in the range 7kb-20kb. The DNA was recovered and the 
quantity of library and therefore the recovery was determined by Qubit assay and the 
average fragment size determined by Fragment Analyser. SMRTbell libraries were 
annealed to sequencing primers at values predetermined by the ‘Binding Calculator’ 
software (Pacific Biosciences) and complexes made with the DNA polymerase (P6/C4 
chemistry). The complexes were bound to Magbeads and loaded onto 3 SMRT cells. 
Sequencing was done using 360-minute movie times. Sequence data from the 3 
SMRT cells was assembled using the HGAP3/Quiver assembler. This resulted in 2 
contigs representing the chromosome and the pSLT virulence plasmid. Terminal 
repeats were manually trimmed to represent circular molecules and the chromosome 
assembly was reordered so that the sequence started at the thrL locus in accordance 
with convention for Salmonella finished genomes. The closed sequences for the U2 
chromosome and pSLT virulence plasmid were 4,811,399bp and 93,862bp 
respectively. Prokka (Seemann, 2014) was used to annotate the two sequences, 
using the –force flag to preferentially annotate CDS from reference databases 
FN424405 for the chromosome and AE006471 for the virulence plasmid. The finished 
U2 genome and annotation were submitted to Genbank and can be accessed using 
the Genbank accession number LT855376 (chromosome) and LT855377 (virulence 
plasmid). 
2.12 Bioinformatic analyses 
2.12.1 Genome sequences used in this study 
All genome sequences used in this thesis are publically available, either as short read 
sequence data, or finished reference genomes. Accession numbers for all genome 
sequences used can be found in Appendix i along with the corresponding database 
where the genome sequence data can be accessed. 
2.12.2 Prophage annotation 
Prophage locations in the D23580 genome were extracted from the Genbank 
annotation (Accession number: FN424405) and confirmed by submitting the D23580 
genome sequence to PHAST (Zhou et al., 2011). The genome of S. Typhimurium 
strain 4/74 (Accession number: CP002487) was used as a comparator to identify 
D23580-specific prophages. Genome comparison was done using blastn alignment 
with default parameters and visualised using the Artemis Comparison Tool (ACT) 
(Carver et al., 2008). Prophage ORFs were characterized by uploading individual 
prophage sequences to the RAST server, and visualised using the SEED viewer in 
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the context of the closest phage relatives in the RAST database (Aziz et al., 2008; 
Overbeek et al., 2014). Protein functions were inferred based on homologies to known 
proteins by the blastp and psiblast server of NCBI using the UniProt/Swiss-Prot 
database. Morphological classification was made based on similarity to other well-
studied phages. Clustering of functional gene groups was based on a similar analysis 
by Zou et al., 2010. Assessment of the conservation of the functionally degradative 
mutations identified in Gifsy-1D23580, ST64BD23580 and Gifsy-2D23580 across other ST313 
isolates was achieved using blastn. Genome assemblies were downloaded from 
Enterobase (http://enterobase.warwick.ac.uk). 
2.12.3 Genomic analysis of Public Health England Salmonella Typhimurium 
isolates 
Genome analysis of sequences of PHE S. Typhimurium isolates was performed by 
Phil Ashton, Public Health England and the Author. Genome sequences from a total 
of 363 Salmonella Typhimurium isolates dating from 2012 and 3,014 Salmonella 
Typhimurium from January 1st 2014 to March 14th 2016 were analyzed. For simplicity, 
if isolates derived from blood culture, the infection was classed as extra-intestinal. If 
only a faecal isolate was received for a patient, the infection was classed as 
gastrointestinal (though this is only suggestive, not conclusive, data that the infection 
was restricted to the gastrointestinal tract). Of these, 7/363 (1.9%) and 79/3,014 
(2.6%) were Salmonella Typhimurium ST313, respectively. Full strain metadata can 
be found in Appendix i. Sequence data (FASTQs) from 23 representative ST313 
sequenced by Okoro et al. (Okoro et al., 2012) were downloaded from the European 
Nucleotide Archive (accessions available in Appendix i) and analyzed in the same 
way as sequence data generated from UK-isolated ST313 isolates. 
The multi-locus sequence type (ST) was determined using a modified version of 
SRST (Inouye et al., 2012). For phylogenetic analysis, processed sequence reads 
were mapped to the S. Typhimurium LT2 reference genome (GenBank: AE006468) 
using BWA mem (Li and Durbin, 2009). SNPs were called using GATK2 (DePristo et 
al., 2011) in unified genotyper mode. Core genome positions that had a high quality 
SNP (>90% consensus, minimum depth 10x, MQ >=30) in at least one strain were 
extracted and IQ-TREE with parameters –m TVM+ASC –bb 1000 was used to 
construct a maximum likelihood phylogeny (Nguyen et al., 2015). The TVM model 
was chosen after using the model test functionality built into IQ-TREE. 
To examine the evolutionary history of ST313, four timed phylogenies were 
constructed using BEAST v1.8.0 (Drummond and Rambaut, 2007), with varying clock 
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rate models and tree priors. The resulting models were compared in terms of their 
tree likelihood and posterior and the strict exponential and strict constant models were 
found to be superior. A comparison using AICM calculated with Tracer v1.6.0 showed 
that the models had very similar values, tree topologies and branching support in 
terms of posterior probability were similar between the models. The 95% HPD for the 
exponential growth rate estimate was -0.0026 to 0.0006; the strict, constant growth 
model was selected as the estimate of growth rate from the exponential model was 
around 0 (i.e. constant). 
Accessory genome analysis was performed using de novo assemblies of quality 
processed FASTQs produced using SPAdes v2.5.1 using default parameters except 
–careful and –k 22, 33, 55, 77 (Bankevich et al., 2012). Whole genome assemblies 
were compared to the reference ST313 strain D23580 using BRIG (Alikhan et al., 
2011). Antibiotic resistance loci present in the genome sequences were identified 
using ResFinder 2.1 (Zankari et al., 2012) 
2.12.4 RNA-seq based transcriptomic analysis 
Investigation of prophage gene expression used data from Canals et al. (2018) and 
Hammarlöf et al. (2017). Normalised mapped reads for the D23580 prophage regions 
were visualised in the Integrated Genome Browser (IGB) (Nicol et al., 2009), and 
transcripts per million (TPM) values (calculated were obtained from Canals et al. 
(2018) based on the approach of Wagner et al. (Wagner et al., 2012, 2013) 
representing a normalised expression value for each gene were used to compare 
gene expression between conditions. As in Kröger et al., 2013, a TPM cut-off score 
of 10 was used to define gene expression, so that only genes with a TPM value of 
>10 were considered to be expressed. Heat maps showing absolute expression were 
made using TPM values and conditional formatting in Microsoft Excel. Prophage 
transcriptome maps were generated by visualisation of sequence reads in the 
Integrated Genome Browser (IGB) (Nicol et al., 2009). For display in IGB, the read 
depth was adjusted in relation to the cDNA library with the lowest number of reads 
(Skinner et al., 2009). IGB was used to generate prophage transcriptome maps shown 
in Chapter 5. 
For analysis of prophage-regulated core genes (Chapter 5.3), RNA-seq data quality 
was assessed using FastQC (version 0.11.5) (Andrews, 2010) and then processed 
with Trimmomatic (version 0.36) (Bolger et al., 2014) to remove Illumina TruSeq 
adapter sequences, leading and trailing bases with a Phred quality score below 20 
and trim reads with an average base quality score of 20 over a 4bp sliding window. 
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All reads less than 40 nucleotides in length after trimming were discarded from further 
analysis.  
The remaining reads of each library were aligned to the PacBio resequenced D23580 
genome (D23580_liv), which differs from the Genbank version by 1 SNP and 2 single 
nucleotide indels (Canals et al., 2018), using Bowtie2 (version 2.2.9) (Langmead and 
Salzberg, 2012) and alignments were filtered with Samtools (version 1.3.1) (Li et al., 
2009) using a MAPQ cut-off of 15. There was an average of 1,998,911 uniquely 
mapped sequence reads per sample (Table 2.9). 
A custom genome annotation for the D23580_liv genome including sRNAs (Canals et 
al. 2018; Hammarlöf et al., 2017) was used to define gene expression. Reads were 
assigned to genomic features using featureCounts (version 1.5.1) (Liao et al., 2014) 
and count data was imported into R (version 3.2) (R Core Team, 2013). Count data 
was then filtered using a Counts Per Million (CPM) threshold of 1.2 (corresponding to 
a count of between 10-15 for library sizes in this study). Trimmed Mean of M values 
(TMM) scaling to adjust libraries for composition bias was performed using EdgeR 
(Robinson and Oshlack, 2010). Normalised count data was converted to logCPMs 
and variance stabilised using VOOM (Law et al., 2014) prior to differential gene 
expression testing using Limma (Ritchie et al., 2015). The analysis and visualisation 
tool Degust (Powell, 2017) was used to identify differentially expressed genes, using 
a minimum gene read count of 10 in at least one replicate (Law et al., 2014), and a 
minimum CPM of ≥1 in more samples than the size of the smallest group, in this case, 
3 (Law et al., 2016). Differentially expressed genes were defined using a Benjamini-
Hochberg adjusted P value (false discovery rate- FDR) of ≤0.01 and a fold change 
value of ≥2. 
2.12.5 Sequence analysis and sequence identity analysis 
Nucleotide sequence identity between single gene or genomic regions was computed 
using blastn. Protein sequence identity was computed using blastp. Either the 
command line version (blastall 2.2.17) or the web server 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) was used. Sequence identity was reported as 
a factor of query coverage and query identity, calculated as [query cover x query 
identity (decimal)]. Sequence alignments computed using BLAST were visualised 
using the artemis comparison tool (ACT) where required and the artemis genome 
browser was used to interrogate genome sequences and genome annotations 
(Carver et al., 2008). 
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Table 2.9 Mapping statistics for RNA-seq data described in Chapter 5.6. Read 
mapping statistics are shown for all experimental samples (Canals et al., 2018. 
Strain Condition 
% 
mapped 
reads 
Total no. 
reads 
Uniquely 
mapped 
Not 
aligned 
Multi-
mapped 
D23580 WT ESP 99.82 7,106,622 2,246,063 12,529 4,848,030 
D23580 WT ESP 99.73 6,317,700 2,459,055 17,102 3,841,543 
D23580 WT ESP 99.65 6,393,126 2,128,022 22,254 4,242,850 
D23580 WT InSPI2 99.78 7,233,754 1,780,649 15,807 5,437,298 
D23580 WT InSPI2 99.51 6,459,816 1,462,484 31,590 4,965,742 
D23580 WT InSPI2 99.81 6,160,957 1,508,700 11,477 4,640,780 
D23580 WT NoO2 99.84 7,123,525 2,303,151 11,305 4,809,069 
D23580 WT NoO2 99.85 8,099,708 2,111,827 11,836 5,976,045 
D23580 WT NoO2 99.85 8,667,400 2,534,019 12,934 6,120,447 
D23580 ΔBTP1 ESP 99.88 7,374,123 2,474,245 8,895 4,890,983 
D23580 ΔBTP1 ESP 99.79 7,608,355 2,691,343 15,825 4,901,187 
D23580 ΔBTP1 ESP 99.65 6,894,681 3,153,897 24,414 3,716,370 
D23580 ΔBTP1 InSPI2 99.82 7,375,387 2,035,307 13,143 5,326,937 
D23580 ΔBTP1 InSPI2 99.86 6,616,691 1,746,450 9,138 4,861,103 
D23580 ΔBTP1 InSPI2 99.79 7,503,062 2,023,998 15,983 5,463,081 
D23580 ΔBTP1 NoO2 99.73 7,843,238 1,985,195 21,417 5,836,626 
D23580 ΔBTP1 NoO2 99.79 6,967,213 1,814,589 14,931 5,137,693 
D23580 ΔBTP1 NoO2 99.80 6,484,729 1,868,969 13,021 4,602,739 
D23580 ΔBTP1 
ΔBTP5 ESP 99.75 6,648,857 1,763,987 16,884 4,867,986 
D23580 ΔBTP1 
ΔBTP5 ESP 99.74 5,598,561 1,708,604 14,561 3,875,396 
D23580 ΔBTP1 
ΔBTP5 ESP 99.79 7,171,494 2,279,589 14,961 4,876,944 
D23580 ΔBTP1 
ΔBTP5 InSPI2 99.78 6,896,453 1,760,546 15,141 5,120,766 
D23580 ΔBTP1 
ΔBTP5 InSPI2 99.75 6,674,203 1,624,967 16,994 5,032,242 
D23580 ΔBTP1 
ΔBTP5 InSPI2 99.81 7,741,768 1,930,829 14,441 5,796,498 
D23580 ΔBTP1 
ΔBTP5 NoO2 99.64 5,187,790 1,302,735 18,563 3,866,492 
D23580 ΔBTP1 
ΔBTP5 NoO2 99.61 5,770,089 1,777,678 22,638 3,969,773 
D23580 ΔBTP1 
ΔBTP5 NoO2 99.68 5,601,759 1,264,197 17,921 4,319,641 
D23580 ΔBTP5 ESP 99.70 7,189,101 2,038,582 21,827 5,128,692 
D23580 ΔBTP5 ESP 99.82 6,718,987 2,117,221 11,763 4,590,003 
D23580 ΔBTP5 ESP 99.80 7,823,044 2,269,812 15,794 5,537,438 
D23580 ΔBTP5 InSPI2 99.88 8,297,362 2,022,696 9,674 6,264,992 
D23580 ΔBTP5 InSPI2 99.89 8,785,241 2,178,345 9,657 6,597,239 
D23580 ΔBTP5 InSPI2 99.79 7,278,270 1,879,197 15,007 5,384,066 
D23580 ΔBTP5 NoO2 99.81 6,352,867 1,748,201 12,141 4,592,525 
D23580 ΔBTP5 NoO2 99.67 5,949,282 1,909,743 19,578 4,019,961 
D23580 ΔBTP5 NoO2 99.86 7,732,496 2,055,886 11,054 5,665,556 
Average - 99.77 6,990,214 1,998,911 15,617 4,975,687 
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Chapter 3 
The Prophage Repertoire of S. 
Typhimurium ST313 
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3.1 Introduction 
All complete genomes of Salmonella encode prophages, and therefore it is likely that 
prophages are harboured by every member of the Salmonella genus (Bobay et al., 
2014; Lemire et al., 2008; Villafane et al., 2008). The prophage sequences found in 
Salmonalla genomes may be classified into 3 classes: functional, defective and 
remnant. 
Functional prophages encode all necessary faculties to complete each stage of the 
prophage lifecycle, including infection, lysogeny, induction and infection. Defective 
prophages arise when mutations occur which impede any stage of the prophage life 
cycle. Mutations that produce defective prophages include those that affect gene 
expression such as disruption of a promoter sequence; or mutations that inhibit 
protein function, such as frame-shift mutations in open reading frames (ORFs) or 
single nucleotide polymorphisms (SNPs) resulting in non-synonomous amino acid 
substitutions. Remnant prophages are prophage-derived sequence islands that have 
lost many of the genes required for prophage function. Remnant prophages may be 
described as ‘domesticated’, because they frequently contain only the subset of 
genes from the ancestral functional prophage which were beneficial to the host 
(Bobay et al., 2014). For example, in Salmonella, many virulence genes are carried 
on prophage remnant sequence islands (Casjens, 2011). The distinction between 
defective and remnant prophages is important, and these terms have been frequently 
used erroneously. Strictly, a defective prophage may be resuscitated by spontaneous 
reversion of the causative mutation, whilst a remnant prophage generally results from 
large deletions and extensive gene loss over a long period of evolutionary time, 
rendering resuscitation very unlikely. Defective prophages may therefore be thought 
of as recent evolutionary events which can be isogenic in closely-related strains, 
whereas remnant prophages are generally conserved across many strains (even 
those that are distantly related), and may be considered to be evolutionarily ‘ancient’. 
Theoretically, a remnant prophage could be pseudo-resuscitated by recombination 
with a functional prophage, however this process would require the introduction of a 
substantial amount of new genetic material, which is not required for resuscitation of 
a defective prophage.  
Due to the subtleties of the distinctions between functional, defective and remnant 
prophages, it is difficult to define prophage status in silico, though prophage remnants 
are generally distinguishable due to their short length and lack of essential phage 
genes, for example structural genes. Functional and defective prophages can only be 
definitively distinguished experimentally, however, a prophage with no overt genetic 
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mutations that does not form plaques on putatively susceptible strains can never be 
definitively proven to be defective, due to the possibility the prophage being studied 
is simply intractable to standard phage-detection methods. This chapter will 
characterise the prophage sequences of ST313 representative strain D23580 in terms 
of gene content and functional status, and describe the phage biology of the functional 
prophages.  
3.1.1 Acknowledgement of the specific contribution of collaborators to the 
results described in Chapter 3.  
Much of the content of this chapter is published in the research article Owen et al., 
(2017). I acknowledge the following contribution of collaborators to the results 
described in this chapter. Unless specified below, all work was completed by the 
Author. 
Nicolas Wenner  
University of Liverpool, UK 
 
Construction of suicide plasmids for deletion 
of the prophages (2.8.2), construction of 
single nucleotide substitution mutant D23580 
PdinI-gfoA14028 (2.6.2) 
Angela Makumi, Abram Aertsen 
KU Leuven, Belgium 
 
Construction (2.6.1) of RecA- strains and 
assay of RecA-independent induction of 
prophages BTP1 & P22 (3.3.4)  
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3.2 The ST313 prophage repertoire 
Six prophages were originally annotated in the genome of ST313 representative strain 
D23580 (Kingsley et al., 2009). I conducted a more detailed analysis, and found that 
in fact, D23580 contains a total of 9 phage-derived sequence islands (Figure 3.1A, 
Table 3.1). Four short prophage-remnants were named Def1-4, using the 
nomenclature defined for S. Typhimurium strain LT2 (Casjens, 2011). Def1-4 are 
found in all complete S. Typhimurium genomes currently available on NCBI (accessed 
28th July 2016) (data not shown) and are likely to be ancestral to the serovar (Casjens, 
2011). One feature designated ‘BTP6’ was included in the original annotation of 
D23580 (accession FN424405) (Kingsley et al., 2009) and is located at the position 
of prophage remnant Def4. The remaining five prophage regions, designated BTP1-
5 by Kingsley et al. (2009), are full-length prophages (Table 3.1) that contain all the 
functional gene clusters required for putative phage function such as 
integration/excision, immunity, lysis, capsid and tail gene clusters. My analysis 
determined that three represent well-characterised prophages, commonly found in S. 
Typhimurium genomes: BTP2 is Gifsy-2 D23580, BTP3 is ST64B D23580 and BTP4 is 
Gifsy-1 D23580 (Figueroa-Bossi et al., 2001; Tucker and Heuzenroeder, 2004). In 
contrast, BTP1 and BTP5 are novel prophages that are only found in ST313 and not 
present in the comparator ST19 strain 4/74 (Figure 3.1B). When compared to ST19 
strain 4/74, the sopEΦ prophage is absent from D23580, however this prophage is 
variably present in ST19 isolates; sopEΦ is not present in most of the reference ST19 
strains such as LT2 or 14028 (Mirold et al., 1999). Together, the phage-derived 
sequence islands found in D23580 harbour many characterised virulence-related 
genes in S. Typhimurium including genes encoding effector proteins and O-antigen 
modification genes (gtr genes) (Table 3.1). 
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Figure 3.1 The prophage repertoire of S. Typhimurium ST313 strain D23580, 
and genome comparison to ST19 strain 4/74. A. Full length (functional or 
defective) prophages are labelled in bold and represented by coloured rectangles, 
whilst remnant prophages are labelled in grey and represented by grey stars. B. 
Alignment of the D23580 chromosome with comparator ST19 strain 4/74 using 
blastn. Red coloured blocks indicate individual blastn hits of more than 90% identity. 
White regions represent sequence that is unique to either genome. The unique 
prophages in both genomes are annotated. 
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Table 3.1 Location of all prophage or remnant prophage elements in the 
D23580 chromosome and the encoded virulence-related genes. All elements 
are present in ST19 representative strain 4/74, apart from BTP1 and BTP5 
(highlighted in red).  
Prophage 
/ remnant 
Location on 
D23580 
chromosome 
Length (bp) Virulence-related genes 
BTP1 368797 - 409321 40,525 st313-td (STMMW_03531), gtrCc (STMMW_03911), gtrAc 
(SMMTW_03921) 
Def1  
(SPI-16) 652441 - 656532 4,091 
gtrCa (STMMW_06231), gtrBa (STMMW_06241), gtrAa 
(STMMW_06251) 
Gifsy-2 
D23580
  
(BTP2) 1094166 - 1140420 46,254 
gtgA (STMMW_10381), sodCI (STMMW_10551), sseI 
(STMMW_10631-pseudogene), gtgE (STMMW_10681) gtgF 
(STMMW_10691) 
Def2 1945242 - 1951433 6,191 sopE2 (STMMW_18441) 
ST64B 
D23580
 
(BTP3) 2065743 - 2105830 40,087 sseK3 (STMMW_19812) 
Def3  
(inc. SPI-12) 2354483 - 2369638 15,155 sspH2 (STMMW_22721) 
Gifsy-1 
D23580
 
(BTP4) 2753352 - 2803478 50,126 
gogB (STMMW_26001), gipA (STMMW_26191), gtgA 
(STMMW_26331),  
BTP5 3370278 - 3401458 31,181 - 
Def4 4440630 - 4461045 20,415 gtrCb (STMMW_41431), gtrBb (STMMW_41541), gtrAb 
(STMMW_41551) 
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3.2.1 Functionality of the D23580 prophages 
Prophages were initially defined as functional if viable (infectious) phage particles 
could be produced, with or without chemical induction by the DNA-damaging agent 
mitomycin C. To test the functionality of each of the D23580 prophages, a series of 
naive indicator strains of D23580 were created using scarless genome editing to 
delete each prophage (Chapter 2.8.2). This resulted in a collection of five isogenic 
D23580 derivative strains, each lacking a single prophage (Table 3.2A) and harboring 
intact phage attachment sites (attB). As Gifsy phages have previously been shown to 
yield visible plaques only on hosts with short LPS, due to the receptor OmpC being 
blocked by the O-antigen (Ho and Slauch, 2001), an additional galE496 mutation was 
introduced to facilitate detection of Gifsy-phage plaques (Chapter 2.6.1). Specific 
indicator strains used to detect each phage are shown in Table 3.2.  
The supernatant from a 16 h LB culture of strain D23580 yielded circular plaques of 
~1 mm in diameter with turbid centres on the specific indicator strain D23580 ∆BTP1 
at a remarkably high abundance of ~109 PFU/ml (plaque-forming units per ml). 
Mitomycin C induction increased the phage titer 10-fold to ~1010 PFU/ml (Table 3.2A). 
PCR from isolated plaques confirmed that the plaques were from the BTP1 phage 
(data not shown). However, plaques for the remaining four prophages were not 
detected using the specific indicator strains, with or without mitomycin C induction. 
Prophages may contain superinfection exclusion systems that give cross-immunity to 
other prophages. To control for the possibility that other D23580 prophages may be 
excluding the target phage in the specific indicator strains, a strain with all five full-
length prophages deleted was constructed (designated D23580 ΔΦ). When 
supernatant from D23580 ΔBTP1 was plated onto a lawn of D23580 ΔΦ, no plaques 
were observed, supporting the conclusion that of the five D23580 prophages, only 
BTP1 is capable of producing viable phages (Table 3.2B).  
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Table 3.2 Detection of active prophage in D23580 by plaque formation on 
specific indicator strains for each D23580 prophage. ‘Not detected’ indicates 
spontaneous phage induction at less than the detection threshold of 1x102 PFU/ml. 
A. D23580 was included as an indicator strain to confirm that the strain does not 
support plaques from induced phages present in its own supernatant.  B. To control 
for the possibility that other prophages may be super-excluding the target phage in 
the specific indicator strains, supernatant from D23580 ΔBTP1 was plated on an 
indicator strain with all 5 prophages removed (D23580 ΔΦ), yielding no detectable 
plaques. Methods describing plaque assay can be found in Chapter 2.4.2. 
A 
 
Specific phage titer (PFU/mL) 
in D23580 WT supernatant * 
Specific indicator strain Target prophage Non-induced + Mitomycin C 
D23580 ∆BTP1 BTP1 1x109 2x1010 
D23580 ∆Gifsy-2 galE496 Gifsy-2 (BTP2) Not detected Not detected 
D23580 ∆ST64B ST64B (BTP3) Not detected Not detected 
D23580 ∆Gifsy-1 galE496 Gifsy-1 (BTP4) Not detected Not detected 
D23580 ∆BTP5 BTP5 Not detected Not detected 
D23580 ∆Gifsy-1 galE496 Gifsy-1 PdinI-gfoA14028s 1x104 2x106 
D23580 WT Putative superimmune 
phage (control) Not detected Not detected 
 B 
  
  Specific phage titer (PFU/mL) 
in D23580 ΔBTP1 supernatant * 
Specific indicator strain Target prophage Non-induced + Mitomycin C 
D23580 ΔΦ (All 5 prophages 
deleted) 
Gifsy-1, Gifsy-2, ST64B 
or BTP5 Not detected Not detected 
    
* Supernatant from an overnight cultures prepared as described in 2.3.1. 
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3.3 BTP1                
3.3.1 Gene content 
The gene content and synteny of BTP1 resembles that of model Salmonella phage 
P22, exhibiting an overall 50% similarity at the nucleotide level, suggesting that BTP1 
belongs to the Podoviridae family of short-tailed phages (Ackermann, 2009). 
Functional annotation of BTP1 genes identified a number of putative cargo loci on the 
prophage: independent transcriptional units that are not required for the prophage 
lytic or lysogenic cycles (Cumby et al., 2012). Like P22, BTP1 contains a gtrAC operon 
(STMMW_03911-03921) (Figure 3.2) which encodes a glycosyltransferase enzyme 
(GtrC) that modifies the O-antigen of the bacterial lipopolysaccharide (Kintz et al., 
2015). This glycosyltransferase mediates the acetylation of the rhamnose residue of 
the O-antigen and is classified as a family 2 GtrC protein, which is typically associated 
with invasive Salmonella serovars such as Typhi and Paratyphi A (Kintz et al., 2015). 
Previously it has been shown that a BTP1 lysogen is highly resistant to superinfection 
by P22 (Kintz et al., 2015), suggesting the two phages contain cross-protective 
superinfection immunity systems, likely the gtr glycosyltransferase.  
The st313-td gene (STMMW_03531) is encoded immediately downstream of the cI 
repressor locus. According to a recent paper, deletion of st313-td decreases survival 
within murine macrophages, and results in attenuation in a mouse infection model 
(Herrero-Fresno et al., 2014). At the time of description of the st313-td gene, prophage 
BTP1 had not been characterised and therefore the fact that st313-td was BTP1-
encoded has not been previously explored. Additionally, the pid ORFan locus 
(STMMW_03751) is present in BTP1. The P22-encoded Pid regulatory protein de-
represses the host dgo operon in S. Typhimurium LT2 (Cenens et al., 2013). The 
complete functionally annotated map of BTP1 is shown in Figure 3.2. The 
chromosomal context of the BTP1 attachment site and the core att sequence for BTP1 
is shown in Figure 3.3. 
A comparative genomic analysis assigned putative function to 43/64 (62.5%) of the 
annotated open reading frames (ORFs) of BTP1 (Figure 3.2). A comparison with 
model phages P22 and Lambda revealed that BTP1 ORFs can be classified into 10 
functional blocks; int/xis, ea region, Recombination, Immunity, Replication, nin region, 
Lysis, Capsid & tail and gtr (glycosyltransferase) (Figure 3.2). 
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Figure 3.2 Functionally annotated map of the BTP1D23580 prophage sequence. Coloured arrows represent ORFs for which a function can be inferred based on sequence. White arrows 
represent ORFs for which no function can be inferred. 
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Figure 3.3 Genomic context and core sequence of the BTP1 attachment site 
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3.3.2 BTP1 homology to other sequenced prophages and phages 
To further understand the genetic context of BTP1 in phage sequence space, the 
nucleotide sequence of the BTP1 prophage was compared to other sequenced 
phages and prophages (Figure 3.4). The functional blocks of BTP1 show mosaic 
conservation in other phage and prophage genomes suggesting functional overlap 
and recombination. Similarity to other phages extends beyond phages that infect the 
Salmonella genus, as BTP1 shares sequence identity with P22-like phages of E. coli 
and Shigella (CUS-3, HK620 and Sf6). Some BTP1 functional blocks are rarer among 
the sequences sampled in this analysis than others. For example, the BTP1 gtr block 
is only found elsewhere in Salmonella phage ε34. Others, such as the capsid & tail 
block, int/xis block and recombination block, are found in the majority of sampled 
sequences. The immunity regions of the P22-like phages and prophages also show 
mosaicism, with some phages sharing an almost identical immunity region, and other 
phages completely lacking homology to the immunity region of BTP1. For example, 
there is no significant nucleotide homology between the immunity regions of BTP1 
and P22. In contrast, prophage ST104 contains a comparable immunity region to 
BTP1 (Figure 3.5). The differences between the immunity regions suggest the 
regulation of lysogeny may differ between these prophages. Notably, the sieB gene, 
encoding an asRNA based superinfection exclusion system (Ranade and Poteete, 
1993), is present in the immunity region of P22 and ST104, and is absent from the 
immunity region of BTP1. 
Comparison of the BTP1 and P22 late genes using tblastx shows that other structural 
regions share extensive homology, with the notable absence of the P22 immunity 
region (imml) in BTP1 (Figure 3.5). Due to the high level of sequence identity and the 
detailed three-dimensional structural information that is available for many P22 
proteins, it was possible to map the protein coding genes of BTP1 onto a structural 
model of P22 (Figure 3.6). The capsid and tail genes of BTP1 show a high level of 
similarity to P22, with the majority of proteins sharing >90% amino acid identity. The 
genes involved in DNA injection (STMMW_03871-91) show less homology, putatively 
suggesting subtle differences between the mechanisms of DNA entry of the phages. 
The tailspike protein of P22-like phages consists of a short head-binding domain 
(HBD) which attaches the tailspike to the capsid, and a receptor-binding domain 
(RBD) responsible for recognition and binding to the bacterial receptor (Steinbacher 
et al., 1997). The HBD of the BTP1 tailspike shares 97% sequence identity with P22, 
however the receptor-binding domain is more divergent and is just 65% identical. This 
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may indicate differences in the enzymatic activity of the tailspike protein, which in P22 
is known to have endorhamnosidase activity (Iwashita and Kanegasaki, 1973). 
 
 
 
Figure 3.4 Functional genetic architecture of BTP1 and homology to sequenced 
Salmonella phages and prophages, and non-Salmonella phages. Starting from 
the inside, circular panels represent functional clusters of genes: ORFs colored 
according to functional cluster with functionally-unknown ORFs colored grey; BLAST 
homology to other Salmonella phage sequences (red-shaded ring), Salmonella 
prophage sequences (green-shaded ring) and non-Salmonella phages (blue-shaded 
ring). The order of sequences represented by each concentric ring of the BLAST 
homology panel are shown on the right.  
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Figure 3.5 The immunity region of BTP1 compared to P22 and ST104. 
Comparison of nucleotide similarity (computed using blastn) of the immunity regions 
of phage P22, BTP1 and ST104. Red blocks indicate individual blastn hits of >90% 
identity. 
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Figure 3.6 Structural gene cluster of BTP1 and virion protein model based on phage P22. (A) The structural gene cluster of prophage BTP1 
consists of 13 ORFs of known function in virion structure and assembly (shown as colored arrows). Additionally, there are three ORFs of unknown 
function (shown as white arrows). Model phage P22 contains an almost identical structural cluster, but with the major addition of the imml region. 
Grey bars show the percentage amino acid identity of gene homologues. Published CDS annotation is shown for both regions. The gene encoding 
the tailspike (STMMW_03901) is separated into its two functional domains: the head-binding domain (HBD) and the receptor-binding domain 
(RBD). (B) Diagram of predicted structure and location of structural proteins in BTP1, based on cryoEM reconstruction of phage P22 by Tang et 
al., 2011. BTP1 shares near identical structural gene content with P22 and colored protein segments correspond to the protein coding genes in 
(A).  
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The complete BTP1 prophage was not detected in any other complete Salmonella 
genomes on publically available databases. However, analysis of draft genome 
sequences on NCBI revealed that a prophage highly similar to BTP1 was present in 
a genome of a S. Typhimurium isolate belonging to the sequence type ST568. Strains 
belonging to ST568 are commonly isolated from wild passerine (garden) birds in the 
UK and frequently belong to the DT56v. phage type (Hughes et al., 2010; Mather et 
al., 2016). Interestingly, African ST313 isolates carrying the BTP1 prophage most 
often belong to the DT56v. phage type (Kingsley et al., 2009). In order to understand 
the presence and distribution of the BTP1 prophage in S. Typhimurium ST568, strains 
belonging to this sequence type were investigated using the open-access genome 
sequence and metadata database, Enterobase, which contains over 100,000 
Salmonella genome sequences (https://enterobase.warwick.ac.uk/). 75 ST568 
genomes are available on Enterobase, and metadata is available for of the 36 
genomes. The majority originated in the UK, and ST568 has also been isolated in 
Ireland, France and Myanmar. Though the sequence type has previously been 
associated with passerine birds in the UK, metadata available in Enterobase suggest 
that this sequence type can also cause disease in humans, as the majority of 
genomes with metadata available are of human origin. However, epidemiological 
conclusions cannot be drawn from this data, as sampling of Salmonella is hugely 
biased towards human isolates (which are routinely sequenced by Public Health 
England, and Public Health England are one of the largest contributors to 
Enterobase). 
The Enterobase ST568 genome with the best genome assembly (as judged by 
highest N50 value) was selected as a representative genome for further analysis of 
the BTP1ST568 prophage. The genome assembly chosen was for a strain called 
201102250 which was isolated in 2011 and uploaded to Enterobase by F.X. Weill 
(Institut Pasteur, Paris); though no country or isolation source are provided. The intact 
BTP1 prophage sequence was located on a large contig of 419,117 bp. The prophage 
was 99.995% identical to BTP1D23580, representing a difference of just 2 SNPs (Figure 
3.7A). Analysis of the chromosomal sequence surrounding the prophage on the contig 
indicated that the attachment site of BTP1201102250 was the same as BTP1D23580 (tRNA-
Thr) (data not shown). 
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Figure 3.7 Prophage BTP1 is found in S. Typhimurium ST568. A. BTP1 is 
99.995% identical to a prophage from ST568 strain 201102250 and differs by just 2 
SNPs. B. The pid gene, representing BTP1 is present in the majority of ST568 
genomes sequences available on Enterobase. Black arrows highlight the genomes 
where the pid gene (and, by inference, BTP1) is not present (grey nodes). 
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The pid gene was used as a marker of the BTP1 prophage, in order to screen all 75 
ST568 genomes on Enterobase and these data were visualised in the context of a 
core SNP phylogeny of the ST568 isolates (Figure 3.7B). The BTP1 prophage 
(indicated by the presence of the pid (STMMW_03751) gene) was present in 69 of 
the 75 ST568 genomes. As both the ST313 and ST568 sequence types of S. 
Typhimurium that carry the BTP1 prophage are associated with the phage type 
DT65v., it is speculated that the BTP1 prophage is the key molecular determinant of 
this phage type i.e. the presence of the BTP1 prophage in S. Typhimurium genomes 
results in the DT56v. phage type. Furthermore, the presence of BTP1 in a clade of S. 
Typhimurium associated with wild birds raises interesting questions concerning the 
transmission of BTP1 between the two distinct sequence types of S. Typhimurium. As 
many wild bird species follow annual migratory cycles, which for some species may 
include sub-Saharan Africa, it is possible that BTP1 was transmitted to ST313 in Africa 
from ST568 in the UK, or vice versa, to ST568 in the UK from ST313 in Africa, via 
wild birds. Though such a scenario cannot be verified from available data, it may 
become an important surveillance consideration should the BTP1 prophage be 
implicated in the disease tropism of S. Typhimurium ST313. 
3.3.3 Structural morphology and taxonomic classification of the BTP1 phage 
The morphology of the BTP1 phage was determined by Transmission Electron 
Microscopy (TEM). The purified BTP1 phage preparation contained short-tailed 
phages with icosahedral capsids of approximately 65 nm in diameter (Figure 3.8B). 
The addition of purified BTP1 phages to susceptible S. Typhimurium 4/74 cells 
allowed the same short-tailed phages to be seen adsorbing to the surface of the 
bacterial cells (Figure 3.8A). Empty ‘ghost’ virions were also observed, suggesting 
that some phages had already adsorbed and injected DNA into the host cell at 20 
minutes post-infection. 
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Figure 3.8 TEM of BTP1 virions infecting S. Typhimurium 4/74. BTP1 virions from 
D23580 overnight supernatant (Chapter 2.3.1) were added to mid-exponential phase 
4/74 (OD600 =0.3) cells in liquid culture. After 20 minutes samples were prepared for 
TEM with negative staining using uranyl acetate (Chapter 2.4.8). (A) BTP1 virions 
adsorbing to a 4/74 cell (black arrows). (B) An isolated BTP1 virion. 
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I propose that BTP1 represents a new species designated Salmonella virus BTP1 
within the P22virus genus (taxonomic proposal pending acceptance). This is 
consistent with the International Committee on Taxonomy of Viruses (ICTV) criterion 
that members of a proposed species differ from those of other species by more than 
5% at the DNA level as confirmed with the blastn algorithm, and the phage has been 
verified by electron microscopy. The BTP1 phage genome was sequenced and re-
ordered to begin at the small terminase subunit, to conform to the reference sequence 
for the P22virus genus, Salmonella virus P22 (accession: BK000582). No sequence 
differences were found between the BTP1 prophage and phage sequences (data not 
shown). The annotated genome and sequencing reads for the BTP1 phage have been 
deposited at the DDBJ/EMBL/GenBank database under the accession LT714109 
(URL: http://www.ebi.ac.uk/ena/data/view/LT714109) and study accession 
PRJEB18919. The proposed species Salmonella virus BTP1 has been assigned the 
taxon ID 1934252. 
3.3.4 Spontaneous induction of prophage BTP1 
BTP1 was the only phage that could be recovered from the D23580 culture 
supernatant using plaque assay methodology (3.2.1) and the uninduced culture 
yielded a titre of ~109 PFU/ml which was increased to ~1010 PFU/ml with the addition 
of mitomycin C (Table 3.2A). The titer of BTP1 in D23580 culture supernatants was 
10,000-fold greater than the titer of P22 in the supernatant of D23580 ΔΦ [P22] 
(Figure 3.9A). To determine whether the unusually high level of spontaneous 
induction (Table 3.2) is an intrinsic characteristic of the BTP1 prophage, a prophage-
cured derivative of Salmonella Typhimurium LT2 (MA8505) was lysogenized with 
BTP1, and compared with LT2 lysogenized with P22. The phage titer of non-induced 
culture supernatants was determined (Figure 3.9D), showing that a high frequency of 
spontaneous induction is an inherent characteristic of phage BTP1, independent of 
the D23580 host. The burst size of BTP1 in D23580 was around 600 (Figure 3.9B), 
resembling the burst size of phage P22 (Aramli and Teschke, 1999). The titer of 109 
PFU/ml in the D23580 non-induced 16 h culture (Table 3.2A) suggests that the 
fraction of the population undergoing phage-mediated lysis is approximately 0.2%. In 
LT2 [BTP1], the fraction of the population undergoing phage-mediated lysis is 
approximately 0.02% (this calculation is explained in Chapter 2.4.5). 
When measured over the course of a growth curve, it was found that BTP1 
spontaneous induction was not phase-specific. Instead, induction occurred 
constitutively so that the increase in PFU/ml was approximately proportionate to the 
increase in CFU/ml over the growth curve (Figure 3.9C). To determine if the high-level 
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of BTP1 spontaneous induction was dependent on the SOS-response, the 
spontaneously induced phage titer in a RecA- BTP1 lysogen was measured, using a 
RecA- P22 lysogen as a comparator (Figure 3.9D). In host strain LT2 (MA8505), P22 
spontaneous induction is virtually abolished in a ΔrecA background, and there is a 3-
log reduction to the order of only 10 PFU/ml. In a LT2 (MA8505) lysogen, BTP1 
spontaneous induction was also dramatically reduced in the ΔrecA background by 5-
log but remained greater than that of P22 at around 500 PFU/ml. Considering that 
LT2 is not the native host of BTP1, the role of RecA on spontaneous induction of 
BTP1 in D23580 was also assessed, and a 4-log reduction was observed. These 
results show that the majority of BTP1 spontaneous induction is RecA-dependent, 
and likely induced by the SOS-response. However, there is still considerable RecA-
independent induction of the BTP1 prophage, and notably, there is 1 log more RecA-
independent induction in the native D23580 background than in an LT2 (MA8505) 
background. 
To understand how unusual the spontaneous induction of the BTP1 prophage was in 
context of other characterised phages, a review of published spontaneously-induced 
phage titers was conducted (Table 3.3). The highest reported spontaneously-induced 
phage titers were in the order of 107 PFU/ml, for prophages ϕadh and φLC3 in 
Lactobacillus gasseri and Lactococcus lactis, respectively. Consequently, it was 
concluded that BTP1 exhibits the highest spontaneously-induced phage titer of any 
published prophage/host system. 
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Figure 3.9 BTP1 spontaneous induction and growth parameters. A. Visualisation 
of BTP1 PFU/ml in the overnight supernatant of a D23580 culture (Chapter 2.3.1), 
compared to a P22 lysogen. B. Single step growth curve of BTP1. ‘B’ indicates burst 
size and ‘L’ indicates latent period. Burst size was calculated as the total number of 
virions produced in the burst divided by the number of infected bacterial cells. C. 
Growth curve of S. Typhimurium D23580 showing CFU/ml on the left y-axis and 
PFU/ml on the right y-axis indicating BTP1 titer. D. Spontaneous induction of BTP1 
and P22 in a RecA- background. RecA-independent spontaneously induced phage 
titers are shown in strain LT2 for P22, and strains LT2 and D23580 for BTP1. 
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Table 3.3 Overview of the order of magnitude of spontaneous induced phage 
titers from published literature and this study. PFU/ml values are ordered by 
smallest to largest. Values resulting from the results of this thesis are shown in red 
text. 
  
Prophage Resident host PFU/ml Reference 
SPO2 Bacillus subtilis 104  (Garro and Law, 1974) 
ST64B  Salmonella Typhimurium 104 (Figueroa-Bossi and Bossi, 2004) 
P1 Enterococcus faecalis 104 .5 (Matos et al., 2013) 
P22 Salmonella Typhimurium 105 This study 
MuSo2 Shewanella oneidensis 105 (Gödeke et al., 2011) 
 ɸ105  Bacillus subtilis 105  (Garro and Law, 1974) 
ϕMMP02 Clostridium difficile 105.5 (Meessen-Pinard et al., 2012) 
ϕMMP04 Clostridium difficile 105.5 (Meessen-Pinard et al., 2012) 
Mu Escherichia coli 106 (Howe and Bade, 1975) 
SV1 Streptococcus pneumoniae 106 (Carrolo et al., 2010) 
ϕadh Lactobacillus gasseri 107 (Baugher et al., 2014) 
φLC3  Lactococcus lactis 107 (Lunde et al., 2003) 
BTP1 Salmonella Typhimurium  109 This study 
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3.3.4.1 Spontaneous induction of BTP1 at the single-cell level 
Studying spontaneous prophage induction by measuring the titer of phages in culture 
supernatants is a simple and effective method that has been employed for decades 
(Lwoff, 1953). However, the titer of induced phage is an indirect measurement of 
spontaneous induction, as the result relies on the secondary infection of an indicator 
strain by the induced phages, rather than the induction event itself. For instance, 
defective prophages may be inducible and capable of cell lysis, but their induction 
would be missed by phage-titering based methods as the resulting phage-particles 
are uninfectious. In order to better understand the prolific spontaneous induction 
phenotype of the BTP1 prophage, a fluorescence reporter system was developed to 
allow study of BTP1 induction at the single-cell level. 
As BTP1 is a lambda-like prophage, the transcriptional architecture of prophage 
induction could be predicted based on the Lambda molecular switch paradigm 
(summarised in Figure 1.8). Upon induction, loss of repressor function putatively 
allows transcription to initiate from the promoters PL, upstream of the gene encoding 
for the n antitermination gene (STMMW_03521), and PR, upstream of the gene 
encoding for the cro regulatory gene (STMMW_03551). Theoretically it would be 
possible to use a plasmid-based system involving a fluorescent marker under the 
control of the PL or PR promoters in order to visualise prophage induction. However, 
plasmid-based systems are highly likely to affect prophage induction dynamics, as 
multiple copies of the PL or PR promoters would titrate the repressor protein away from 
the native promoter. Additionally, as a number of tightly controlled molecular events 
have to occur following the initiation of prophage induction by transcription at PL or 
PR, this event in itself is not necessarily indicative of successfully completed prophage 
induction. In light of these drawbacks, a plasmid-based system was not adopted to 
study the induction of BTP1 and instead, a chromosomal system was developed.  
After initial transcription from PL and PR, it is predicted based on studies in Lambda 
that the N protein antiterminates both the n and cro transcripts to allow transcription 
of the ‘early’ genes, from n to int (STMMW_03521 to STMMW_03341) and from cro 
to q (STMMW_03551 to STMMW_03691). Subsequently, the Q protein is thought to 
antiterminate a small transcript (pR’) occurring prior to the lysis genes. In the BTP1 
prophage, there are 2 tRNA genes between the q gene and the lysis genes, therefore 
it is unclear how and where Q-mediated antitermination occurs. However, Q protein 
synthesis likely results in the transcription of the lysis and structural genes, known 
collectively as the phage ‘late’ genes (STMMW_03711 to STMMW_03901). The late 
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genes are the final genes transcribed in prophage induction, and were chosen as the 
best marker for prophage induction. Initially, a system was developed as shown in 
Figure 3.10. A gfp construct consisting of a promoter-less gfp+ gene from the pZEP08 
plasmid (Hautefort et al., 2003) and the FRT-flanked kanamycin resistance gene from 
the pKD4 plasmid (Datsenko and Wanner, 2000) was designed (Figure 3.10B). The 
construct was amplified to contain 50 bp flanking ends corresponding to an intergenic 
position in the late genes (Chapter 2.6.4), recombined into the chromosome using the 
lambda-red recombineering methodology (Datsenko and Wanner, 2000), resulting in 
transcription of gfp+ with the late gene operon (Figure 3.10A). Importantly, the 
kanamycin gene was orientated in the opposite direction to the gfp+ to prevent the 
aberrant transcription of late genes downstream of the construct in non-induced cells. 
Once the construct was inserted into the chromosome the kanamycin gene was 
removed by FLP-mediated recombination of the FRT sites. Description of the 
methods used to construct the reporter systems can be found in Chapter 2.6.4.  
Though the system functioned correctly, and fluorescent cells were visualised upon 
chemical induction, the fluorescence signal was transient and lost around 1 hour after 
chemical induction (data not shown). It is likely that the loss of fluorescence signal 
shortly after induction is the result of cell lysis and phage release at the end of the 
induction process (schematic shown in Figure 3.11). Consequently, this construct 
could only be used to measure the number of cells undergoing induction at any one 
time, rather than to measure the total number of cells in the population that have 
spontaneously induced. 
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Figure 3.10 Illustration of initial GFP reporter system for BTP1 induction. A. 
Genetic context of the gfp+ in the final construction. B. Architecture of the gfp+ 
kanamycin resistance construct used to create the florescence reporter system on the 
chromosome of D23580. Methods used to develop the construct can be found in 
Chapter 2.6.4. 
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Figure 3.11 Schematic illustration of the expected fate of induced cells 
containing the initial GFP reporter construct. 
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A second system was developed using the same construct, but instead of using an 
intergenic position, the entire lysis gene cluster was replaced with the gfp+ construct 
(Figure 3.12). As the synthesis of the lysis proteins are likely to be essential for cell 
lysis, loss of these genes would allow induced cells to remain fluorescent in the 
culture, without loss of signal (schematic shown in Figure 3.13). A time-course of 
chemical induction of the D23580 ∆lysis::gfp+ strain is shown in Figure 3.14. This 
system was used to study the natural spontaneous induction of D23580 cultures.  
Overnight cultures of D23580 ∆lysis::gfp+ were screened for fluorescent cells. As 
expected, the majority of the population were non-fluorescent, short rods, resembling 
healthy stationary phase Salmonella bacteria. However, it was also possible to find 
highly fluorescent cells in the culture (Figure 3.15). The fluorescent cells in the 
overnight culture of D23580 ∆lysis::gfp+ were observed to be highly heterologous in 
size; some resembled the non-fluorescent bacteria in size, whilst others resembled 
large filaments (an example is shown in Figure 3.15). As it was previously observed 
that BTP1 spontaneous induction occurs throughout the growth curve, this 
dimorphism in size may correspond to the growth-phase the cell was in when it 
became induced; exponentially growing cells that become induced may form large 
filaments, whilst cells that become induced towards stationary phase may remain as 
single cells. 
The visualisation of fluorescent cells in the overnight culture of the D23580 ∆lysis::gfp+ 
shows that this approach can be used to study the cell population in which the BTP1 
prophage becomes spontaneously induced, without subsequent cell lysis. In the 
future these constructs could be used to accurately enumerate the induced fraction of 
the population using flow cytometry techniques, though optimisation will be required 
to control for the impact of heterogeneity of fluorescent cell sizes upon cell detection 
and sorting. In addition, similar constructs could be made in other prophages, allowing 
comparison of the rate of spontaneous induction of the lysogenic population, and the 
factors that contribute to spontaneous prophage induction. 
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Figure 3.12 Illustration of the Δlysis::gfp+ construct for BTP1 induction. Genetic 
context of the gfp+ in the final construction. The gfp+ gene replaces the entirety of the 
lysis gene cluster. 
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Figure 3.13 Schematic illustration of the expected fate of induced cells 
containing the Δlysis::gfp+ reporter construct.  
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Figure 3.14 Time course of D23580 BTP1 ∆lysis::gfp+ cell fluorescence post 
chemical induction. Samples were collected and fixed at 5 minute intervals after 
addition of mitomycin C (Chapter 2.3.6). Transmitted light and fluorescent light images 
of the same field visualised using a 40X objective are shown (Chapter 2.3.6). 
  
102  
 
 
Figure 3.15 Example of elongated fluorescent cell morphology found in 
overnight culture of D23580 ∆lysis::gfp+. Both transmitted light and fluorescent light 
images of the same field using a 100X oil immersion objective are shown. Microscopy 
methods can be found in Chapter 2.3.6. 
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3.3 Gifsy-2 (BTP2) 
The Gifsy prophages are lambdoid prophages present in the majority of S. 
Typhimurium strains (Lemire et al., 2008). However, of the Gifsy-family of prophages, 
Gifsy-2 is the most widely distributed and can be found in a number of Salmonella 
serovars apart from S. Typhimurium (Lemire et al., 2008; Thomson et al., 2004). 
Gifsy-2 is required for S. Typhimurium virulence in the mouse infection model, and a 
Gifsy-2 cured strain of S. Typhimurium was found to be attenuated 100-fold relative 
to the wildtype (Ho et al., 2002). Gifsy-2 contains a number of virulence genes which 
include genes encoding for the periplasmic superoxide dismutase SodCI and the 
secreted effector proteins GtgE and SseI (Bossi and Figueroa-Bossi, 2005) (Figure 
3.16). 
The Gifsy-2 prophage of D23580 is 98% identical to the Gifsy-2 prophage of ST19 
strain 4/74 at the nucleotide level (data not shown). Gifsy-2 is located in the same 
intergenic chromosomal site in D23580 and 4/74, between the pncB and pepN genes. 
Notably, the prophage is orientated in the opposite direction in D23580 relative to 
4/74, suggesting that the prophage has not remained as a stable lysogen over the 
course of the evolution of these two strains, but has excised and reintegrated. My 
comparative analysis of the Gifsy-2 nucleotide sequence showed that the gene 
encoding the O replication protein of Gifsy-2D23580 was a pseudogene; a 71 bp deletion 
in the middle of the coding sequence caused a frame shift at position 1,102,739 on 
the D23580 chromosome, and the generation of a truncated O protein (Figure 3.17). 
The O protein of lambdoid phages is required for replication of the phage chromosome 
during lytic growth and contains the phage origin of replication (Taylor and Wegrzyn, 
1995). As the replication of the phage chromosome is an essential part of the lytic 
cycle, this pseudogene is likely to be responsible for the lack of functional Gifsy-2 
D23580 viruses detectable in the supernatant when D23580 is grown with and without 
mitomycin C.  
Additionally, a putative tail fibre gene (STMMW_10601) is ~ 200 bp longer in D23580 
relative to the ortholog in 4/74, though analysis of more Gifsy-2 sequences would be 
required to determine if this represents an insertion event in Gifsy-2 D23580 or a deletion 
event in Gifsy-2 4/74. Lastly, the sseI gene of Gifsy-2 D23580 (STMMW_10631) has been 
disrupted by the insertion of a transposase gene (STMMW_10641), which has caused 
the loss of function of the SseI effector protein in D23580 (Carden et al., 2017). 
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Figure 3.16 Functionally annotated map of the Gifsy-2D23580 prophage sequence. Coloured arrows represent ORFs for which a function can be inferred based on sequence. 
White arrows represent ORFs for which no function can be inferred. Arrows filled with slanted black stripes represent pseudogenes. Red dotted lines connect the separated parts of pseudogenised 
genes which have been disrupted by early truncation or insertion. 
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Figure 3.17 Gifsy-2D23580 is likely to be defective due to a frame shift mutation 
in the o replication gene. 
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3.4 ST64B (BTP3) 
ST64B is lambdoid siphovirus present in a number of Salmonella genomes, in 
particular those of epidemiological relevance, such as the multidrug resistant DT104 
clone (Tucker and Heuzenroeder, 2004). Though the prophage was not required for 
Salmonella virulence in a murine model (Bossi and Figueroa-Bossi, 2005.), ST64B 
harbours the sseK3 gene (Figure 3.18) which has been shown to be an important 
secreted effector protein modulating the host immune response (Günster et al., 2017; 
Yang et al., 2015).  
ST64BD23580 is almost 100% identical to ST64B4/74, with just 6 SNPs separating the 
two prophages (data not shown). ST64B is located in the same position and 
orientation in D23580 and 4/74, within tRNASer gene. ST64B is defective in S. 
Typhimurium 14028, due to a frame-shift mutation in a tail assembly gene that 
prevents assembly of viable phage particles, and creates two short gene fragments 
annotated sb21 and sb22 (Figueroa-Bossi and Bossi, 2004). The tail gene frame-shift 
mutation is conserved in ST64BD23580 (D23580 genes STMMW_19871 and 
STMMW_19861 are the homologs of sb21 and sb22, respectively). The frameshift 
mutation that prevents viable ST64B phage production in ST19 strain 14028 can 
spontaneously revert to a functional form, particularly under conditions that positively 
select for resuscitation of the functional prophage, such as when a strain containing 
the defective prophage is co-cultured with a sensitive host (Figueroa-Bossi and Bossi, 
2004).  
Together with the failure of D23580 supernatant to produce plaques on a ST64B-
sensitive host strain, and the conservation of the frame-shift mutation of strain 14028, 
these results indicate that ST64B is defective in S. Typhimurium ST313 (Figure 3.19).  
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Figure 3.18 Functionally annotated map of the ST64BD23580 prophage sequence. Coloured arrows represent ORFs for which a function can be inferred based on sequence. White arrows 
represent ORFs for which no function can be inferred. Arrows filled with slanted black stripes represent pseudogenes. Red dotted lines connect the separated parts of pseudogenised genes 
which have been disrupted by early truncation or insertion. 
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Figure 3.19 ST64BD23580 is likely to be defective due to a frame shift mutation in 
a tail assembly gene.
109 
 
 
3.5 Gifsy-1 (BTP4) 
Gifsy-1 is a lambdoid siphovirus like its relative Gifsy-2 (Chapter 3.3). Gifsy-1D23580 
carries the important virulence factors gipA (STMMW_26192), gogB 
(STMMW_26001, and gtgA (STMMW_26331) (Figure 3.20) (Coombes et al., 2005; 
Moreno Switt et al., 2012). The chromosomal attachment site for Gifsy-1 is the 
Salmonella lepA gene (STM2583, STMMW_25991). The Gifsy-1 phage genome 
contains a small piece of the lepA gene which reconstitutes the intact lepA locus upon 
prophage integration (Casjens, 2011). Gifsy-1 is known to be more genetically diverse 
than Gifsy-2 (Hiley et al., 2014). Whilst the location and attachment site of Gifsy-1 is 
conserved in D23580, there is considerable genetic divergence relative to Gifsy-14/74 
in a ~5kb region towards the right terminus of the prophage sequence (Figure 3.21) 
which includes the replication and immunity genes as well as a number of ORFs of 
unknown function. However, the function of Gifsy-1 in comparator strain 4/74 has not 
been defined, so the sequence of Gifsy-114028 (a strain where Gifsy-1 is known to be 
functional) was used as a comparator to identify potential degradative mutations 
(Figueroa-Bossi and Bossi, 1999). 
All coding genes remain intact in Gifsy-1D23580 compared to Gifsy-114028, with no 
evidence for functional degradation via pseudogene formation. However, a single 
SNP was detected in the -10 promoter region of the dinI gene of Gifsy-1D23580 
compared to the same region in S. Typhimurium 14028 (Gifsy-114028), where Gifsy-1 
is functional (Bossi et al., 2003) (Figure 3.22A). It has previously been shown that the 
anti-repressor gene of Gifsy-1, gfoA, is located immediately downstream of dinI and 
is co-transcribed from the dinI promoter (PdinI-gfoA), making gfoA essential for the 
induction of Gifsy-1 phage (Lemire et al., 2011). This finding raised the possibility that 
the promoter SNP could be responsible for the lack of detectable Gifsy-1 in the 
D23580 supernatant (Table 3.2). Single nucleotide allelic exchange of PdinI-gfoAD23580 
with PdinI-gfoA14028 yielded viable (infectious) Gifsy-1 phages that formed plaques on 
D23580 ∆Gifsy-1. Furthermore, D23580 PdinI-gfoA14028 produced a Gifsy-1 titer 
consistent with that reported for 14028, both with and without mitomycin C induction 
(Figueroa-Bossi and Bossi, 2004) (Table 3.2A; Figure 3.22B). The fact that a single 
modified nucleotide caused the production of functional phage shows that the PdinI-gfoA 
SNP is responsible for lack of Gifsy-1 viability in D23580. 
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Figure 3.20 Functionally annotated map of the Gifsy-1D23580 prophage sequence. Coloured arrows represent ORFs for which a function can be inferred based on sequence. White arrows represent 
ORFs for which no function can be inferred. 
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Figure 3.21 Comparison between the Gifsy-1 prophage of strains D23580 and 
4/74. Red coloured blocks indicate individual blastn hits of more than 90% identity. 
White regions show represent sequence that is unique to either genome. 
Figure 3.22 Gifsy-1D23580 is defective due to a single SNP in the promoter of the 
antirepressor gene. A. A SNP in the -10 region of the dinI-gfoA promoter is likely to 
abolish transcription of these genes. B. Restoration of the SNP to the genotype 
found in Gifsy-114028 restored the formation of functional phages by Gifsy-1. Methods 
used for the single nucleotide allelic exchange are found in Chapter 2.6.2. 
112  
 
3.6 BTP5                
3.6.1 Gene content of BTP5 
The BTP5 structural genes suggest that the phage is a member of the Myoviridae 
family of long contractile-tailed phages and it shares sequence similarity with P2-like 
phages including P2, WΦ, and 186 which infect E. coli. P2 has been described as the 
prototype for the non-inducible class of temperate phages, as its repressor protein 
lacks an identified RecA cleavage site (Kalionis et al., 1986), and P2-like phages are 
known to be associated with satellite phages (Nilsson and Haggård-Ljungquist, 2006). 
However, BTP5 contains two genes that show homology to the SOS operon of 
coliphage 186 (Brumby et al., 1996): tum (STMMW_32041) and orf97 
(STMMW_32031), which function as an antirepressor system and facilitate induction 
of coliphage 186 (Shearwin et al., 1998). No function could be inferred based on 
sequence homology to other studied phages for 7/42 of BTP5 open reading frames 
(ORFs). The complete functionally annotated map of BTP5 is shown in Figure 3.23. 
The chromosomal context of the BTP5 attachment site (tRNA-Met) and the core att 
sequence for BTP5 are shown in Figure 3.24. 
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Figure 3.23 Functionally annotated map of the BTP5D23580 prophage sequence. Coloured arrows represent ORFs for which a function can be inferred based on sequence. 
White arrows represent ORFs for which no function can be inferred. 
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Figure 3.24 Chromosomal genomic context and core sequence of the BTP5 
attachment site. 
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3.6.2 BTP5 homology to other sequenced phages and prophages 
Comparison of BTP5 to other P2-like phages and prophages suggests that there is 
less genetic mosaicism than in the P22-like group described for the BTP1 prophage 
(Figure 3.25). The majority of the P2-like phages and prophages show conservation 
of nearly the entire capsid and tail gene clusters, which make up approximately 60% 
of the phage chromosome. Structural gene homology is not restricted to prophages 
of the genus Salmonella, as BTP5 shares >70% sequence identity to the structural 
genes of phages and prophages from other Enterobacteriaceae including 
Escherichia, Klebsiella, Serratia and Enterobacter. However, outside of the structural 
gene clusters, there is limited homology to other phages or prophages, suggesting 
that BTP5 may represent novel phage biology. 
Analysis of publically available draft genome assemblies identified a putative BTP5-
like prophage in a genome of a single strain of S. Typhi called 238675, that was 
isolated from blood in South Africa in 2008 and sequenced (short read accession 
number: ERR338011) as part of a study to describe the global population structure of 
S. Typhi (Wong et al., 2015). Strain 238675 has subsequently been classified as 
belonging to S. Typhi clade 2.4 (Wong et al., 2016). The prophage was located on a 
short contig of 31,288 bp, which spanned the entire length of the BTP5 prophage. As 
the prophage assembled as a whole contig, rather than as part of a larger 
chromosomal contig, it was not possible to ascertain from the genome assembly 
whether the attachment site of BTP5S.Typhi 238675 is the same as the attachment site of 
BTP5D23580. Alignment of the BTP5S.Typhi 238675 with BTP5D23580 showed that the 
prophages were 98.27% percent identical at the nucleotide level, a difference of 537 
SNPs (Figure 3.26). The location of the SNPs within the genome relative to BTP5D23580 
was determined, and showed that the SNPs are restricted to the structural and lysis 
regions of the prophage (Figure 3.26). This finding raises the intriguing possibility that 
BTP5 is a broad-host range phage capable of infecting both S. Typhimurium and S. 
Typhi, or that some of the detected SNPs may be responsible for restricting the host 
range of the phage to serovar Typimurium or Typhi. 
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Figure 3.25 Functional genetic architecture of BTP5 and homology to 
sequenced phages and prophages from Salmonella and other bacteria. Starting 
from the inside, circular panels represent functional clusters of genes: ORFs coloured 
according to functional cluster with the functionally unknown ORFs colored grey; 
BLAST homology to other Salmonella phage sequences (red-shaded ring), 
Salmonella prophage sequences (green-shaded ring), non-Salmonella phages (blue-
shaded ring) and non-Salmonella prophages (orange-shaded ring). The order of 
sequences represented by each concentric ring of the BLAST homology panel are 
shown on the right.  
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Figure 3.26 Prophage BTP5 is found in S. Typhi strain 238675. BTP5 is 98.27% 
identical at the nucleotide level to a prophage from ST568 strain 201102250, a 
difference of 537 SNPs. Red coloured blocks indicate individual BLAST hits of more 
than 90% identity.  The location of the SNPs relative to BTP5D23580 is shown by black 
lines at the top of the BLAST hits. 
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3.6.3 Functional assessment of the BTP5 prophage 
Despite the presence of a very similar prophage in S. Typhi suggesting that BTP5 
represents a functional, broad-host range phage, the supernatant from a 16 h culture 
of strain D23580 (Chapter 2.3.1) did not form plaques on the specific indicator strain 
D23580 ∆BTP5, even after mitomycin C exposure. Consequently, an alternative 
approach was used to determine whether putative BTP5 phages present in the culture 
supernatant were capable of injecting DNA into susceptible bacteria to form lysogens.  
A D23580-derived strain that carried a kanamycin resistance gene (KmR) inserted into 
a non-coding region of BTP5 was constructed (designated D23580 BTP5::KmR) 
(methods described in Chapter 2.6.2). The presence of functional BTP5 phages in the 
culture supernatant was assayed by the formation of kanamycin-resistant BTP5 
lysogens when culture supernatant was added to the putatively BTP5-sensitive strain 
D23580 ∆BTP5. The supernatant from a 16 h LB culture of D23580 BTP5::KmR 
yielded kanamycin-resistant colonies when mixed with the indicator strain D23580 
∆BTP5 (Figure 3.27). Lysogenization with the BTP5::KmR prophage at the BTP5 
attachment site was confirmed by PCR (data not shown, primers given in Table 2.4). 
To confirm that lysogenization by BTP5 was not dependent on the presence of BTP1 
(for example, transmission of KmR by generalised transduction by BTP1 phage 
particles), the experiment was repeated using supernatant from D23580∆BTP1 
BTP5::KmR to remove BTP1 phage (Figure 3.27). No effect on lysogen formation was 
observed, showing BTP5 is functional in the absense of BTP1. No increase in 
efficiency of lysogenization was observed with mitomycin C induction, consistent with 
reports that P2-like phages are not sensitive to induction by activated RecA protein 
(Kalionis et al., 1986). 
Taken together, these data suggest that BTP5 is capable of infection and 
lysogenization of D23580 ∆BTP5, but does not form visible plaques. To check that 
the kanamycin-resistant colonies were not the result of a low-frequency resuscitation 
of a defective BTP5 by spontaneous mutation, as has been described for prophage 
ST64B (Figueroa-Bossi and Bossi, 2004), the experiment was repeated using a 16 h 
supernatant from one of the kanamycin-resistant colonies (putative BTP5::KmR 
lysogens). The number of kanamycin-resistant colonies produced after infection of 
strain D23580 ∆BTP5 did not increase, suggesting that no spontaneous resuscitation 
of BTP5 had occurred to produce the lysogens.  
  
119 
 
 
Figure 3.27 Schematic describing experiments to determine the function of 
BTP5. A kanamycin resistance locus was inserted into a non-coding position in the 
BTP5 prophage (D23580::KmR). Supernatant from this strain was added to D23580 
ΔBTP5 and plated on agar containing kanamycin. Resistant colonies indicated 
lysogeny of BTP5::KmR. To test whether the colonies were the result of resuscitation 
of a defective BTP5, the experiment was repeated with donor supernatant from one 
of the kanamycin-resistant colonies. 
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Taken together these experiments suggest that BTP5 is a functional prophage, but 
the frequency of lysogenisation by BTP5 in the D23580 culture supernatant was 
extremely low. As enumeration of the phage by titration could not be achieved, 
empirical calculation of lysogenisation efficiency was not possible. However, on 
average, 50 µl of culture supernatant yielded just 8 KmR colonies (putative BTP5::KmR 
lysogens). It is unclear whether the low level of lysogenisation is simply a result of 
very low-level spontaneous induction of BTP5, or of inefficient infection of the indicator 
strain D23580 ∆BTP5.  
Without a way to enumerate BTP5 phage particles, or visualisation by electron 
microscopy, the function of BTP5 remains unclear. Further exploratory work with 
BTP5 must be undertaken in order to determine its functionality definitively. 
3.7 Prophage remnant elements 
The prophage remnant elements found in ST313 strain D23580 are also present in 
many other S. Typhimurium strains, and therefore their gene content has been well-
described (Casjens, 2011). All four prophage remnants are highly conserved in strain 
D23580, probably because they all contain important virulence associated genes. 
Even though the remnant prophages derive from horizontally acquired elements, their 
high conservation across Salmonella serovars means they are considered to belong 
to the core genome. 
Remnant prophage Def1 (Figure 3.28) has also been designated SPI-16 in the 
Salmonella literature. Def1 is a very short remnant, which is thought to be of prophage 
origin because of its location adjacent to a tRNA (common prophage attachment sites) 
and the presence of its gtr (glycosyltransferase) operon. The gtrABC encodes a family 
III-type glycosyltransferase system, which mediates the addition of a glucose 
molecule to the galactose moiety of the repeating sub-units of the O-antigen, and is 
thought to be a molecular determinant for the O-antigen serotype of Typhimurium 
(Davies et al., 2013). Because S. Typhimurium genomes commonly harbour multiple 
gtr systems, the operons are conventionally given the suffix ‘a’, ‘b’ or ‘c’ to distinguish 
the genes. The gtr operon encoded by Def1 (STMMW_06231- STMMW_06251) is 
commonly known as gtrABCa, and is important for persistence in a murine infection 
model (Bogomolnaya et al., 2008). 
Remnant prophage Def2 encodes the type III secretion system effector protein SopE2 
which affects mammalian Rho-GTPases (Figure 3.29) and a putative acyltransferase 
(STMMW_18481). The Def2 prophage remnant of ST313 strain D23580 is 
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considerably smaller than the strain in which it was first described, LT2 (Casjens, 
2011), due to a ~9500 bp deletion that has been previously described (Kingsley et al., 
2009). The deleted portion of Def2 includes the genes pagO, pagM, pagK and mig-
13 along with the small non-coding RNAs RyeA and SdsR. This large deletion, 
removing over half of Def2, illustrates how rapidly the process of genome degradation 
can create remnant prophage islands, and very few prophage-like genes now remain 
on Def2D23580. 
The third remnant prophage, Def3, is located adjacent to a tRNA-Pro gene (Figure 
3.30). A subset of the genes in Def3 are known as SPI-12 in the Salmonella literature. 
Def3 contains the oafA gene, which acetylates the abequose moiety in the repeating 
sub-units of the O-antigen (Slauch et al., 1996). Along with a number of phage-like 
genes, Def-3 also encodes the type III effector protein SspH2, which can modulate 
host Nod1-mediated IL-8 secretion to affect inflammation (Bhavsar et al., 2013). 
Finally, Def4, the largest remnant prophage in D23580, contains phage tail tube and 
sheath proteins that resemble phage P2, suggesting it is derived from a Myovirus 
(Casjens, 2011). Along with phage-like structural proteins, Def4 encodes a 
glycosyltransferase operon gtrABCb. This glycosyltransferase operon has not been 
mechanistically described, and the molecular target of GtrABCb is unknown (Davies 
et al., 2013). Though genome-wide mutagenesis studies have implicated some of the 
Def4 genes in long-term systemic infection in mice, these were the genes resembling 
phage structural proteins (Lawley et al., 2006), and the role of the gtrABCb system in 
Salmonella infection is unknown (Bogomolnaya et al., 2008) 
Overall the prophage remnants of D23580 present a compelling case for investigation 
of novel prophages as a source of virulence factors in S. Typhimurium ST313. All four 
of the prophage remnants described encode O-antigen modification systems, and two 
of the four carry type III-secreted effector genes. 
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Figure 3.28 Gene map and functional annotation of prophage remnant 
Def1
D23580
. 
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Figure 3.29 Gene map and functional annotation of prophage remnant 
Def2D23580. 
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Figure 3.30 Gene map and functional annotation of prophage remnant 
Def3D23580. 
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Figure 3.31 Gene map and functional annotation of prophage remnant 
Def4D23580. 
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3.8 Discussion 
Representative ST313 strain D23580 was reported to carry five prophages (Kingsley 
et al., 2009). Three of these, Gifsy-2, ST64B and Gifsy-1, are present in many S. 
Typhimurium genomes, whilst BTP1 and BTP5 are novel prophages. The prophage 
repertoire of D23580 was reported to be highly conserved in other ST313 genomes 
of both described ST313 lineages (Kingsley et al., 2009; Okoro et al., 2015). The 
presence of novel prophages in the genome of ST313 S. Typhimurium is not in itself 
surprising as prophages are known to be highly variable in Salmonella populations 
(Brüssow et al., 2004; Figueroa-Bossi et al., 2001). However, despite their intrinsic 
mobility and apparent transience, prophage carriage has also been strongly 
associated with Salmonella epidemics and the link between prophage carriage and 
Salmonella disease epidemiology is highlighted by the continual use of phage typing 
schemes for surveillance of Salmonella outbreaks since the 1970s (Rabsch, 2007). 
Consequently, the potential contribution to the virulence of ST313 by novel prophages 
BTP1 and BTP5 remains intriguing. Certainly, the presence of a number of putative 
accessory genes in novel phages BTP1 and BTP5 warrants further investigation.  
One BTP1 gene, st313-td, has been reported to be associated with virulence of ST313 
in a mouse infection model (Herrero-Fresno et al., 2014). Though no mechanism of 
action was described for the virulence effect of st313-td, if the gene proves to be 
important for bloodstream invasion, its high conservation among ST313 isolates 
would be strong evidence that prophage BTP1 contributes to the virulence of ST313. 
Additionally, the high level of similarity of BTP1 to the generalized-transducing phage 
P22 raises interesting implications for horizontal gene transfer among BTP1-
susceptible Salmonellae. Due to the high level of conservation in ST313 genomes, it 
is tempting to speculate that prophages are important within the ecological niche of 
ST313, whether through immunity to environmental phage predation, permitting 
colonization of environmental reservoirs in Africa or by contributing to bacterial 
virulence through lysogenic conversion.  
As well as putative cargo virulence factors, genetic analysis revealed that the BTP1 
tailspike may be unusual. Amino acid sequence comparison of the BTP1 and P22 
tailspike protein receptor-binding domains (RBD) showed considerable divergence 
(65% amino acid percent identify), suggesting the enzymatic activity of the BTP1 
tailspike may differ from other P22-like phages. In their thorough review on the 
evolution of P22-like phages, Casjens & Thuman-Commike included the BTP1 
prophage sequence in detailed phylogenetic analysis of capsid assembly genes 
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(Casjens and Thuman-Commike, 2011) where it is designated ‘Typh1’. Figures 7, 
S1Z4 and S1Z5 in the aforementioned review show that whilst the BTP1 tailspike 
head-binding domain is very closely related to P22-like phages, the RBD falls on a 
deep branch amongst non-P22-like Salmonella phages, sharing more recent common 
ancestors with the RBDs of sipho- and myovirus tailspikes than P22-like phages. The 
significance of the unusual BTP1 tailspike RBD is unclear. 
Investigation of the biology of the novel prophages in ST313 revealed that the titer of 
phage BTP1 in the 16 h culture supernatant is about 109 PFU/ml without chemical 
induction, approximately equal to the bacterial CFU/ml, suggesting a high frequency 
of spontaneous induction. The spontaneous induction of BTP1 was visualized at the 
single-cell level using a fluorescent reporter system. In fact, BTP1 has the highest 
spontaneous induction titer of any prophage in the contemporary literature. The high 
frequency spontaneous induction was maintained in a different host strain (LT2), 
indicating it is an intrinsic characteristic of prophage BTP1. However, it should be 
noted that, in part due to the lack of functional prophage characterisation studies, 
spontaneously induced phage titers are not reported for the vast majority of known 
prophages. Additionally, some caution has to be taken when interpreting the 
spontaneously induced phage titers described in the literature. Spontaneous phage 
titers are likely to be frequently underestimated due to low efficiency of plating of the 
phage in question on non-optimal indicator strains. Accurate estimation of phage titer 
using plaque assay methodology relies on the efficiency of plating of the indicator 
strain, and indicator strains with maximal efficiency of plating may have to be made 
synthetically using genome editing approaches to remove any elements that confer 
phage resistance, as has been undertaken in this study.  
Spontaneous prophage induction is a well-known phenomenon in bacteria and the 
presence of free phages in the cultivation media of lysogens has been reported as 
early as the 1950s (Lwoff, 1953). However, spontaneous induction and its potential 
effect on host biology has not been well documented among clinically relevant 
bacteria. Furthermore, the effect of spontaneous prophage induction specifically on 
Salmonella infection dynamics and virulence is not well understood. There is evidence 
that spontaneous phage induction directly contributes to virulence in a number of 
other bacterial pathogens (reviewed in (Nanda et al., 2015). Phage induction causes 
an increase in biofilm formation by releasing extracellular DNA in organisms including 
Streptococcus pneumoniae and Shewanella oneidensis (Carrolo et al., 2010; Gödeke 
et al., 2011). More recently, spontaneous prophage induction was shown to modulate 
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Pseudomonas aeruginosa biofilm formation by stimulating biogenesis of membrane 
vesicles (Turnbull et al., 2016). However, contrary to published associations between 
spontaneous prophage induction and biofilm formation, recent publications have 
shown ST313 to be defective at forming RDAR (red, dry, and rough) colonies and 
biofilms (Ramachandran et al., 2016; Singletary et al., 2016). 
It has also been reported that phage-mediated lysis may act as a crude method of 
toxin delivery, facilitating human gingival fibroblast invasion by Aggregatibacter 
actinomycetemcomitans (Stevens et al., 2013), and enabling Stx toxin release in 
Shiga toxin-producing E. coli (Shimizu et al., 2009; Xu et al., 2012). Salmonella Typhi 
is known to produce a specific toxin, CDT (Galan, 2016), but no candidate toxin genes 
have been identified in the genome of ST313 strain D23580. It is possible that BTP1-
mediated lysis causes increased release of cellular material such as endotoxin during 
infection, and this deserves further investigation. 
Examples of prophages enhancing bacteria fitness by expressing advantageous 
accessory genes or by mediating spontaneous lysis are numerous (Fortier and 
Sekulovic, 2013; Nanda et al., 2015). However, the inevitable result of spontaneous 
induction of tailed phages is cell death, and therefore any benefit of lysogenic 
conversion or spontaneous induction itself is offset by the negative impact on bacterial 
growth dynamics. The high level of spontaneous BTP1 induction equates to the lysis 
of approximately 0.2% of the bacterial population in strain D23580. It seems likely that 
if BTP1-mediated cell death was deleterious, ST313 derivatives containing mutations 
in the BTP1 prophage would have been positively selected (Bobay et al., 2014; 
Lawrence et al., 2001), and in fact, the BTP1 prophage is highly conserved in ST313 
from across Africa (Okoro et al., 2015). This leaves the intriguing possibility that 
phage-mediated lysis could be tolerated by the ST313 population if the benefit of 
lysogenic conversion factors such as immunity from BTP1-like phages and cargo loci 
were advantageous enough to outweigh the cost of spontaneous lysis. The functional 
conservation of BTP1 across all African ST313 isolates of both described lineages 
supports the hypothesis that the high rate of BTP1 spontaneous induction benefits 
the pathogen in some way. The impact of BTP1-mediated lysis on ST313 growth 
dynamics, ecological niche, virulence and fitness will be an important topic for further 
study. 
Despite this, if there was a strong selection pressures to retain the accessory 
functions of BTP1, mutations could arise that inactivate prophage induction whilst 
retaining the lysogenic conversion phenotype, such as the mutations reported in this 
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chapter for the defect Gifsy-2, ST64B and Gifsy-1 prophages of ST313. The finding 
that the non-ST313-specific prophages Gifsy-1, ST64B and Gifsy-2 are defective in 
D23580 is intriguing. Although these prophages are present in most sequenced S. 
Typhimurium genomes in NCBI (accessed June 2016), this is the first report of 
mutational inactivation of all three prophages in the same chromosome. The 
significance of these inactivations remains to be established. 
From a phage perspective, it could be argued that temperate phages exploit their 
capacity to transmit either horizontally (i.e. lytically as a virion) or vertically (i.e. 
lysogenically as a prophage) as a bet-hedging strategy to improve overall 
transmission. In fact, it was recently shown that during an active infection, phage P22 
regularly engages in an asymmetrically segregating phage carrier state that results in 
the cultivation of a transiently P22 resistant subpopulation of host cells that can 
subsequently be lytically consumed (Cenens et al., 2015). As such, P22 likely 
manages to maintain an active infection with high virion titers in a host population that 
is progressively taken over by P22 lysogens. In the same bet-hedging context, the 
BTP1 prophage could have evolved to vastly increase its spontaneous induction rate 
in order to ensure high virion titers that increases the opportunity for the phage to 
mediate horizontal transmission whenever the BTP1 lysogen would encounter a niche 
with susceptible host cells. Furthermore, such BTP1-mediated lysis of susceptible 
competitors would likely contribute to the ecological fitness of BTP1 lysogens as well, 
as demonstrated previously with Gifsy-1 and Gifsy-2 lysogens (Bossi et al., 2003). 
In summary, this thorough characterization of the prophage repertoire of S. 
Typhimurium ST313 poses interesting questions about the potential fitness costs and 
benefits of novel prophages in epidemic S. Typhimurium ST313. The high rate of 
BTP1-mediated spontaneous lysis represents novel biology in this clinically important 
sequence type, and could modulate the behavior of the pathogen in terms of 
ecological niche, host range or invasiveness in humans. 
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Chapter 4 
Diverse UK lineages of 
S. Typhimurium ST313 
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4.1 Introduction 
Multi locus sequence typing (MLST) is a molecular approach for typing micro-
organisms and uses the allelic varation of seven highly conserved Salmonella 
housekeeping genes to infer bacterial phylogeny (Achtman et al., 2012). Whole 
genome sequence studies of isolates collected from patients with iNTS disease in 
sSA initially identified a novel sequence type (ST), ST313, of S. Typhimurium in 2009 
(Kingsley et al., 2009). Subsequent genome-based studies confirmed two distinct 
phylogenetic lineages of ST313 associated with iNTS and spatio-temporal 
phylogenetic reconstruction suggested that lineage 1 emerged around 1960 in south 
west Africa, whereas lineage 2 emerged around 1977 in Malawi (Okoro et al., 2012). 
Both lineages are associated with antimicrobial resistance (AMR) mediated by 
differing Tn21-like integrons on the virulence plasmid pSLT (Kingsley et al., 2009) and 
it was proposed that clonal replacement of lineage 1 by lineage 2 had occurred, driven 
by the acquisition of chloramphenicol resistance in lineage 2 (Okoro et al., 2012). S. 
Typhimurium ST313 has recently been detected in Brazil (Almeida et al, 2017). Unlike 
African ST313, the nine Brazilian ST313 isolates were predominantly associated with 
gastro-intestinal infection and were antibiotic-susceptible. 
It has been suggested that the link between S. Typhimurium ST313 and iNTS disease 
in sSA is that, compared with the generalist S. Typhimurium ST19, ST313 has 
adapted to an extra-intestinal/invasive lifestyle via genome degradation (Kingsley et 
al., 2009; Okoro et al., 2015). This would be consistent with the finding of an 
accumulation of pseudogenes in pathways associated with gastrointestinal 
colonization, as observed in host-restricted Salmonella serovars such as S. Typhi and 
in Yersinia pestis, Shigella spp, Mycobacterium leprae and Bordetella pertussis (Cole 
et al., 2001; McClelland et al., 2004; McNally et al., 2016; Nuccio and Bäumler, 2014; 
Parkhill et al., 2001; The et al., 2016; Yang et al., 2005). Another observation from 
comparative genomic studies, which supports the hypothesized enhanced virulence 
of ST313 includes the detection of novel prophages BTP1 and BTP5 (Owen et al., 
2017; Chapter 3) including the reported BTP1 phage-encoded putative virulence 
gene, st313-td (Herrero-Fresno et al., 2014). 
A number of phenotypic characteristics which distinguish ST313 from gastroenteritis-
associated ST19 strains have been described, including a reduction in motility, 
flagellin expression, stationary-phase catalase activity and biofilm formation (Carden 
et al., 2015; Ramachandran et al., 2015; Singletary et al., 2016). Despite these 
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phenotypes, it remains to be proven whether ST313 are intrinsically capable of 
causing a higher level of systemic disease than ST19.  
Since April 1st, 2014, every presumptive Salmonella isolate received by the 
Salmonella Reference Service (SRS) of Public Health England (PHE) has been whole 
genome-sequenced (WGS) to allow identification, characterization and typing in one 
laboratory process (Ashton et al., 2016). In this chapter, I investigate the prevalence 
of ST313 in cases of laboratory-confirmed S. Typhimurium infections reported in 
England and Wales, analyse clinical data regarding the origin of isolates (faeces or 
blood) and review information collected from patients regarding whether infection was 
associated with travel to high-incidence areas such as sSA. A phylogenetic approach 
is used to place the UK-isolated ST313 into the evolutionary context of ST313 
lineages isolated in Africa (hereafter referred to as African ST313).  
4.1.1 Acknowledgement of the specific contribution of collaborators to the 
results described in Chapter 4.  
The majority of this chapter has been submitted for publication and makes up an 
article entitled “Public health surveillance in the UK revolutionises our understanding 
of the invasive Salmonella Typhimurium epidemic in Africa”. The manuscript is 
available as an un-reviewed preprint (https://doi.org/10.1101/139576), and is currently 
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4.2 Epidemiology of ST313 in the UK 
Between January 2014 and May 2016, 2,888 S. Typhimurium isolates were whole-
genome sequenced by Public Health England (all Salmonella isolates sequenced by 
PHE are available from the NCBI SRA BioProject PRJNA248064), of which 79 (2.7%) 
were of multi-locus sequence type ST313. Whole genome sequence data were 
available for a further 363 S. Typhimurium isolates from 2012, of which 7 (1.9%) were 
ST313. Of these 86 ST313 isolates, 75 were derived from human patients (5 patients 
had two isolates sequenced and one patient had 5 isolates sequenced), 1 from a dog 
and 1 was isolated from an unspecified raw food sample. The sample type was 
recorded for 72 of the 75 human patient isolates; 13 patients had one or more isolate 
from extra-intestinal sites (blood, pus or bronchial alveolar lavage) indicating iNTS 
disease and 59 isolates were from faeces alone (indicating gastrointestinal infection). 
Travel information was available for 51 of the 75 human patients, of whom 8 reported 
travel to sSA during the estimated disease incubation period and one adult male 
reported consuming food of West African origin in London. 
Of the 51 patients with travel information, 48 had sample type recorded. Of the 8 
patients who reported travel to Africa, 6 had extra-intestinal infections. In contrast, just 
2 of 40 patients for whom travel information was available and did not report travel to 
Africa had extra-intestinal infection, showing that travel to Africa is significantly 
associated with iNTS disease in the UK (OR 57.0 [95% CI: 6.7, 484.8], p-value = 
0.0002) (Table 4.1A). 
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Table 4.1 Summary of key epidemiological features of ST313 sampled by PHE 
in 2012 and 2014-2016. Odds ratios, 95% confidence intervals (CI) and p-values 
are shown for each association. 
 
 
4.3 Phylogenetic analysis reveals unprecedented diversity of 
ST313 
Sequence data quality was sufficient to permit whole genome single nucleotide 
polymorphism (SNP) phylogenetic analysis of the isolates from 76 of the 77 patient 
and non-human isolates. Within the wider phylogenetic context of S. Typhimurium, all 
ST313 isolates submitted to PHE formed a monophyletic group that clustered with 
135 
 
previously described African ST313 isolates (Okoro et al., 2012) (Figure 4.1). A 
second maximum likelihood ST313 phylogeny was generated with a closely-related 
ST19 strain also received by PHE (strain U21) as an outlier, to study phylogenetic 
relationships (Figure 4.2). Of the 76 isolates from distinct patients/sources, 12 
belonged to the previously described lineage 2,  and 64 did not fall within any ST313 
lineage that has been reported to date. No lineage 1 isolates were identified. 
Furthermore, the African associated lineages 1 and 2 did not form a monophyletic 
group within the novel diversity observed. Both of the African lineages share more 
recent common ancestors with UK-associated strains than with each other. Neither 
the food nor the animal isolate belonged to lineage 2. All the UK-derived isolates in 
this study originated from diagnostic laboratories in England and Wales. To simplify 
the categorization/differentiation of the lineages for discussion purposes, isolates 
belonging to lineage 1 and 2 (including those isolated in the UK) will be referred to as 
African lineages and the non-lineage 1 and 2 isolates will be referred to as UK-ST313.  
The UK-ST313 isolates do not themselves form a coherent monophyletic cluster, 
revealing an unappreciated level of genetic diversity within ST313 (Figure 4.1).To 
examine the evolutionary history of ST313, a maximum clade credibility tree was 
inferred using Bayesian Evolutionary Analysis Sampling Trees (BEAST) (Figure 4.3) 
and the topology was largely congruent with respect to the Maximum Likelihood tree 
(Figure 4.1, Figure 4.3). The most recent common ancestor (MRCA) of ST313 is 
estimated to have been in approximately 1787 (95% highest posterior distribution 
(HPD), 1735 - 1836). Lineage 1 was estimated to have diverged from other ST313 
sampled in this study in approximately 1796 (95% HPD 1744-1842), while lineage 2 
diverged from other ST313 sampled here in 1903 (95% HPD 1876 - 1927). The 
lineage 1 MRCA dated to around 1984 (95% HPD 1979-1987), while the lineage 2 
MRCA dated to around 1991 (95% HPD 1986-1995). These confidence intervals 
overlap with the confidence intervals reported for the emergence of the two lineages 
by Okoro et al., 2012 (Okoro et al., 2012). The two African lineages do not form a 
monophyletic group, and share an MRCA which is very close to that of ST313 as a 
whole. Both lineages 1 and 2 are separated from others by long branches, indicating 
a distant MRCA with other isolates and suggesting that a tight population bottleneck 
has occurred relatively recently in evolutionary history. 
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Figure 4.1 UK-ST313 isolates are phylogenetically distinct from African lineages. Unrooted maximum likelihood phylogeny of ST313 in the 
context of reference Salmonella Typhimurium ST19 isolates (2.12.3). Isolate U21 was an ST19 isolate, closely related to ST313, that was used 
as an outgroup in further ST313 analyses. The African epidemic ST313 lineages 1 and 2 are labelled. Branch colour indicates phylogenetic 
groupings; ST19 stains are shown with grey branches, African lineage 1 or 2 are shown with red branches, and the novel diversity represented 
by the UK-ST313 isolates are shown with black branches. The scale bar indicates the SNP-distance represented by branch lengths. 
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Figure 4.2 UK-ST313 are associated with gastrointestinal infection and not 
associated with travel to Africa. A Maximum likelihood phylogeny of 77 UK-
isolated ST313 strains received by PHE in the context of 24 African ST313 
sequenced by Okoro et al. (2012). Red branches indicate ST313 lineage 1 and 2. 
Adjacent metadata panel showing: 1. Country isolate was associated with, Africa- 
black, not Africa- blue; 2. Travel association, reported travel to Africa- orange, no 
reported travel to Africa-grey, travel history unknown- white; 3. Source, extra-
intestinal- red, faecal- brown, environmental- green, unknown- grey.  
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Figure 4.3 The timed phylogeny of all UK-isolated ST313 strains from this 
study and a representative sub-sample of ST313 genomes from Okoro et al., 
2012. BEAST analysis was conducted by P. Ashton, Public Health England. Figure 
shows the maximum clade credibility tree from BEAST. Branches 95% highest 
posterior density (HPD) are displayed in blue for key nodes defining lineage 1 and 
lineage 2. Branches belonging to lineage 1 are coloured orange and branches 
belonging to lineage 2 are coloured brown. 
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4.4 The association between phylogenetic context and travel 
to Africa 
The association between reported travel to sSA and infection with the lineage 2 
isolates was investigated with assistance from epidemiologists from Public Health 
England. Of the 8 UK patients reporting travel to sSA during the seven days before 
disease onset, 7 were infected with a lineage 2 isolate. In contrast, of the 43 patients 
who reported no travel to sSA, 2 were infected with lineage 2 (Table 4.1B). This shows 
that travel to sSA was significantly associated with infection by ST313 lineage 2 (OR 
143.5 [95% CI: 11.4,1802], p-value = 0.0001).  
We investigated whether the ST313 lineage 2 isolates were more frequently 
associated with extra-intestinal or gastro-intestinal infection. Of the 11 patients 
infected with lineage 2 (and for which source of isolation data was available), 10 
patients had isolates that originated from extra-intestinal sites. In contrast, for the 
patients infected with UK-ST313 isolates, 3 of 60 isolates were from extra-intestinal 
sites (Table 4.1C). These data show that in the UK, infection with ST313 lineage 2 is 
significantly associated with invasive disease (OR 190.0 [95% CI: 17.9, 2014.0], p-
value < 0.0001). 
4.5 Accessory genome signatures of ST313 
Multi-drug resistance is a key phenotypic feature associated with both the African 
ST313 lineages and is encoded by Tn21-like integron insertions on the pSLT virulence 
plasmid. Analysis of the genome sequences indicated that all 76 ST313 isolates in 
this study carried the pSLT plasmid. However, the majority of the UK-ST313 isolates 
were antibiotic-sensitive (59/64 were sensitive to all antimicrobials tested) and no 
consistent AMR gene profile was identified. In contrast, 10 of 12 UK-isolated lineage 
2 isolates contained the same pSLT-associated MDR locus as the African lineage 2 
reference strain D23580 (Kingsley et al., 2009). Four UK-isolated lineage 2 strains 
exhibited an atypical AMR gene profile; one isolate (U45) lacked the chloramphenicol 
resistance catA gene and another (U73) was not MDR and only carried the beta-
lactamase gene blaTEM1. A third isolate, U1, was inferred to have acquired resistance 
to fluoroquinolones via a mutation in the DNA gyrase subunit A gene, gyrA. 
The fourth atypical UK-isolated lineage 2 isolate, U60, carried additional antibiotic 
resistance genes including extended-spectrum beta-lactamases (ESBL) blaCTX-M-15 
and blaOXA-1, and genes conferring resistance to aminoglycosides, trimethoprim and 
tetracycline; aac(6')-Ib-cr, dfrA-14, tet(A)-1 (Figure 4.4). Isolate U60 also encoded the 
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tellurium heavy metal resistance operon (terBCDEF). Comparison to lineage 2 
reference strain D23580 identified a 29kb deletion in the pSLT-BT virulence plasmid 
(Kingsley et al., 2009), which corresponded to the conjugal transfer region. 
Additionally, sequence reads mapped to 97% of the IncHI2 pKST313 plasmid, a novel 
plasmid which has recently been reported in lineage 2 isolates from Kenya and is 
known to encode ESBL resistance loci (Kariuki et al., 2015). Interestingly, enhanced 
epidemiological data for isolate U60 showed recent travel to Kenya by the patient. 
Figure 4.4 Isolate U60 contains additional resistance genes including a 
blaCTX-M-15 locus inserted into the chromosomal ompD locus. A. Antimicrobial 
resistance typing data (2.3.5) and resistance genes (2.12.3) detected in genome 
sequences for isolate U60, compared to data for typical lineage 2 and UK-ST313 
isolates. Heat map indicates resistance to the specified antibiotic concentration 
(black), or sensitivity (white). The resistance gene profiles are shown below. B. 
Schematic illustrating the insertion of blaCTX-M-15 element into the chromosomal ompD 
locus in isolate U60.  
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Figure 4.5 Sequence-based validation of the insertion of a blaCTX-M-15 locus into 
the chromosomal ompD locus of UK-isolates lineage 2 isolate U60. A. Mapping 
coverage plots of U60 sequence reads on the pSLT-BT plasmid of D23580 
(accession: LN794248 ) and the incH12 plasmid pKST313 (accession: FN432031). 
Read boxes indicate areas of zero coverage, suggesting the loss of these regions in 
isolate U60. The genes in the putative absent regions are listed above. B. Paired end 
read mapping of U60 sequence reads to the U60 genome assembly. An artemis 
screen shot shows part of the contig containing the disrupted ompD sequence and 
the blaCTX-M-15 insertion. Sequence reads are represented as blue lines with grey lines 
joining each pair. Paired reads span the point of insertion, confirming the location of 
the blaCTX-M-15 locus on the chromosome. 
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A more detailed analysis of the genome of isolate U60 identified a copy of the blaCTX-
M-15 gene inserted into the chromosome (location 1648104-1648109 on the D23580 
reference genome), disrupting the ompD locus (Figure 4.4B, Figure 4.5). ESBL 
resistance genes have previously been reported in African ST313 isolates carrying 
plasmids such as pKST313 (Feasey et al., 2014; Kariuki et al., 2015), but this is the 
first report of a chromosomally-encoded ESBL resistance gene in S. Typhimurium 
ST313. 
In order to assess the chromosomal similarity of UK-ST313 genomes to African 
ST313 genomes, the assembled UK-ST313 genome were compared to the African 
ST313 reference strain D23580 using BLAST (Figure 4.6). In agreement with 
published data (Kingsley et al., 2009), the majority of the core genome, including the 
Salmonella Pathogenicity Island (SPI) repertoire was conserved in the ST313 isolates 
in this study and in three ST19 gastroenteritis isolates (Figure 4.6). The African ST313 
lineages carry two prophages, BTP1 and BTP5, that are absent from ST19 strains 
(Owen et al., 2017; Chapter 2). The entire BTP1 and BTP5 prophages were found in 
most ST313 isolates that belonged to African lineage 2 (12/13), but one UK-isolated 
lineage 2 strain, U68, lacked both prophages. The complete BTP1 and BTP5 
prophages were not identified in any of the UK-ST313 isolates (Figure 4.6), though 
some isolates contained partial and fragmented identity to BTP1 and BTP5, indicating 
the presence of related prophages which may not occupy the same attachment site 
(Casjens and Thuman-Commike, 2011; Hatfull, 2008). As expected, the st313-td 
gene (Herrero-Fresno et al., 2014) was carried by all twelve lineage 2 strains isolated 
from the UK that contained prophage BTP1. Only 1/51 UK-ST313 isolates contained 
the st313-td gene (isolate U76), where it was located on a prophage with 90% identity 
to BTP1. 
To confirm the conservation of chromosomal organization in the UK-ST313 isolates, 
a representative isolate U2 was re-sequenced by PacBio long-read sequencing 
(Chapter 2.11.2). The assembly produced two closed circular contigs representing 
the chromosome and the pSLT virulence plasmid (Figure 4.7). Comparison with the 
ST313 lineage 2 reference genome D23580 identified no large chromosomal re-
arrangements, deletions or duplications, and confirmed that the BTP1 and BTP5 
attachment sites were unoccupied and did not contain additional prophages. No 
additional plasmids larger than the detection limit of the PacBio sequencing (~10kb in 
the case of the library preparation procedure used here- Chapter 2.11.2) were 
detected in isolate U2.  
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Figure 4.6 UK-ST313 lack the BTP1 and BTP5 prophages that are characteristic 
of African ST313 lineages. BLAST ring image showing BLAST comparison of all 76 
UK-isolated ST313 genomes (red and grey rings) along with 3 reference ST19 strains 
(blue rings) 4/74, LT2 and DT104 against lineage 2 representative strain D23580. The 
position of the prophages (coloured blocks) and Salmonella pathogenicity islands 
(grey blocks) in lineage 2 strain D23580 are shown around the outside of the ring. 
This analysis was gererated using the BLAST ring image generator (BRIG) and 
methods are descibred in Chatpter 2.12.3. 
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4.5 Genome degradation and pseudogenes in UK and African 
ST313 
The ST313 lineages 1 and 2 responsible for iNTS disease in Africa have undergone 
genome degradation (Kingsley et al., 2009; Okoro et al., 2015). The pseudogenes 
identified in lineage 2 representative strain D23580 were put into the context of the 
high-quality finished genome of UK-ST313 isolate U2 (Figure 4.7). The majority 
(34/44) of pseudogene mutations were conserved between strains U2 and D23580. 
The only pseudogenes associated with characterized genes present in lineage 2 that 
were functional in UK-ST313 strain U2 were macB, sseI and lpxO (Figure 4.8). Of the 
19 isolates (originating from 12 patients) of lineage 2, all had disruptions to the lpxO, 
ratB, allP, allB, pagO and pipD genes, confirming that the genome degradation 
reported in African lineage 2 is conserved in lineage 2 strains isolated in the UK. 
 
Figure 4.7 Circular representation of the finished genome of UK-ST313 
representative strain U2, showing the chromosome and the pSLT-U2 virulence 
plasmid. The two outer most circles show the position of annotated CDS on the sense 
(red) and antisense (blue) strands respectively. For the chromosome, the location of 
the 3 prophages; Gifsy-1, ST64B and Gifsy-2 are shown as black bars. Finally, the 
G+C content (by 10kb windows) and the GC skew ([G-C]/[G+C] by 10 kb windows) is 
shown in the two center-most circles. The Genbank accession number for the U2 
genome is LT855376 and U2 virulence plasmid accession number is LT855377. 
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Figure 4.8 The majority of pseudogenes identified in lineage 2 strain D23580 
are conserved in UK-ST313 representative strain U2. Heatmap adapted from 
Kingsley et al (2009) showing genome degradation in ST313 strain D23580 (first 
heatmap column) in the context of strain U2 (final column). Grey indicates 
pseudogenes conserved in both strains, whilst red indicates genes which are not 
degraded and likely to be functional in strain U2. 
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4.6 UK and African ST313 strains share key phenotypes 
Several studies have associated the ability of ST313 to cause iNTS disease with 
particular phenotypic characteristics, such as the lack of RDAR morphotype 
formation, reduced swimming motility and the inability to produce catalase at 
stationary phase (Carden et al., 2015; Ramachandran et al., 2015; Singletary et al., 
2016). Logically if the reported phenotypes are important for, and have been selected 
for, in the sub-Saharan African niche, the phenotypes should be absent from non-
African, UK ST313 isolates. I investigated whether the phenotypic characteristics 
were associated with UK-ST313 strains using a subset of 16 UK-isolated ST313 that 
included 13 UK-ST313 isolates and 3 lineage 2 isolates. The phylogenetic context of 
these 16 isolates is shown in Figure 4.9 Lineage 2 representative strain D23580 and 
ST19 representative strain 4/74 were included as positive and negative controls.  
The swimming motility of UK-isolated ST313 was highly variable between isolates 
(Figure 4.10A). One lineage 2 strain, U1, appeared to show low levels of motility but 
this strain was observed to have a significant growth defect (data not shown). The 
ST313 lineage 2 representative strain D23580 was less motile than ST19 strain 4/74, 
consistent with previous reports (Ramachandran et al., 2015). However, there was no 
apparent correlation between motility (as measured by migration diameter) and the 
phylogenetic context of the lineage 2 strains and the UK-ST313 strains.  
The SNP mutation in the katE gene was reported to be responsible for the lack of 
catalase activity in ST313 lineage 2 (Singletary et al., 2016). All 16 UK-isolated strains 
were negative for stationary phase catalase activity, as was the lineage 2 
representative strain D23580 (Figure 4.10B). In contrast, ST19 strain 4/74 showed 
high levels of stationary phase catalase activity, consistent with previous findings 
(Singletary et al., 2016). 
The RDAR morphotype of Salmonella enterica is linked to resistance to desiccation 
and exogenous stresses (White et al., 2006). African lineage 2 ST313 are reported to 
be defective in RDAR morphotype formation due to a truncated BcsG protein 
generated by a premature stop codon (Singletary et al., 2016). All the UK-isolated 
strains and the African lineage 2 reference strain D23580 did not exhibit the RDAR 
morphotype. Only the ST19 strain 4/74 exhibited the RDAR morphotype (Figure 
4.10C). 
These experiments did not identify any phenotypic differences that distinguished the 
UK-ST313 isolates from ST313 lineage 2. Future work is needed to identify African 
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ST313-specific phenotypes, which may provide clues to the evolutionary selection 
pressures that contributed to the niche adaptation of S. Typhimurium ST313 in Africa. 
 
Figure 4.9 Dendrogram representation of the phylogenetic tree shown in Figure 
4.1 but with fully labelled tips to highlight the 16 UK-isolated ST313 strains 
included in phenotypic testing (tips labelled in light blue text). Lineage 1 and 2 
are shown with red branches, ST19 strains with blue branches and UK-ST313 with 
black branches. 
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Figure 4.10 In vitro phenotypes of a subset of UK-isolated ST313 strains in the 
context of the representative ST313 lineage 2 and ST19 strains D23580 and 4/74. 
UK-isolated strains that belong to African lineage 2 (U1, U6 and U13) are highlighted 
in red throughout. A. Motility as represented by migration diameter after 5 hours 
(average of 3 replicates is shown together with error bars representing standard 
deviation) (2.3.2). A representative plate is shown, right. B. Stationary phase catalase 
activity represented by bubble column height after 5 minutes exposure to 20µl 20% 
H2O2 (2.3.4). C. RDAR morphology assay. RDAR phenotype forms after prolonged 
incubation at 25°C but not at 37°C (2.3.3). 
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4.7 UK-ST313 strains carry BTP1-like and BTP5-like 
prophages 
Alignment of the UK-ST313 genomes to the lineage 2 representative strain D23580 
showed that some UK-ST313 strains carry prophages with mosaic homology to BTP1 
and BTP5 (Figure 4.6). To reveal the true extent of homology between the BTP1 and 
BTP5-like prophages detected, prophages were manually extracted from a subset of 
12 UK-ST313 draft genome assemblies that were representative of the phylogenetic 
diversity of all UK-ST313s. Draft genome assemblies consist of a number of short 
assembled fragments (contigs), which increase in length and frequency depending on 
the quality of the genome assembly. To extract prophages sequences, the contigs 
containing the phage attR and attL sites (proximal sites to either end of the prophage) 
were identified, and the sequence between these sites was determined to be a 
putative prophage. In some cases, it was not possible to extract prophage sequences, 
as the BTP1 or BTP5 attachment sites were separated across contigs. However, in 
most cases, the BTP1 or BTP5 attachment site was either intact on a single contig 
(indicating no prophage), or separated by a length corresponding to a putative 
prophage on a single contig (indicating the presence of a prophage occupying the 
attachment site). Additionally, to control for the possibility that the BTP1 and BTP5-
like prophages in the UK-ST313 strains might have distinct attachment sites to BTP1 
and BTP5, large contigs (>50 kb) were extracted which contained homology to BTP1 
or BTP5, and contained core genome sequence (non-phage). Using this approach, 3 
BTP1 or BTP5 like prophages were identified in a total of 10 of the 12 UK-ST313 
genomes. 
Two UK-ST313 strains, U15 and U8 contain a prophage with 71% identity to BTP1 at 
the nucleotide level (Figure 4.11A). This prophage, denoted BTP1UK-1, contains 
almost identical structural genes to BTP1, but differs in the immunity, tail and gtr 
operon regions. The attachment site of BTP1UK-1 was the same as that of BTP1 (data 
not shown). 
Two UK-ST313 strains, U12 and U5 contain a prophage with 48.5% identity to BTP1 
at the nucleotide level (Figure 4.11B). This prophage, denoted BTP1UK-2, contains 
many of the same structural genes as BTP1, but has no similarity to the tailspike and 
gtr operon of BTP1. Interestingly, prophage BTPUK-2 carries a repressor region with 
considerable identity to the repressor region of BTP1 including the ST313-td gene, 
but contains a different cI repressor and cro allele to BTP1. Prophage BTP1UK-2 was 
found to be > 99% identical to a temperature phage called SE1. Phage SE1 was 
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originally isolated from a strain of S. Enteritidis, and mediates generalised 
transduction in S. Typhimurium (Llagostera et al., 1986). The attachment site of the 
prophage BTP1UK-2 (SE1) was the same as BTP1, as the core chromosomal sequence 
bordering the prophage on this contig corresponds to the attachment site of the BTP1 
prophage in D23580. 
Finally, a prophage with 57% identity to BTP5 at the nucleotide level was found in 6 
UK-ST313 strains (U11, U16, U7, U9, U10, U4) (Figure 4.12). This prophage, denoted 
BTP5UK-1, encoded identical capsid, tail and lysis genes to BTP5, but did not encode 
genes homologous to the replication, immunity or integrase genes of BTP5. The BTP5 
attachment site was intact in strains containing prophage BTP5UK-1. The attachment 
site of the prophage was found to be between the CpxQ sRNA and the fieF gene 
(STMMW_40261), though neither element was interrupted by the integration of the 
prophage (data not shown). 
The presence of the novel BTP1-like and BTP5-like prophages discovered in the UK-
ST313 genomes did not correlate with the phylogeny (Figure 4.13) i.e. prophages 
were not associated with particular phylogenetic clusters, showing that the presence 
of these prophage is not under high selection pressure in the UK-ST313 niche. For 
example, BTP5UK-1 was present in UK-ST313 isolates spanning the diversity of the 
tree, which may suggest that, though there is considerable genetic diversity amongst 
the UK-ST313 isolates in this study, they exist within the same ecological niche, and 
are therefore exposed to the same phage population. 
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Figure 4.11 Novel BTP1-like prophages identified in the genomes of UK-ST313 
isolates. A. Prophage BTP1UK-1 was identified in UK-ST313 strains U15 and U8 and 
shares 71% identity to prophage BTP1. B. Prophage BTP1UK-2 was identified in UK-
ST313 strains U12 and U5 and shared 48.5% identity with BTP1. Prophage BTP1UK-2 
was found to be more than 99% identical to phage SE1 derived from Salmonella 
Enteritidis (inset). Comparative genomic analysis was conducted as described in 
2.12.5. 
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Figure 4.12 A novel BTP5-like prophage identified in the genomes of UK-
ST313 isolates. A. Prophage BTP5UK-1 was identified in UK-ST313 strains U11, 
U16, U7, U9, U10 and U4. BTP5UK-1 was 57% identical to BTP5. B. Prophage 
BTP5UK-1 occupies a distinct attachment site to BTP5, between the CpxQ sRNA and 
the fieE gene. Comparative genomic analysis was conducted as described in 2.12.5. 
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Figure 4.12 The phylogenetic distribution of 
the BTP1-like and BTP-5 like prophages 
identified in the UK-ST313 genomes. The 
BTP1 & BTP5 attachment site are represented 
as grey and black un-filled squares. Presence of 
a prophage (indicated by a filled coloured 
circle), in an attachment site is indicated by the 
position of the circle inside the square. Circles 
outside of the attachment site boxes represent 
prophages occupying attachment sites distinct 
from that of BTP1 and BTP5. Prophages were 
identified by comparative genomic analysis as 
described in 2.12.5. 
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4.8 Discussion 
Recent reports of iNTS disease have been associated with Salmonella Typhimurium 
ST313 in sSA (Kingsley et al., 2009; Okoro et al., 2015) and suggested that ST313 
was geographically restricted to sSA. This prompted investigation into the presence 
of ST313 amongst S. Typhimurium isolates from the UK. 
It was discovered that 2.7% of Salmonella Typhimurium isolates referred to Public 
Health England are of MLST type ST313 and that this sequence type is 
heterogeneous in terms of clinical presentation, genomic characteristics and 
epidemiology. The UK-isolated ST313 strains are predominantly fully antimicrobial-
susceptible and cause gastroenteritis. This was also the case with the recently 
described ST313 strains from Brazil (Almeida et al., 2017), raising the possibility that 
the Brazilian isolates are more closely related to the UK-ST313 reported here than to 
African lineage 2.  
Significant correlation was identified between travel to Africa and infection with the 
previously described African-associated, ST313 lineage 2. The amount of diversity 
between the lineage 2 ST313 isolates from the UK (Figure 4.4) was not consistent 
with an immediate, common source of exposure. Instead, it is more probable that 
these isolates were linked to travel to Africa, a hypothesis that was supported by 
epidemiological data that linked the isolates to African travel (Table 4.1).  
This study revealed novel diversity within ST313, which was previously restricted to 
two African lineages that had exhibited recent clonal expansion (Okoro et al., 2012). 
The African lineages are placed into an evolutionary context by showing that lineage 
1 and 2 do not form a monophyletic group within ST313, which is suggestive of two 
separate introductions of ST313 into sSA. African lineages 1 and 2 diverged from their 
MRCA with UK-lineages around 1796 and 1903 respectively (4.3). These findings 
reflect the limitations of classifying bacterial pathogens simply on the basis of 
sequence type and show that in the post-genomic era, the resolution offered by MLST 
may not be sufficient to describe epidemiologically relevant population structures of 
Salmonella. 
It has been estimated that 9.2% of cases of Salmonellosis in the EU can be attributed 
to international travel and therefore sequencing Salmonella isolated in Europe can 
provide valuable information regarding the global diversity of Salmonella associated 
with human disease (Guerin et al., 2007; Pires et al., 2014). The genome of one UK-
isolated lineage 2 isolate associated with travel to Kenya, U60, contained sequences 
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with high nucleotide similarity to a recently described IncHI2 plasmid, pKST313, that 
was carried by ceftriaxone-resistant ST313 isolates from Kenya (Kariuki et al., 2015). 
Until now the blaCTX-M-15 gene has only been found to be plasmid-associated in 
Salmonella. A blaCTX-M-15 gene carried on the chromosome was discovered in UK-
isolated lineage 2 strain U60, causing disruption of the ompD locus which has two 
implications. Firstly, chromosomal integration ensures stability of ESBL-resistance 
even in the absence of the plasmid. Secondly, ompD encodes an outer membrane 
porin of S. Typhimurium that is highly immunogenic (Gil-Cruz et al., 2009) and absent 
from S. Typhi. Accordingly, the disruption of ompD could enhance the reported 
“stealth” phenotype of ST313 lineage 2 infection (Carden et al., 2015). Notably, OmpD 
has been proposed as a vaccine target for iNTS (Ferreira et al., 2015) and the 
absence of OmpD from African ST313 populations could have implications for future 
iNTS vaccine development. 
People infected with ST313 lineage 2 in the UK were significantly more likely to suffer 
from invasive disease than patients infected with UK-ST313 isolates, though the HIV 
/ immunosuppression-status was not known for these patients. This observation 
provided an excellent opportunity to use comparative genomics to put genetic findings 
that have been linked the pathology of lineage 2 ST313 into the context of closely 
related, gastrointestinal-associated strains. The only genetic characteristics found to 
be common to both lineages 1 and 2 and absent from the UK-ST313 genomes were 
the BTP1 and BTP5 prophages and the plasmid-associated MDR loci. The two African 
lineages do not share a common ancestor that carried either prophage, suggesting 
independent acquisition of BTP1 and BTP5 by ST313 lineage 1 and 2. Whilst the 
MDR loci of lineage 1 and 2 confer similar patterns of AMR, they are genetically 
distinct indicating independent origins. The maintenance of the prophage and 
plasmid-encoded accessory genome in two distinct ST313 lineages in Africa implies 
a strong selection pressure that caused convergent evolution of the two African 
lineages. In contrast, there was evidence for an assortment of distinct prophage 
repertoires in the UK-ST313 isolates, indicating an absence of selection for specific 
mobile elements. 
Aside from the addition of mobile genetic elements and virulence factors, genome 
degradation by the accumulation of pseudogenes and deletion events accompanies 
adaption to a more invasive lifestyle (Georgiades and Raoult, 2011; Nuccio and 
Bäumler, 2014). Initial analysis of the African ST313 representative strain D23580 
genome identified 23 pseudogenes compared to the 6 present in ST19 strain SL1344 
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(Kingsley et al., 2013). However, the majority of the genome degradation found in 
lineage 2 strain D23580 was conserved in UK representative strain U2. The only 
pseudogenes associated with characterized genes that were found to be specific to 
African lineage 2 ST313 were the SPI2-secreted effector gene sseI, lipid A 
modification gene lpxO and macrolide efflux pump gene macB, each of which could 
potentially play a role in infection dynamics (Andersen et al., 2015; Carden et al., 
2017; Gibbons et al., 2005). 
A number of the in vitro phenotypes that have been reported for lineage 2 ST313, 
which could contribute to a host-adapted lifestyle (Carden et al., 2015; Ramachandran 
et al., 2015; Singletary et al., 2016), were examined in the UK-ST313 to look for an 
African lineage-specific phenotype. Swimming motility was highly variable amongst 
the strains tested, and UK-ST313 isolates behaved identically to African lineage 2 
isolates in the catalase and RDAR morphotype assays. No African lineage-specific 
phenotypic characteristics were detected, suggesting that reduced motility, defective 
catalase activity and loss of RDAR formation are not directly linked to iNTS disease. 
A key contributing factor to iNTS disease is host immunosuppression (Feasey et al., 
2012), and one limitation of this retrospective study was that the underlying health 
status of the patients was unknown. This study does highlight the extraordinary 
epidemiological insights that routine genomic surveillance of pathogens by public 
health agencies can offer and the ability to understand the pathogenesis of novel 
pathovars.  
This chapter has described previously unknown diversity in the ST313 sequence type 
that gives an insight into the convergent evolution towards niche specialization that 
has occurred in African ST313 lineages 1 and 2. The routine genomic surveillance of 
pathogens described here is now being adopted internationally and will bring an 
unprecedented ability to monitor emerging threats, such as the arisal of extended-
spectrum beta-lactamase resistance. More generally, whole-genome sequencing of 
clinical isolates represents a new window with which to view the epidemiology and 
microbiology of infectious diseases. 
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Chapter 5 
Investigating novel prophages 
BTP1 & BTP5 at the 
transcriptional level 
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5.1 Introduction 
The BTP1 and BTP5 prophages are a defining feature of African S. Typhimurium 
ST313 isolates belonging to both lineages, and ST313 genomes lacking either or both 
of the prophages are rare (Okoro et al., 2015). Findings described in Chapter 4 
suggested that the BTP1 and BTP5 prophages were acquired independently by the 
two African lineages of S. Typhimurium ST313, suggesting a strong selection 
pressure for this particular prophage complement in the sub-Saharan African niche, 
and representing convergent evolution of the two lineages in Africa (Chapter 4.5). 
What is the selection pressure that drove the acquisition and is driving the 
conservation of these prophages? The aim of this chapter is to put the prophages 
characterised in Chapter 3 into context within the genome of African S. Typhimurium 
ST313, and to explore how the novel prophages may contribute to the biology of the 
lysogen, at the transcriptomic level. 
5.1.1 Acknowledgement of the specific contribution of collaborators to the 
results described in Chapter 5.  
The work described in this chapter is unpublished. I acknowledge the following 
contribution of collaborators to the results described in this chapter. Unless specified 
below, all work was completed by the Author. 
Rocío Canals & Disa Hammarlöf 
University of Liverpool, UK 
 
Collection of all D23580 WT RNA-seq & 
dRNA-seq samples  
(Canals et al., 2018; Hammarlöf et al., 2017) 
Will Rowe 
University of Liverpool, UK 
 
Generation of differential gene expression 
values (CPMs) for prophage mutant RNA-
seq experiments (described in 2.12.4) 
 
5.2 The D23580 prophage transcriptome 
As in previous analysis, strain D23580 was used as a representative of African S. 
Typhimurium as it was the first strain for which a completed genome sequence was 
made publically available. RNA-seq data from Canals et al. (2018) was used to 
analyse the transcriptomes of the five D23580 prophages in 16 infection-relevant 
conditions, following a previously described approach (Kröger et al., 2013). The suite 
of conditions in which the bacteria were grown before RNA extraction were designed 
to represent the different environments that pathogens experience during infection of 
a mammalian host. The data also include RNA-seq experiments from strain D23580 
during infection of murine macrophages, following previously described methods 
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(Srikumar et al., 2015). The transcriptomes reveal the expression patterns of 
prophage genes whilst the prophages are in a lysogenic state within the cell.  
As well as looking at gene expression profiles, the transcription start sites (TSS) 
located in the prophage regions were also analysed. The approach pioneered by 
Kröger et al., 2012 to define TSS known as differential RNA-seq (dRNA-seq) was 
used to locate the TSS in the prophage regions (Hammarlöf et al., 2017). TSS are 
important as they indicate the activity of promoters. Together, these data reveal the 
transcriptional landscape of five distinct prophages during lysogeny. Prophage genes 
which are expressed during lysogeny are frequently associated with lysogenic 
conversion of the host, such as genes encoding virulence factors or superinfection 
immunity factors (Casjens and Hendrix, 2015).  
5.2.1 BTP1 prophage transcriptome 
The transcriptome map (Figure 5.1) of BTP1 in a lysogenic state showed relatively 
little transcription, interspersed with a small number of highly transcribed regions. Five 
genes (excluding the two central tRNAs) showed particularly high expression (Figure 
5.2); ST313-td (STMMW_03531), cI (STMMW_03541), pid (STMMW_03751), gtrC 
(STMMW_03911) and gtrA (STMMW_03921).  The cI and the ST313-td genes 
represent an operon, as only one TSS was associated with the two genes, and RNA-
seq reads mapped across the 88 bp intergenic region. The cI-ST313-td operon 
showed a high level of expression in most conditions, consistent with the putative role 
of the CI protein as the prophage repressor. The pid gene, linked to maintenance of 
the pseudolysogenic state in phage P22 (Cenens et al., 2013) also showed a high 
level of transcription in the majority of conditions (TPM >10 in all conditions) (Figure 
5.2). Lastly, a two-gene operon encoding gtrA and gtrC showed high expression in 
the majority of conditions (TPM >10 in 16/17 conditions). gtrA encodes a bactoprenol-
linked glucosyltranslocase (also known as the ‘flippase’) and gtrC encodes a putative 
acetyltransferase that mediates the addition of an acetyl group to the rhamnose 
subunit of the O-antigen (Kintz et al., 2015). The gtr operon is commonly found in 
P22-like phages and functions to modify the O-antigen component of the 
lipopolysaccharide to inhibit superinfection of the lysogen (Davies et al., 2013). The 
high expression of the BTP1 gtr operon in the majority of conditions tested suggests 
that unlike the gtr operon of phage P22 (Wallecha et al., 2002) the acetylation of the 
rhamnose LPS moiety is not a phase-variable phenotype and occurs in all growth 
conditions (Kintz et al., 2015). 
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The structural (capsid and tail) and lysis genes (late lytic genes) showed some, albeit 
low level, expression in the majority of conditions tested (Figure 5.1, Figure 5.2). Work 
described in Chapter 3 showed that the BTP1 prophage exhibits an extremely high 
level of spontaneous induction within the cellular population, and BTP1 is estimated 
to undergo spontaneous induction in 0.2% of bacterial cells. As the transcriptome 
generated by RNA-seq represents the average gene expression across an entire 
bacterial population, I hypothesise that the apparent low-level late lytic gene 
transcription is derived from extremely high level transcription of these genes within 
the fraction of the population in which the BTP1 prophage is spontaneously induced. 
This hypothesis is discussed in the context of the other prophages of D23580 in 
section 5.4. Late lytic-gene expression was highest in the ESP and oxygen shock 
conditions, which may suggest that proportionately greater spontaneous induction 
occurs in these growth conditions, though this possibility has not been tested 
experimentally.  
The prophage late lytic genes were transcribed in one long operon that begins 
upstream of the lysis gene cluster, directly after the central tRNA genes. Due to 
position of the tRNA genes upstream of this transcript, the exact position of the TSS 
for this transcript is not clear. As well as primary TSS, operons may also exhibit 
secondary TSS, which are located downstream of the initial TSS and produce shorter 
transcripts (Kröger et al., 2012). Within the BTP1 prophage capsid gene cluster there 
were three putative secondary TSSs on the coding strand. The BTP1 tailspike gene 
contained a number of secondary TSS, and showed a different transcriptional pattern 
to the rest of the late lytic gene operon (Figure 5.1). Antisense transcription of the 
tailspike gene is investigated in Chapter 6.4. A total of 10 putative non-coding RNAs 
(ncRNAs) were identified in the BTP1 transcriptome (Figure 5.1) (Hammarlöf et al., 
2017). One of these, designated OOPBTP1, occupies the same position as the OOP 
sRNA of phage Lambda, antisense to and overlapping, the 3’ end of the cII gene 
(Krinke and Wulff, 1987). In phage lambda, OOP is thought to regulate the expression 
of the cII gene, thereby modulating the switch between lysogenic and lytic infection. 
The remaining 9 putative ncRNAs have not been identified in other lambdoid phages 
and prophages and therefore their function is unknown.  
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Figure 5.1 Transcriptional map of prophage BTP1 of D23580 in 17 infection-relevant conditions. RNA-seq and dRNA-seq data from Canals et al. (2018) and Hammarlöf et al. (2017). Each track 
represents a different condition, and upper panel shows sequence reads mapped to the positive strand and lower panel, negative strand. TSS were identified by dRNA-seq and are indicated by curved 
black arrows on the annotation track. Methods associated with this analysis can be found in Chapter 2.12.4. 
  
162  
 
Figure 5.2 Heat map showing the absolute expression of BTP1 genes in 17 
infection-relevant conditions. RNA-seq data from Canals et al. (2018) were used 
to generate transcript per million (TPM) absolute expression values for each gene and 
annotated ncRNA of the BTP1 prophage. Methods associated with this analysis can 
be found in Chapter 2.12.4. 
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5.2.2 The Gifsy-2 prophage transcriptome in D23580 & 4/74 
Unlike the BTP1 prophage transcriptome, where expression of the lytic genes can be 
seen in most conditions tested, the late-lytic genes of Gfisy-2 were not expressed 
(TPM <10) (Figure 5.3, 5.4). The highly expressed genes of Gifsy-2 were restricted to 
known prophage accessory genes, such as the virulence-associated genes sodCI, 
gtgE and sseI (known to be a pseudogene in D23580). 
To examine the conservation of gene expression patterns between prophages in 
different host backgrounds, the expression of Gifsy-2 genes in D23580 was compared 
to the expression in ST19 strain 4/74 (Kröger et al., 2013) (Figure 5.4). The most 
obvious difference between the expression patterns is that Gifsy-2 sRNA IsrB-1 
appeared to be expressed in strain 4/74 but not in D23580. However, subsequent 
investigation showed that IsrB-1 is duplicated in the D23850 genome (it is present on 
both Gifsy-2D23580 and Gifsy-1D23580), meaning that IsrB-1 RNA-seq reads cannot be 
uniquely mapped to the D23580 genome and the absence of IsrB-1 expression in 
D23580 is likely to be an artefact. Aside from this discrepancy, there was remarkable 
consistency in the gene expression of the two Gifsy-2 prophages, showing that 
prophage gene expression is independent of host background, and that the RNA-seq 
conditions were highly reproducible between the two Salmonella strains. 
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Figure 5.3 Transcriptional map of prophage Gifsy-2 of D23580 in 17 infection-relevant conditions. RNA-seq and dRNA-seq data from Canals et al. (2018) and Hammarlöf et al. (2017). Each track 
represents a different condition, and upper panel shows sequence reads mapped to the positive strand and lower panel, negative strand. TSS were identified by dRNA-seq and are indicated by curved 
black arrows on the annotation track. Arrows filled with slanted black stripes represent pseudogenes. Red dotted lines connect the separated parts of pseudogenised genes which have been disrupted 
by early truncation or insertion. Methods associated with this analysis can be found in Chapter 2.12.4. 
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Figure 5.4 Heat map showing the absolute expression of the Gifsy-2 prophage 
of D23580 and 4/74 strains in 17 infection-relevant conditions. RNA-seq data 
from Canals et al. (2018) were used to generate transcript per million (TPM) 
absolute expression values for each gene and annotated RNA of the Gifsy-2 
prophage. Ortholog IDs in red text indicate genes unique to Gifsy-2D23580 or Gifsy-
24/74. Methods associated with this analysis can be found in Chapter 2.12.4.  
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5.2.3 The ST64B prophage transcriptome in D23580 & 4/74 
The ST64B prophage transcriptome only showed significant late lytic-gene 
transcription in 2 of the RNA-seq conditions; peroxide shock and nitric oxide shock 
(Figure 5.5 and Figure 5.6). As hydrogen peroxide and nitric oxide cause oxidative 
stress and putative DNA damage, transcription of the lytic genes in these conditions 
is likely to represent induction of the ST64B prophage. The lack of evidence for 
increased induction of the remaining D23580 prophages in these conditions suggests 
that the ST64B prophage in D23580 is specifically sensitive to peroxide and nitric 
oxide stress. The prophage contains a gene that encodes the secreted effector protein 
SseK3. The sseK3 gene was only expressed in conditions linked to intracellular 
infection, such as InSPI2 (a medium designed to mimic intracellular conditions), 
peroxide shock, nitric oxide shock and the intra-macrophage environment. A similar 
expression profile has been observed for genes that encode other SPI2-translocated 
effector proteins in S. Typhimurium strain 4/74 (Srikumar et al., 2015). The patterns 
of gene expression of ST64BD23580 and ST64B4/74 showed many similarities, though in 
the 4/74 data the prophage did not show late lytic gene expression in the peroxide 
shock condition suggesting that the prophage may exhibit different induction 
behaviour in strain 4/74. 
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Figure 5.5 Transcriptional map of prophage ST64B of D23580 in 17 infection-relevant conditions. RNA-seq and dRNA-seq data from Canals et al. (2018) and Hammarlöf et al. (2017). Each 
track represents a different condition, and upper panel shows sequence reads mapped to the positive strand and lower panel, negative strand. TSS were identified by dRNA-seq and are indicated 
by curved black arrows on the annotation track. Arrows filled with slanted black stripes represent pseudogenes. Red dotted lines connect the separated parts of pseudogenised genes which have 
been disrupted by early truncation or insertion. Methods associated with this analysis can be found in Chapter 2.12.4. 
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Figure 5.6 Heat map showing the absolute expression of the ST64B prophage 
of D23580 and 4/74 strains in 17 infection-relevant conditions. RNA-seq from 
Canals et al. (2018) was used to generate transcript per million (TPM) absolute 
expression values for each gene and annotated RNA of the ST64B prophage. 
Ortholog IDs in red text indicate genes unique to ST64BD23580 or ST64B4/74. White 
colouring of the heatpmaps indicates that there is no ortholog in the opposing strain. 
Methods associated with this analysis can be found in Chapter 2.12.4.  
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5.2.4 The Gifsy-1 prophage transcriptome in D23580 & 4/74 
Like the Gifsy-2 prophage, Gifsy-1 showed no evidence of lytic-gene transcription in 
any of the 17 environmental conditions. This is consistent with the very low level of 
spontaneous induction that was observed for the resuscitated Gifsy-1 prophage in 
Chapter 3.5. However, Gifsy-1 contained a number of ncRNAs which were highly 
transcribed in all conditions tested (Figure 5.7). The virulence-associated genes gogB 
(STMMW_26001), pagJ (STMMW_26011) and pagK (STMMW_26041) were only 
expressed in intracellular infection-linked conditions. Contrastingly, the virulence-
associated gene gipA (STMMW_26191) was transcribed in all conditions tested, 
despite being previously reported to be specifically induced during colonisation of the 
small intestine (Stanley et al., 2000). Another virulence-associated gene, gtgA 
(STMMW_26331) showed very little transcription in any of the conditions tested. The 
functionally uncharacterised gene STMMW_26411 was specifically induced in the 
anaerobic shock and anaerobic growth conditions, suggesting that this gene could be 
important during anaerobic conditions. 
The Gifsy-1 prophage is not identical between strains D23580 and 4/74, and shows 
considerable difference in gene content particularly at the terminal end. Therefore, 
comparison of the Gifsy-1 gene expression profiles between the two strains is difficult 
to interpret (Figure 5.8). However, the expression patterns of orthologous genes 
shared by the two prophages showed many similarities across the conditions.  
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Figure 5.7 Transcriptional map of prophage Gifsy-1 of D23580 in 17 infection-relevant conditions. RNA-seq and dRNA-seq data from Canals et al. (2018) and Hammarlöf et al. (2017). Each track 
represents a different condition, and upper panel shows sequence reads mapped to the positive strand and lower panel, negative strand. TSS were identified by dRNA-seq and are indicated by curved 
black arrows on the annotation track. Methods associated with this analysis can be found in Chapter 2.12.4. 
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Figure 5.8 Heat map showing the absolute expression of the Gifsy-1 prophage 
of D23580 and 4/74 strains in 17 infection-relevant conditions. RNA-seq data 
from Canals et al. (2018) were used to generate transcript per million (TPM) absolute 
expression values for each gene and annotated RNA of the Gifsy-1 prophage. 
Ortholog IDs in red text indicate genes unique to Gifsy-1D23580 or Gifsy-14/74. Methods 
associated with this analysis can be found in Chapter 2.12.4. 
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5.2.5 The BTP5 prophage transcriptome 
The BTP5 prophage showed the least transcriptional activity of all the D23580 
prophages (Figure 5.9, Figure 5.10). However, the expression of BTP5 genes 
presents a confusing insight into the biology of the prophage. The most highly 
expressed transcript in the prophage belonged to the tum gene (STMMW_32041), a 
homolog of the tum antirepressor of coliphage 186 (Shearwin et al., 1998). The 
antirepressor was expressed particularly highly in the nitric oxide shock condition, 
raising the possibility that nitric oxide could stimulate induction of BTP5. However, this 
observation does not fit the inability to identify spontaneously induced BTP5 phages 
in Chapter 3.6, even with chemical induction. Additionally, transcription was observed 
from the TSS upstream of the apI gene (STMMW_32112) through to the 
uncharacterised gene STMMW_32601 in certain conditions, including early stationary 
phase (ESP), bile shock and anaerobic shock. The corresponding genes in coliphage 
186 have been defined as the early lytic operon (Shearwin and Egan, 2000) and 
represent the genes initially expressed during lytic phage replication. Expression of a 
3-gene operon consisting of tail structural genes (STMMW_31821, STMMW_31811 
and STMMW_31801) was also observed in a number of conditions, particularly ESP, 
bile shock and nitric oxide shock. However, the tail structure of P2-like phages 
(Myoviruses) is complex (Nilsson and Haggård-Ljungquist, 2006), and expression of 
these three genes alone would not produce functional phage tail particles and 
therefore the functional relevance of this putative transcript is unclear. Additionally the 
ogr gene (STMMW_31741), reported to be involved in control of late gene expression 
in phage P2 (Christie et al., 1986), is expressed in all conditions tested. 
Despite the evidence for transcription of late lytic genes in the BTP5 prophage, the 
repressor and integrase genes were expressed in all conditions tested, albeit at low 
levels relative to the level of tail gene transcription. In summary, the BTP5 prophage 
transcriptome does not help to ascertain the functionality of the prophage, and as in 
Chapter 3, the lysogeny and lysis behaviour of the BTP1 prophage remains 
mysterious. There may be further control of prophage BTP5 at the post-transcriptional 
level, or alternatively the transcriptome may reflect heterogeneity in the activity of the 
BTP5 prophage across the cellular population, suggested for the BTP1 prophage 
transcriptome (Chapter 5.2.1).  
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Figure 5.9 Transcriptional map of prophage BTP5 of D23580 in 17 infection-relevant conditions. RNA-seq and dRNA-seq data from Canals et al. (2018) and Hammarlöf et al. (2017). Each 
track represents a different condition, and upper panel shows sequence reads mapped to the positive strand and lower panel, negative strand. TSS were identified by dRNA-seq and are indicated by 
curved black arrows on the annotation track.  Methods associated with this analysis can be found in Chapter 2.12.4. 
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Figure 5.10 Heat map showing the absolute expression of BTP5 genes in 17 
infection-relevant conditions. RNA-seq data from Canals et al. (2018) were used 
to generate transcript per million (TPM) absolute expression values for each gene and 
annotated ncRNA of the BTP5 prophage. Methods associated with this analysis can 
be found in Chapter 2.12.4.  
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5.3 Investigating the regulatory contribution of BTP1 & BTP5 
at the transcriptional level 
The function of temperate phages in bacterial pathogens is exemplified by the 
presence of phage-encoded toxins, for example the Shiga toxin of Stx phages in 
Shiga-toxinigenic E. coli (STEC), or the cholera toxin carried by the CTXΦ phage of 
Vibrio cholera (Brüssow et al., 2004). The acquisition of a temperate phage carrying 
a toxin or virulence gene by a bacterial pathogen may facilitate rapid adaption to a 
new niche, for example by altering the disease tropism of the pathogen, known as 
‘lysogenic conversion’. However, the mechanism of lysogenic conversion of a 
bacterial pathogen by a prophage may not always be as overt as the addition of a 
toxin gene. For example, whilst Stx phages encode the Stx enterotoxin, the cII 
regulatory gene of Stx phage Φ24B has also been shown to up-regulate the glutamic 
acid decarboxylase operon, conferring acid resistance to the lysogen which may 
increase bacterial survival in the intestinal tract (Veses-Garcia et al., 2015). 
Additionally, the A118 prophage of Listeria monocytogenes dynamically integrates 
and excises from its attachment site within the comK gene, encoding the master 
activator of the competence system. This mechanism serves as a genetic switch that 
modulates the intracellular lifestyle of the pathogen (Rabinovich et al., 2012). 
Evidently, a prophage could plausibly transcriptionally rewire a host bacterium for its 
own benefit (Feiner et al., 2015), perhaps akin to examples of protozoan parasites 
such as Toxoplasma gondii, for which infection of an intermediate rodent host appears 
to enhance transmission to the feline definitive host (Adamo and Webster, 2013). 
Could the disease tropism differences between African S. Typhimurium ST313 and 
more typical S. Typhimurium sequence types such as ST19, be due to transcriptional 
changes mediated by novel prophages BTP1 and BTP5? 
5.3.1 Identification of D23580 genes differentially expressed by the presence of 
prophages by RNA-seq 
To investigate the transcriptional contribution of prophages BTP1 and BTP5, 
RNA-seq experiments were conducted on isogenic mutants lacking either one, or both 
of the prophages (the strains used in these experiments are represented 
diagrammatically in Figure 5.11, and strain construction is detailed in chapter 2.8.2). 
Gene expression was investigated in 3 different environmental conditions (Kröger et 
al., 2013); early stationary phase growth in L-broth (ESP), anaerobic growth in L-broth 
(noO2), and a Salmonella Pathogenicity Island 2-inducing condition in PCN media 
(inSPI2) (see chapter 2.9.1 for full description of growth conditions). All experiments 
were conducted in triplicate, and an overview of the experiment is shown in Table 5.1.  
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Figure 5.11 Schematic representation of the strains used in Chapter 5.6. Grey 
regions indicate shared sequence identity. White regions indicate missing/deleted 
regions.  
 
Table 5.1 Experimental design of the RNA-seq experiments described in 
Chapter 5.6. Final column indicates who the RNA samples were collected by.  
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All experiments were conducted by the Author, except the comparator D23580 WT 
samples, which were generated by Dr Rocio Canals for logistical reasons. 
How the differential gene expression analysis of the RNA-seq data was conducted is 
described in chapter 2.12.4. Using D23580 WT as a comparator, up to 1100 gene 
genes were differentially expressed by more than 2-fold (FDR ≤0.01) in the prophage 
mutants in the ESP and anaerobic growth conditions (Figure 5.12). In the SPI-2 
inducing condition (inSPI2), very few genes were differentially expressed more than 
2-fold (only 3 were up-regulated in D23580 ΔBTP5 and D23580 ΔBTP1ΔBTP5 vs. 
D23580 WT).  
Recent experiments in the Hinton Lab have identified a high level of variability 
between RNA-seq replicates collected by different lab workers (R. Canals, Pers. 
Comm.), leading to the conclusion that the very high numbers of differentially 
expressed genes seen in the ESP and anaerobic growth conditions are likely to 
represent experimental noise caused by comparing the D23580 prophage mutants 
(RNA-seq samples collected by the Author), with D23580 WT (RNA-seq samples 
collected by Rocio Canals).  
To reduce any experimental noise that may result from such experimental variation, 
a second comparison was analysed that only involved RNA-seq samples generated 
by the Author. It was reasoned that, assuming the effects of the BTP1 and BTP5 
prophages are independent from each other, the impact of the BTP1 prophage upon 
global gene expression should be evident by comparing D23580 WT to D23580 
ΔBTP1 (as described above), or by comparing D23580 ΔBTP5 to D23580 
ΔBTP1ΔBTP5. This is because, in both cases, the difference between the strains is 
the presence of BTP1 (illustrated in Figure 5.13, comparison A vs. B). Equally, the 
effect of the BTP5 prophage should be revealed by comparing D23580 WT to D23580 
ΔBTP5, or by comparing D23580 ΔBTP1 to D23580 ΔBTP1ΔBTP5 (Figure 5.13, 
comparison C vs. D). Using this single vs. double prophage mutants comparator 
strategy, the number of genes differentially expressed >2-fold (FDR ≤0.01) in the 
presence of prophage BTP1 and BTP5 was significantly reduced (Figure 5.14). The 
comparison showed that the greatest impact upon global gene expression was 
mediated by the presence of the BTP5 prophage in the ESP condition, with a total of 
91 genes differentially expressed >2-fold (FDR ≤0.01). In general, more genes were 
up-regulated in the presence of the prophages than down-regulated, suggesting the 
prophages are more likely to activate gene expression than to repress gene 
expression. 
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Figure 5.12 Number of genes differentially expressed more than 2-fold in the 
D23580 prophage mutants compared to D23580 WT in three growth conditions, 
ESP, InSPI2 and NoO2. Details of growth conditions are given in Table 2.8. 
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Figure 5.13 Figurative representation of the transcriptomic comparisons used 
to identify the differential gene expression mediated by the BTP1 and BTP5 
prophages. Prophages are represented by coloured blocks (see key). Comparisons 
A and B  reveal the transcriptomic impact of the BTP1 prophage (indicated by red 
arrow) and comparisons C and D reveal the effects of the BTP5 prophage (indicated 
with blue arrow). 
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Figure 5.14 Number of genes differentially expressed more than 2-fold in the 
presence of the BTP1 or BTP5 prophage, using the D23580 ΔBTP1 ΔBTP5 
mutant as a comparator in the three growth conditions, ESP, InSPI2 and NoO2. 
Growth conditions are described in Table 2.8.  
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5.3.2 Impact of the BTP1 prophage upon global gene expression of D23580 
To further minimise experimental noise and identify only the most significant 
transcriptomic changes, the data were further scrutinised. The comparisons which 
should show the effects of the BTP1 prophage were determined to be: 
 D23580 WT vs D23580 ΔBTP1 
 D23580 WT vs D23580 ΔBTP1ΔBTP5 
 D23580 ΔBTP5 vs D23580 ΔBTP1ΔBTP5 
 D23580 ΔBTP1 vs D23580 ΔBTP5 
Genes differentially expressed >2-fold (either up-regulated or down-regulated) (FDR 
≤0.01), in all four comparisons were cross-referenced to identify common signatures 
(Figure 5.15). Genes identified in at least 3 of the 4 comparisons were judged to be 
most significant. 
In the ESP condition, the uncharacterised sRNA STnc3870 was putatively repressed 
by the BTP1 prophage, as the sRNA was up-regulated in D23580 ΔBTP1 nearly 8-
fold compared to D23580 WT (Figure 5.16). No significant changes were identified in 
the inSPI2 condition. In the anaerobic growth condition, 3 genes showed BTP1-
associated differential expression; gtrBa (STMMW_06241), gtrCa (STMMW_06231) 
and gtrAa (STMMW_06251). The gtrABCa operon encodes a glycosyltransferase 
enzyme system that mediates the addition of a glucose moiety to the galactose 
subunit of the O-antigen. The operon is encoded on the Def-1 remnant prophage 
element (Chapter 3.7). The gtrABCa was putatively repressed by the BTP1 prophage 
in the anaerobic growth condition, as the genes were up-regulated approximately 4-
fold in D23580 ΔBTP1 vs. D23580 WT.  
Figure 5.16 shows the expression values for STnc3870 and gtrABCa for all strains in 
ESP and anaerobic growth respectively, as well as a normalised read-coverage plot 
for the gtrABCa operon. In both cases, though the difference between D23580 WT 
and D23580 ΔBTP1 was significant, a much greater differential expression effect was 
seen in D23580 ΔBTP5. The STnc3870 sRNA appeared to be moderately down-
regulated by the presence of the BTP1 prophage, and highly down-regulated by the 
presence of the BTP5 prophage, leading to high repression in the double prophage 
mutant as anticipated. On the other hand, the gtrABCa operon was moderately down-
regulated in D23580 ΔBTP1, highly down-regulated in D23580 ΔBTP5, but only 
moderately down-regulated in the double prophage mutant. There are two possible 
explanations for this result. It is possible that the BTP1 prophage mildly represses the 
gtrABCa operon, whilst the BTP5 prophage highly represses the operon, but the mild 
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repression mediated by BTP1 is dominant when both prophages are present. 
Alternatively, the strains can be considered in terms of which prophages they 
possess, rather than which have been deleted. If D23580 ΔBTP1ΔBTP5 can be 
considered to be analogous to a version of D23580 before it acquired the two 
prophages, then D23580 ΔBTP5 is analogous to the ancestor after acquisition of 
BTP1. In this scenario, the BTP1 prophage highly activates expression of gtrABCa by 
26-fold. Likewise, D23580 ΔBTP1 could represent the phage-less ancestor after 
acquisition of BTP5, which results in no change in gtrABCa expression. However, 
following acquisition of both prophages (D23580 WT), there is an overall repression 
of gtrABC by 3.7-fold.  
Experimental validation of these data by methods such as quantitative PCR, or 
analysis of the LPS to study the GtrABCa-modification, are necessary to verify these 
results. 
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Figure 5.15 Four-way Venn diagrams showing the shared BTP1-associated 
differential gene expression in all three conditions tested. Numbers represent 
all differentially expressed genes (both up and down-regulated). ‘double’ refers to 
the D23580 ΔBTP1 ΔBTP5 mutant. 
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Figure 5.16 The STnc3870 sRNA and gtrABCa operon show prophage-
associated expression level changes. Counts per million (CPM) and normalised 
RNA-seq coverage plots for the STnc3870 sRNA in ESP and the gtrABCa genes in 
anaerobic growth. Data are presented for all mutants. For the gtrABCa gene operon, 
transcriptomic data is also represented as mapped read coverage plot. The average 
fold-change in expression level (CPM) between the mutants is indicated. 
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5.3.3 Impact of the BTP5 prophage upon global gene expression of D23580 
The same approach described in chapter 5.3.2 was used to identify significant 
transcriptional changes mediated by the BTP5 prophage. The comparisons which 
should show the effects of the BTP5 phage were determined to be: 
 D23580 WT vs D23580 ΔBTP5 
 D23580 WT vs D23580 ΔBTP1ΔBTP5 
 D23580 ΔBTP1 vs D23580 ΔBTP1ΔBTP5 
 D23580 ΔBTP1 vs D23580 ΔBTP5 
A total of 30 genes were found to be >2-fold (FDR ≤0.01) differentially expressed in 
the ESP condition in all four comparisons associated with the presence of the BTP5 
prophage (Figure 5.17). No genes showed significant BTP5-associated differential 
expression in the inSPI2 condition, and only the gtrABCa genes showed differential 
expression in the anaerobic growth condition (discussed in 5.3.2). The 30 genes that 
showed BTP5-associated differential expression in the ESP condition are listed in 
Table 5.2. 11 out of 30 genes were up-regulated in D23580 ΔBTP5 vs. D23580 WT, 
and 19 out of 30 genes were down-regulated, suggesting that BTP5 is responsible for 
both repression and activation of transcription. The expression values for the genes 
putatively repressed by BTP5 (up-regulated in D23580 ΔBTP5 vs. D23580 WT) are 
shown in Figure 5.18. To visualise the variability associated with this experiment, 
expression values for each strain from three biological replicates are shown. Amongst 
the genes putatively down-regulated by the presence of BTP5 are the co-transcribed 
genes ripA and lgl, which encode enzymes associated with itaconate metabolism and 
methylglyoxal detoxification respectively (Chakraborty et al., 2014; Sasikaran et al., 
2014), and are down-regulated between 19 and 42-fold in D23580 WT compared to 
D23580 ΔBTP5. A normalised read coverage plot for the operon that encodes the 
ripABC and lgl genes as well as the downstream STnc3870 sRNA is shown in Figure 
5.19. Additionally, the type III secreted effector gene, steB, is putatively down-
regulated 3-fold in the presence of BTP5. 
Among the genes putatively activated by BTP5 (those down-regulated in D23580 
ΔBTP5 vs D23580 WT) in ESP are katE and putA (Figure 5.20). Interestingly, the 
putA gene and the protein encoded by the katE gene have been found to be 
differentially expressed at both the transcriptomic and proteomic levels in ESP, 
comparing strains D23850 vs. 4/74 (R. Canals, Pers. comm), consistent with the 
activation of katE and putA  by BTP5 (the BTP5 prophage is not present in strain 
4/74). The putA gene encodes a membrane-bound dehydrogenase enzyme that 
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oxidises proline to glutamate when proline is transported into the cell via the PutP 
permease (Surber and Maloy, 1998). This result suggests that D23580 WT may have 
an enhanced ability to metabolise proline, a phenotype which may be able to be 
verified by growth experiments using proline as a carbon source. 
The katE gene encodes a stationary-phase catalase enzyme which is required for 
oxidative stress-resistance during multi-cellular colonial growth (Ma and Eaton, 1992). 
However, the katE gene of S. Typhimurium ST313 strain D23580 encodes a non-
functional catalase protein due to a non-synonymous SNP mutation (Singletary et al., 
2016). Consequently, the up-regulation of katE by prophage BTP5 is unlikely to confer 
a biological advantage. Detection of the katE mRNA or the KatE protein by 
quantitative PCR or western blot respectively would allow the confirmation of these 
findings. 
Furthermore, many of the genes in the ATP synthase operon were found to be up-
regulated by the BTP5 prophage including atpA, atpC, atpD, atpG and atpH, as well 
as the Cytochrome O ubiquinol oxidase operon cyoAB.  
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Figure 5.17 Four-way Venn diagrams showing the shared BTP5-associated 
differential gene expression in all three conditions tested. Numbers represent all 
differentially expressed genes (both up and down-regulated). ‘double’ refers to the 
D23580 ΔBTP1 ΔBTP5 mutant. 
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Table 5.2 Genes that showed BTP5-associated differential expression. Genes 
differentially expressed more than 2-fold in D23580 ΔBTP5 vs D23580 WT and also 
differentially expressed in the three other comparisons (Figure 5.17). 
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Figure 5.18 Genes putatively repressed by BTP5 in ESP. Counts per million (CPM) 
data for all mutants with three biological replicates of RNA-seq in the ESP growth 
condition are presented   
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Figure 5.18 (continued) Genes putatively repressed by BTP5 in ESP. Counts per 
million (CPM) data for all mutants with three biological replicates of RNA-seq in the 
ESP growth condition are presented.
191 
 
 
Figure 5.19 Normalised RNA-seq read coverage plot of the ripABC, lgl and STnc3870 region of D23580 in ESP. Mapped 
sequence reads are shown for D23580 ΔBTP1 and D23580 ΔBTP1 ΔBTP5.  
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Figure 5.20 Genes putatively activated by BTP5 in ESP. Counts per million (CPM) 
data for all mutants with three biological replicates of RNA-seq in the ESP growth 
condition are presented. 
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Figure 5.20 (continued) Genes putatively activated by BTP5 in ESP. Counts per 
million (CPM) data for all mutants with three biological replicates of RNA-seq in the 
ESP growth condition are presented. 
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5.3.4 An overall picture of the transcriptomic contribution of BTP1 & BTP5 
A summary of the putative impact of the BTP1 and BTP5 prophages of D23580 at the 
phenotypic level is shown in Figure 5.21. Overall, the BTP5 prophage had the largest 
effect on global gene expression, and the BTP1 prophage did not mediate many 
transcriptomic changes. No significant effects of either prophage were observed in 
the inSPI2 condition. The only effect of the BTP1 prophage in anaerobic growth was 
a putative activation of the glycosyltransferase operon gtrABCa, whilst the presence 
of both prophages in anaerobic growth led to a putative repression of gtrABCa. In 
ESP, the BTP5 prophage putatively mediated a number of effects including activation 
of the proline dehydrogenase putA, the non-functional catalase gene katE, and many 
genes in the ATP synthase operon (atpACDGH). Putative repression effects of BTP5 
in ESP include the down-regulation of the itaconate degradation genes ripABC, the 
uncharacterised sRNA STnc3870 and the outer membrane protein encoding gene 
ompF.  
Confirmation of the transcriptomic changes mediated by the BTP1 and BTP5 
prophages could not be pursued due to time constraints. Further experiments will 
prove critical to understand the contribution of the novel prophages to the biology of 
African S. Typhimurium ST313. 
  
195 
 
 
 
Figure 5.21 Summary of the putative phenotypic effects of BTP1 and BTP5 
based on prophage-associated transcriptomic changes of global expression 
levels identified. Red indicates up-regulated functions whereas blue indicates down-
regulated functions. 
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5.4 Discussion 
In this chapter I have investigated the hypothesis that novel prophages associated 
with African ST313 lineages, BTP1 and BTP5, modulate the biology of their host 
bacterium at the transcriptional level. The rationale for this hypothesis was the 
evidence for co-evolution of the African ST313 lineages that cause iNTS disease with 
the BTP1 and BTP5 prophages. The results of Chapter 4 suggested that these 
prophages were acquired independently by the two African ST313 lineages in sub-
Saharan African, as they were absent from the UK-ST313 strains which are more 
closely related to Lineage 1 or Lineage 2 than the African lineages are to each other.  
The transcriptome of the D23580 prophage regions were generally consistent with 
the findings on the functionality of the prophages described in Chapter 3. BTP1, a 
prophage which exhibits an unusually high level of spontaneous induction (Chapter 
3.3.4), also showed an unusually high level of transcriptional activity for a prophage 
region. Canonically, the prophage genes are transcriptionally repressed during 
lysogeny, apart from those genes whose products maintain prophage lysogeny, such 
as the gene encoding the CI repressor in lambdoid prophages (Ptashne, 2004) or 
genes with accessory functions that affect the lysogen. Studies investigating the gene 
expression of phage λ lysogens using microarray or ribosome profiling analysis have 
shown that most transcriptional activity arises from the cI gene encoding the 
repressor, the rexA, rexB encoding a superinfection immunity factor, and the lom and 
bor genes which encode virulence factors (Chen et al., 2005; Liu et al., 2013; 
Osterhout et al., 2007). 
 Unlike the other prophage regions of D23580, transcription of the BTP1 structural 
genes was observed in almost all growth conditions tested. It is impossible for a 
lysogen to constitutively express phage structural and lytic genes, because once the 
prophage molecular switch has moved to lytic from lysogenic replication, the terminal 
consequence is cell death (Ptashne, 2004). Therefore, if the lytic gene expression 
observed in the RNA-seq data occurred in the entire cellular population, we would 
expect to see a population collapse as ultimately sufficient lysis proteins were 
accumulated to initiate cell lysis. However, the BTP1 prophage lysogen (D23580) 
exhibits normal growth dynamics that are comparable to strains not lysogenised by 
the BTP1 prophage. I hypothesis that the lytic gene expression observed in the RNA-
seq data is the consequence of averaging gene expression across a heterogeneous 
population which has very high lytic gene expression in the subset of the population 
undergoing spontaneous BTP1 prophage induction. This gene expression appears 
as low-level expression when it is averaged across the majority of the population in 
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which the BTP1 lysis genes are transcriptionally repressed. Consistent with this 
hypothesis, the remaining D23580 prophages; Gifsy-2, ST64B, Gifsy-1 do not exhibit 
significant spontaneous induction levels and show very little lytic gene expression in 
the majority of conditions tested. I propose that the absolute expression level of 
prophage structural genes could therefore be used as an in silico marker of the 
fraction of the population undergoing lytic prophage replication.  
As well as providing insight into the replication state of the D23580 prophages, the 
transcriptome maps also allow the identification of putative accessory regions; genes 
(or transcripts) that are expressed during lysogenic replication and so may not be 
necessary for phage function. Such regions are of importance in regard to 
understanding pathogen disease tropism, as they represent ‘smoking guns’ that could 
function as virulence factors. The transcriptome maps of prophages BTP1 and BTP5 
show several more regions of transcription than are theoretically necessary in a 
lambdoid prophage to maintain lysogeny (typically the cI repressor only) (Hendrix et 
al., 1983). A number of genes of the BTP1 prophage show an expression pattern 
consistent with an accessory function, including ST313-td, pid, gtrA and gtrC. In the 
BTP5 prophage, fewer ‘smoking guns’ were identified, as the majority of regions with 
expression patterns indicative of accessory function corresponded to genes with 
homology to genes with reported phage function, such as the two adjacent genes 
STMMW_32031 and STMMW_32041 which are homologous to the tum antirepressor 
or orf97 of coliphage186 (Shearwin et al., 1998).  
However, it cannot be ruled out that phage genes expressed during lysogeny may 
serve a dual purpose by additionally regulating the core genome. For example, 
recently the cII gene of Stx-phage Φ24B was shown to control acid response genes in 
the lysogen as well as performing the phage-related function of controlling expression 
of the cI repressor (Veses-Garcia et al., 2015). One confounding result was the high 
expression of the putative BTP5 antirepressor gene in the transcriptome data. 
Expression of the antirepressor gene should theoretically cause prophage induction, 
but figures 5.9 and 5.10 show the BTP5 structural genes are not wholly expressed. 
This contradiction casts doubt on the putative function of STMMW_32041 as an 
antirepressor, and further investigation is required to understand the molecular 
mechanisms governing the lysis-lysogeny control of the BTP5 prophage. 
A number of putative RNA transcripts in the BTP1 prophage which did not correspond 
to protein coding sequences were observed to have an expression pattern consistent 
with an accessory function, including the 10 putative novel ncRNAs (Hammarlöf et al., 
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2017). Several prophage-encoded ncRNAs have been implicated in bacterial 
virulence, for example, the Gifsy-1 prophage encoded sRNA IsrJ which is an ~74 nt 
transcript reported to be required for efficient invasion of Salmonella into non-
phagocytic cells and effector translocation by the SPI-1 T3SS (Padalon-Brauch et al., 
2008). Prophage-encoded ncRNAs are also known to mediate non-virulence 
accessory functions. For example, the sas asRNA of phage P22 induces a 
translational switch between distinct peptides encoded by the sieB gene, which is 
critical to the function of the SieB superinfection exclusion system (Ranade and 
Poteete, 1993). Lastly, the phage λ sRNA OOP inhibits CII protein synthesis thereby 
pushing the phage molecular decision towards lysis, rather than lysogeny (Krinke and 
Wulff, 1987). 
The second approach taken in this chapter was a transcriptional ‘target-hunt’ 
experiment to identify genes regulated by the BTP1 & BTP5 prophages. RNA samples 
were collected from the D23580 WT, D23580 ΔBTP1, D23580 ΔBTP5 and D23580 
ΔBTP1ΔBTP5 in three different growth conditions. A number of putatively prophage-
regulated genes were identified, however, more transcriptional changes were found 
in the D23580 ΔBTP5 mutant compared to D23580 ΔBTP1. In order to increase the 
probability of finding significant transcriptional changes, genes changing in four 
different comparisons were cross-referenced to highlight the changes which made the 
most biological sense (e.g. genes that changed in both the single prophage mutant 
and the double prophage mutant). Using this approach, it was found that the 
expression of the core genome gtrABCa operon was affected differentially by the 
presence of the BTP1 and BTP5 prophages. The gtrABCa operon demonstrated a 
complex interaction with the BTP1 and BTP5 prophages, and appeared to be highly 
up-regulated in the presence of BTP1, not affected by the presence of BTP5 alone, 
but moderately down-regulated in the presence of both prophages together.  
All the findings from the transcriptional target hunt approach require further validation 
in the form of qPCR or phenotypic experiments to confirm these findings, however the 
hypothesis that there may be crosstalk between the prophages and the core-genome 
encoded gtr system is compelling. The gtr operons are thought to be phage-derived 
systems, utilised by phages to modulate the receptor biology of the host to prevent 
the infection of self-lysogens or to prevent self-adsorption upon lysis (Davies et al., 
2013). In Salmonella the phenomenon of polylysogeny is common, and the majority 
of Salmonella strains are lysogenised with multiple temperate phages (Thomson et 
al., 2004). Crosstalk between Salmonella prophages has been demonstrated by a 
study that showed the antirepressor of Gifsy phages can recognise non-cognate 
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repressors, allowing one Gifsy prophage to be induced by the natural induction of 
another in the same cell. It is therefore plausible that another element of prophage 
crosstalk could be the antagonism, or even cooperation of accessory functions that 
modulate the physiology of the host. It is worth noting that the BTP1 phage encodes 
its own O-antigen modification system, gtrACc (though the function of these enzymes 
is to acetylate, rather than glycosylate the O-antigen) (Kintz et al., 2015). 
Amongst the other putatively prophage-regulated genes identified here were the 
ripABC operon which appeared to be down-regulated in the presence of the BTP5 
prophage in early stationary phase. The ripABC operon is thought be involved in 
Salmonella infection as it’s expression is highly activated inside macrophages 
(Srikumar et al., 2015). The RipABC proteins are associated with itaconate 
metabolism and Lgl is responsible for methylglyoxal detoxification (Chakraborty et al., 
2014; Sasikaran et al., 2014). The modulation of expression of this operon by the 
BTP5 prophage therefore deserves further investigation. 
Perhaps the most counter-intuitive result from this experiment was the putative up-
regulation of the katE gene in the presence of BTP5 in early stationary phase. The 
KatE protein has been found to be highly abundant in D23580 WT cells in early 
stationary phase compared to ST19 strain 474 (which does not harbour the BTP5 
prophage) (R. Canals- Pers. comm.). Though these two results are consistent, and 
strongly suggest the BTP5 prophage is activating expression of the katE gene, the 
finding is confounded by the fact that katE encodes a non-functional catalase enzyme 
in African ST313 strains due to a single non-synonymous SNP (Singletary et al., 
2016). What could be the biological advantage of activating the expression of a non-
functional protein? It is a possibility that the modified KatE protein of African S. 
Typhimurium ST313 performs a different function mediated by the substitution of a 
single amino acid. 
Overall, the results of this chapter provide evidence that the prophages are not 
discrete transcriptional units, but undergo regulatory interactions with the core 
genome and each other. The presence of genes exhibiting expression patterns 
consistent with an accessory function, and the putative dysregulation of chromosomal 
genes upon removal of the BTP1 & BTP5 prophages represents a promising basis for 
further research into the impact of the prophages at the phenotypic, as well as 
transcriptional level.   
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Chapter 6 
Evidence for lysogenic 
conversion of African S. 
Typhimurium ST313 by 
prophages BTP1 & BTP5 
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6.1 Introduction 
The transcriptomic data presented in Chapter 5 identified a number of highly 
expressed regions of the BTP1 and BTP5 prophages that could encode accessory 
genes because they are expressed during lysogeny. Chapter 3 described the unusual 
spontaneous induction phenotype associated with the BTP1 prophage lysogen and 
speculated that the spontaneous induction may contribute to the infection biology of 
African S. Typhimurium ST313 isolates. An explanation for the putative evolutionary 
convergence of prophage profiles between the two African ST313 lineages detected 
in Chapter 4 could be that prophages BTP1 and BTP5 contribute to the niche 
adaptation of the iNTS-associated lineages in sub-Saharan Africa. Temperate phages 
are known to increase their own evolutionary fitness by encoding genetic elements 
that benefit the host in a phenomenon known as lysogenic conversion (Brüssow et 
al., 2004). In this chapter, I investigate the hypothesis that novel prophages BTP1 and 
BTP5 contribute to the biology of African ST313 lineage using a molecular genetic 
approach. 
6.1.1 Acknowledgement of the specific contribution of collaborators to the 
results described in Chapter 6.  
The work described in this chapter is unpublished. Unless specified below, all work 
was completed by the Author. 
Rocío Canals 
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Conducted chicken infection 
experiments together with the Author 
Nico Wenner 
University of Liverpool 
 
Constructed prophage deletion 
mutants in strain 4/74 (6.3.3) and 
STnc6030 expression plasmid (6.4.1) 
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6.2 Assessment of virulence phenotypes associated with 
prophages BTP1 & BTP5 
6.2.1 Motility phenotypes of prophage mutants 
Motility is linked to the virulence of many bacterial pathogens including Salmonella 
(Ottemann and Miller, 1997; Wang et al., 2004). Additionally, motility and motility-
related phenotypes have previously been shown to differentiate African S. 
Typhimurium ST313 strains from gastrointestinal-associated ST19 strains (Carden et 
al., 2015; Ramachandran et al., 2015). To determine whether the novel prophages 
BTP1 & BTP5 may contribute to motility differences in ST313, the swimming motility 
of prophage mutants was assayed. 
Motility assays showed that ST19 strain 4/74 was significantly more motile than strain 
ST313 strain D23580 (P=0.03) (Figure 6.1A), as has been reported previously 
(Carden et al., 2015; Ramachandran et al., 2015). However, there was no significant 
difference between the motility of D23580 WT, D23580 ΔBTP1::FRT and D23580 
ΔBTP5::FRT. These results show that the novel prophages do not affect motility. 
6.2.2 Intra-macrophage replication of prophage mutants 
Successful intracellular replication within phagocytic cells such as macrophages is a 
defining part of Salmonella infection in mammalian hosts that allows bloodstream-
associated Salmonella to evade host immune defences and disseminate through the 
lymph and bloodstream (Fàbrega and Vila, 2013). Consequently, an enhanced ability 
to replicate within phagocytic cells may indicate an adapation to an invasive, extra-
intestinal niche (though this may not always be the case- Chapter 1.4.1). Several 
studies have reported differential phenotypes for African S. Typhimurium ST313 
strains during proliferation assays in cultured mammalian macrophages (Carden et 
al., 2015; Herrero-Fresno et al., 2014; Ramachandran et al., 2015). To test whether 
the BTP1 or BTP5 prophages modulate the replication of ST313 in macrophages, the 
proliferation of prophage mutants was assayed in cultured murine macrophages. 
The strains D23580 ΔBTP1::FRT and D23580 ΔBTP5::FRT replicated well inside 
macrophages over a 15 h infection period, relative to the attenuated negative control 
strain D23580 ΔrpoE::FRT. No significant difference was observed between the level 
of intra-macrophage proliferation for the prophage mutants and D23580 WT (Figure 
6.1B). These results indicate that novel prophages BTP1 and BTP5 do not affect the 
ability of their Salmonella host to replicate inside macrophage cells. 
203 
 
6.2.3 Phenotypes in a chicken infection model 
Animal infection models are arguably the most relevant and most practical method to 
assess the virulence potential of a bacterial pathogen in a human or animal host 
(Tsolis et al., 2011). S. Typhimurium ST313 strains have been reported to show 
enhanced virulence in a number of animal infection models including the chicken  
(Parsons et al., 2013). Therefore, the chicken model was used to test whether the 
novel prophages of ST313 are required for successful animal infection. Due to 
resource constraints, only data for the BTP1 prophage mutant were obtained. 
The numbers of bacteria in the spleen of 2-week-old chickens were enumerated 2 
days after initial oral infection (Figure 6.1C). The burden of bacteria in the spleen of 
chickens infected with either D23580 WT or D23580 ΔBTP1::FRT was similar. The 
number of infected vs. uninfected spleens in the D23580 ΔBTP1::FRT group was 
reduced compared to D23580 WT (2 splenic infected chickens in the D23580 
ΔBTP1::FRT group vs. 5 splenic infected chickens in the D23580 WT group). 
However, the difference between the two strains was not statistically significant 
(P=0.11). Further experiments are required to elucidate the role of prophages BTP1 
& BTP5 in the chicken infection model. 
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Figure 6.1 Assessment of virulence-associated phenotypes of the BTP1 and 
BTP5 prophages. A. Swimming motility of strain 4/74, D23580 WT, D23580 
ΔBTP1::FRT and D23580 ΔBTP5::FRT. Migration diameter was measured after 5 
hours (Chapter 2.3.2) B. Intramacrophage proliferation of D23580 WT, D23580 
ΔBTP1::FRT and D23580 ΔBTP5::FRT. D23580 ΔrpoE::FRT is shown as a negative 
control. Proliferation is given as the fold-change in CFU/ml between 1.5 h vs 15 h of 
infection in RAW 264.7 murine macrophages (Chapter 2.10.1). C. Virulence of 
D23580 WT and D23580 ΔBTP1 in the chicken infection model. 2 week old chicks 
were inoculated orally with D23580 WT or D23580 ΔBTP1::FRT (Chapter 2.10.2). The 
CFU/ml of bacteria in the spleen was enumerated 2 days post infection.  
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6.3 Assigning function to the ST313-td gene of BTP1 
The ST313-td gene of S. Typhimurium ST313 has previously been reported to confer 
a virulence phenotype in mice and cultured human macrophages (Herrero-Fresno et 
al., 2014). Transcriptome analysis of the BTP1 prophage showed that the ST313-td 
gene is co-transcribed from the same promoter as the cI prophage repressor gene 
from a promoter analogous in position to the PRM promoter of phage λ (Hammarlöf et 
al., 2017). The consequence of this transcriptional organisation is that the expression 
of the ST313-td gene is implicitly associated with prophage lysogeny, and this gene 
is unlikely to be expressed during lytic replication (when the Cro protein blocks 
transcription from PRM (Ptashne, 2004)). In phage P22 no additional genes are 
encoded between the cI gene and PL (the left-ward lytic promoter), whereas in phage 
λ this region contains the rexAB genes, which are also co-transcribed with the 
repressor gene. The rexAB genes are not required for phage Lambda replication, but, 
in the λ lysogen, mediate infection exclusion to certain phages, and increase the 
growth rate of λ lysogens in glucose-limited conditions (Lin et al., 1977; Parma et al., 
1992). However, the rexAB genes are not conserved in other lambdoid phages and 
the genetic space between the end of the cI gene and the PL promoter has been noted 
to be a region of high mosaicism in lambdoid prophage (Degnan et al., 2007). It has 
been hypothesised that exchange of different alleles in this region may confer λ 
lysogens fitness in different niches (Degnan et al., 2007). Certainly, this hypothesis 
would be consistent with the reported contribution of the ST313-td gene to the 
virulence of African S. Typhimurium ST313. However, when the ST313-td gene was 
initially described, the significance of its genetic context within prophage BTP1 had 
not been appreciated. Therefore, the contribution of ST313-td towards the biology of 
the BTP1 prophage was investigated. 
The ST313-td coding sequence is 924 bp long, encoding a putative protein of 308 
amino acids. blastn analysis of the NCBI non-redundant nucleotide database shows 
the ST313-td gene is present in at least one isolate of Salmonella enterica serovars 
Typhimurium, Dublin, Anatum and Bardo. Additionally, a gene with 85% identity to 
ST313-td is present in a single isolate of Klebsiella pneumoniae (Accession number 
CP021960). The ST313-td protein sequence does not contain significant homology to 
any characterised proteins or domains (as judged by blastp analysis of the SwissProt 
database). However, the NCBI non-redundant protein database contains proteins with 
more than 90% identity to ST313-td in a number of Enterobacteriaceae genomes 
including isolates of Salmonella enterica, Klebsiella pneumoniae, Cronobacter 
sakazakii and Citrobacter braakii. 
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6.3.1 ST313-td confers immunity to infection by phage P22 
Figure 6.2A shows a detailed transcriptomic context of the ST313-td gene region. In 
order to investigate whether the ST313-td gene confers infection immunity to 
heterologous phages like the λ rexAB system, two stop codons were introduced into 
the beginning of the coding sequence (Figure 6.2). This mutation was designed to 
prevent synthesis of functional ST313-td protein, but not affect the transcription of the 
gene. The strain containing the mutated ST313-td gene was designated 
D23580ST313-tdSTOP. The methods used to construct the D23580ST313-tdSTOP strain can be 
found in Chaper 2.6.2. 
The mutation of the ST313-td gene did not affect the spontaneous induction frequency 
of the BTP1 prophage, and culture supernatants from D23580 WT and D23580ST313-
tdSTOP contained similar levels of BTP1 phage (Figure 6.3A). 
To test the effect of the ST313-td premature stop codon mutation on phage immunity, 
a high titre P22 WT phage stock was plated onto bacterial lawns of D23580 WT and 
D23580ST313-td--STOP. As has been observed previously (Kintz et al., 2015), D23580 WT 
showed a high degree of immunity to P22 infection, with only a faint zone of growth 
inhibition observed at the highest P22 concentration tested (undiluted stock) (Figure 
6.3B). Contrastingly, for D23580ST313-tdSTOP, which differs from D23580 WT by just 4 
nucleotides, zones of confluent lysis were visible at lower phage dilutions, and 
individual phage plaques were seen at the lowest P22 phage dilution (10-6) (Figure 
6.3B). It has previously been described that LPS-acetyltransferase activity encoded 
by the gtrC gene of BTP1 mediates a high degree of immunity in a BTP1 phage 
lysogen to infection by P22 (Kintz et al., 2015), and other studies have shown that 
acetylation, as well as glycosylation, of the O-antigen rhamnose moiety can block P22 
phage infection (Wollin et al., 1987). These results have identified the ST313-td gene 
as a second factor mediating immunity to P22 in the BTP1 lysogen. 
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Figure 6.2 A transcriptomic view of the ST313-td gene. A. The transcriptomic 
region of the ST313-td gene expanded from Figure 5.1. B. The mutation strategy 
taken to study the role of the ST313-td gene. Two stop codons were introduced into 
the beginning of the coding sequence representing a total of 4 nucleotide substitutions 
(Chapter 2.6.2). 
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Figure 6.3 The ST313-td protein is not required for spontaneous induction of 
prophage BTP1, but reduces susceptibility to P22 infection. A. Titration of the 
over-night culture supernatant of strain D23580 WT and D23580 ST313tdSTOP using 
D23580 ΔBTP1 as a host. B. Plaque assay of phage P22 using strain D23580 WT 
and strain D23580 ST313tdSTOP as a host. 
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To gain further insight into the mechanism of ST313-td-mediated phage immunity, the 
WT and defective alleles of the ST313-td gene, were inserted into the pPL expression 
plasmid under the control of the strong PLlacO-1 promoter (Figure 6.4A). A gentamicin 
resistant derivative of the pPL plasmid was constructed (Table 2.5, Table 2.7), as 
D23580 is resistant to ampicillin, which is the selectable marker in the original pPL 
(pJV300) plasmid (Sittka et al., 2007). pPL constructs result in over-expression of the 
inserted gene due to the high activity of the PLlacO-1 promoter and the high copy number 
of the plasmid. Studying the WT and defective versions of the gene in a genetic 
background independent of the BTP1 prophage allowed interrogation of whether the 
ST313-td gene conferred immunity alone or in concert with other elements of the 
BTP1 phage. The defective, stop-codon-containing, version of the gene controls for 
the possibility that the ST313-td gene transcript, rather than the protein, contributes 
to the immunity phenotype. The plasmids, together with an empty-vector control 
plasmid, were transformed into a D23580 ΔBTP1 background. The pPL-ST313-td 
plasmid conferred a high degree of immunity to P22 infection in the D23580 ΔBTP1 
background, but the pPL-ST313-tdSTOP plasmid did not provide any immunity to P22 
infection, showing that the ST313-td protein alone is sufficient to mediate immunity to 
P22 (Figure 6.4B). Interestingly, the pPL-ST313-td plasmid did not provide any 
immunity to BTP1 infection in the D23580 ΔBTP1 (Figure 6.4B). This result suggests 
that either the BTP1 prophage is not susceptible to infection interference by ST313-
td, or that the BTP1 phage contains an immunity factor to prevent self-interference by 
ST313-td. 
To control for interference, or contributing effects of other prophages in the D23580 
genome, the experiment was repeated in a D23580 ΔΦ background, where all five 
full-length prophages of D23580 have been removed (Figure 6.4C). The effect of the 
pPL-ST313-td plasmid on immunity to P22 and BTP1 was identical to the D23580 
ΔBTP1 background, showing that the function of ST313-td is not dependent on the 
presence of other D23580 prophages. 
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Figure 6.4 Heterologous expression of ST313-td protein confers immunity to 
P22 infection but not BTP1 infection. A. Schematic illustration of plasmid constructs 
used to investigate ST313-td function. B. Plaque assay of BTP1 phage and P22 
phage on D23580 ΔBTP1 strains containing the plasmid constructs described in A. 
C. Plaque assay of BTP1 phage and P22 phage on D23580 ΔΦ strains containing the 
plasmid constructs described in A. 
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 6.3.2 ST313-td does not affect P22 adsorption 
The first event during the interaction between a phage and its host is the adsorption 
of phage to the host receptor. Therefore, the most direct way to gain immunity to 
phage infection is to prevent phage adsorption via receptor modification or loss (Seed, 
2015). To determine whether the immunity conferred by ST313-td to P22 infection is 
mediated by adsorption interference, the adsorption of P22 to D23580 ΔBTP1 
containing the three test plasmids described above (Figure 6.4A) was measured (as 
described in Chatper 2.4.6). Adsorption can be easily assayed by quantifying the free-
phage in supernatant following addition of host bacteria; if adsorption occurs, there 
will be a reduction in free phage particles in the supernatant once bacteria are 
removed. Figure 6.5 shows that P22 could adsorb to all three test strains, regardless 
of the presence of the pPL-ST313-td plasmid. The results indicate that ST313-td-
mediated immunity to P22 infection is not associated with prevention of phage 
adsorption. 
6.3.3 The ST313-td protein is not effective in a heterologous host background 
The BTP1 prophage is strongly associated with African S. Typhimurium ST313 
isolates, though the prophage has also been found in another sequence type of S. 
Typhimurium associated with passerine birds (ST568) (Chapter 3.3.2). To test 
whether the immunity conferred by the ST313-td protein is effective even in other 
Salmonella strains that do not natively contain the BTP1 prophage, the three test 
plasmids were transformed into S. Typhimurium strain 4/74. Unexpectedly, in the 4/74 
background, the plasmid-borne ST313-td gene was not effective at preventing P22 
infection (Figure 6.6A). Though the efficiency of plating of P22 on 4/74 pPL-ST313-td 
appears slightly reduced compared to that on 4/74 pPL-ST313-tdSTOP, the effect was 
much less dramatic to that observed in the D23580 strain background.  
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Figure 6.5 Heterologous expression of ST313-td protein does not affect P22 
adsorption to D23580 ΔBTP1. A. Plaque assay of free phage after adsorption to 
D23580 ΔBTP1. B. Graph showing there is no difference in the number of phage 
remaining post adsorption to the test any of the test strains. The assays were 
conducted as described in Chapter 2.4.6. 
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Figure 6.6 ST313-td-mediated immunity to P22 infection is not functional in 
strain 4/74. A. Plasmid constructs described in Figure 5.14 were transformed into 
strain 4/74 and these strains were used as host strains for plaque assays of BTP1 
phage and P22 phage. B. The effect of 4/74 native prophages on immunity to 
infection by P22 or BTP1. Prophage mutants of 4/74 were assayed for the efficiency 
of plating (EoP) and plaquing morphology, upon six host strains specified at the 
bottom of the panel.  
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To test whether the poor efficacy of the ST313-td protein in strain 4/74 could be the 
result of interference by the native prophages of strain 4/74, BTP1 and P22 efficiency 
of plating and plaque morphologies were tested on various prophage mutants of strain 
4/74 (Figure 6.6B). The efficiency of plating of both phages is reduced in strain 4/74 
WT compared to control strain D23580 ΔΦ, which contains no prophages. This result 
suggests that the native prophages of 4/74 (or another element of the accessory 
genome, such as plasmids) confers some immunity to the BTP1 and P22 phages. 
Deletion of the Gifsy-1 prophage of 4/74 increased the size of BTP1 & P22 plaques 
but decreased the efficiency of plating (EoP) for both phages. Deletion of the Gifsy-2 
prophage of 4/74 did not affect plaque morphology but reduced the EoP of BTP1 & 
P22 even more than the deletion of Gifsy-1. Surprisingly, deletion of both Gifsy 
phages produced larger plaque morphologies and did not affect the EoP. Lastly, 
deletion of the ΦsopE prophage of 4/74 significantly increased the EoP and resulted 
in plaque morphologies comparable to those obtained on positive control strain 
D23580 ΔΦ. This suggests that the ΦsopE prophage confers resistance to both the 
P22 and BTP1 phages. These findings raise the possibility that the mechanism of 
ST313-td-mediated immunity to P22 infection may be redundant in 4/74 because a 
similar system is conferred by the ΦsopE prophage.  
More work is required to clarify the role of the ST313-td gene of prophage BTP1. In 
particular, the mechanism by which ST313-td confers infection immunity to P22 is not 
known. Other mechanisms to inhibit phage infection include: blocking DNA entry into 
the cell, destroying phage DNA once it is inside the cell (e.g. restriction modification 
systems), inhibiting phage assembly, and mediating cell death (e.g. abortive infection) 
(Seed, 2015). Assessment of the range of phages to which the ST313-td protein 
confers immunity is needed, and may offer clues into the mechanism of action. 
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6.4 Assigning function to the STnc6030 antisense transcript of 
BTP1 
Small, non-coding RNAs (commonly referred to as sRNAs or ncRNAs) are short RNA 
transcripts (usually 50-500 nt) that do not encode for proteins (Gottesman and Storz, 
2011). Instead, ncRNAs often have regulatory roles in bacteria. Recent advances in 
sequencing technologies have led to a huge expansion of research into the non-
coding genome, and it is now widely accepted that ncRNAs are abundant in bacterial 
genomes and play an integral role in the molecular circuitry of the cell (Han et al., 
2013; Luco, 2013; Vogel, 2009). In Salmonella, sRNAs have been shown to regulate 
the transcription of master regulatory genes, for example the sRNA ArcZ regulates 
the alternative sigma factor RpoS (σ38) which is required for Salmonella infection 
(Hébrard et al., 2012). By regulating the transcription of such important genes, sRNAs 
have a global impact upon Salmonella metabolism and virulence (Vogel, 2009). 
Transcriptomic analysis of the prophages of D23580 identified a number of putative 
novel ncRNAs in the BTP1 prophage. One of the novel RNAs, designated STnc6030, 
was selected for further investigation for a number of reasons. STnc6030 is highly 
expressed in the majority of conditions for which RNA-seq data are available (Chapter 
5.2.1). Additionally, the putative RNA is of an unusually large size >700 nucleotides 
in length and is positioned antisense to the BTP1 tailspike gene (STMMW_03901) 
and a putative DNA injection protein (STMMW_03891). It should be noted that the 
region where the STnc6030 asRNA is located is an area of unusual transcription, with 
10 TSS (sense and antisense) defined within the tailspike gene alone. Due to the 
length and antisense position of the STnc6030 transcript, the putative RNA was 
hypothesised to be an asRNA species. The majority of asRNAs that have been 
identified in bacteria function as inhibitors of target RNA function (Wagner et al., 
2002), and asRNAs are commonly found in accessory genome elements such as 
phages and plasmids (Thomason and Storz, 2010). I hypothesised that STnc6030 
interacted with the transcription of the BTP1 tailspike gene, and the function of 
STnc6030 was further investigated. 
6.4.1 STnc6030 encodes an approximately 500 nt transcript 
Figure 6.7 shows a detailed view of the STnc6030 transcript region within the BTP1 
transcriptome. The RNA is encoded antisense to the end of the putative DNA injection 
gene (STMMW_03891) and the tailspike gene (STMMW_03901). The beginning of 
the STnc6030 transcript corresponds to the beginning of RNA-seq reads mapping to 
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the tailspike gene on the sense strand, which may suggest antisense interference with 
the tailspike gene transcript. 
The putative STnc6030 transcript as identified in the BTP1 transcriptomic data was 
cloned into the pPL expression plasmid under the control of the constitutive PLlacO-1 
promoter, and an empty vector control plasmid was used as a negative control in all 
experiments (Chapter 2.7). To confirm the presence of the STnc6030 transcript, an 
anti-STnc6030 riboprobe was synthesised in order to detect the RNA by Northern blot 
(Figure 6.8). The riboprobe was designed to cover the totality of the STnc6030 
transcript as estimated from the transcriptomic data, allowing the detection of any 
transcripts corresponding to this region. 
Transcripts corresponding to the STnc6030 RNA were detected by Northern blot 
using both an agarose and an acrylamide gel to allow optimal visualization and size 
estimation. The anti-STnc6030 riboprobe detected a number of transcripts for D23580 
WT RNA, whilst no transcripts were detected by the probe using D23580 ΔBTP1 RNA, 
showing that the detected bands do not reflect non-specific probe binding. The largest 
transcript detected by the anti-STnc6030 probe in the D23580 WT RNA was 
approximately 500 nt in length, significantly shorter than the putative length identified 
from the transcriptomic data (786 nt). At least 2 other smaller transcripts were 
detected, of ~500 nt and 480 nt in length. However, these smaller transcripts may be 
the result of RNA processing or degradation product, and may not necessarily 
correspond to additional transcription start sites, as has been seen for other 
Salmonella sRNAs such as ArcZ (Papenfort et al., 2009). 
  
217 
 
 
Figure 6.7 The transcriptomic context of the STnc6030 ncRNA. The 
transcriptomic data is expanded from Figure 5.1.  
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Figure 6.8 The STnc6030 transcript can be detected by northern blot but is 
shorter than indicated in transcriptomic data. A. Schematic illustration of plasmid 
constructs used to study the function of the STnc6030 transcript. A 786 bp region of 
DNA was cloned into the plasmid based on location coordinates inferred from the 
transcriptomic data (Figure 6.7). B. Detection of the STnc6030 transcript by northern 
blot on an agarose and acrylamide gel using an anti-STnc6030 DIG-labelled 
riboprobe (Chapter 2.9.5). The two most abundant transcripts detected by the anti-
STnc6030 riboprobe are indicated along with the approximate size estimated from the 
molecular weight ladder employed on the agarose gel. 
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6.4.2 Heterologous expression of STnc6030 confers immunity to phage BTP1 
infection in a naïve host 
In order to test the function of STnc6030, the pPL-STnc6030 and empty vector control 
plasmids were transformed into D23580 WT and D23580 ΔBTP1 backgrounds. Over-
expression of the STnc6030 RNA did not affect the level of BTP1 spontaneous 
induction in the D23580 WT background, as there was no difference in the number of 
BTP1 phage in culture supernatants of D23580 WT, D23580 pPL-STnc6030 and 
D23580 pEMPTY (Figure 6.9A). 
Expression of STnc6030 in a naïve host (D23580 ΔBTP1) was found to mediate 
complete immunity to BTP1 infection (Figure 6.9B), but did not modulate susceptibility 
to P22 infection. These results were consistent with a regulatory mechanism in which 
STnc6030 targeted the sense transcript of the BTP1 DNA injection and tailspike 
genes. RNA-RNA interaction requires nucleotide complementarity, and it should be 
noted that the corresponding region of the P22 genome does not share similarity to 
BTP1 at the nucleotide level. 
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Figure 6.9 Over-expression of the STnc6030 RNA in D23580 WT background 
does not affect BTP1 spontaneous induction, but heterologous expression in 
D23580 ΔBTP1 completely protects against BTP1, but not P22 infection. A. 
Plaque assay of overnight culture supernatants of D23580 WT, D23580 pPL-
STnc6030 and D23580 pEMPTY on host strain D23580 ΔBTP1. B. Plaque assay of 
BTP1 and P22 phage on D23580 ΔBTP1 strains containing the pPL-STnc6030 
expression plasmid or the negative control plasmid. 
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6.4.3 The isolation of STnc6030 escape mutants indicate that the 3’ end of the 
STnc6030 RNA is functionally active 
To better understand the functionality of the STnc6030 transcript, a high titre BTP1 
phage stock was screened for the presence of naturally occurring mutants resistant 
to interference by STnc6030 (Figure 6.10). The BTP1 phage stock was plated on 
lawns of D23580 ΔBTP1 containing the pPL-STnc6030. Escape phages were 
estimated to occur at a frequency of 4x10-8 in the BTP1 phage stock, and were 
associated with varying plaque sizes (Figure 6.10A). Five escape phages were 
isolated and purified, and a nested PCR strategy was used to amplify the STnc6030 
transcript region in the escape phages. Sequencing of the STnc6030 region revealed 
that each escape phage contained one single nucleotide polymorphism (SNP) relative 
to the BTP1 WT sequence (Figure 6.10B). The two escape phages associated with 
small plaque morphologies were found to harbour an identical SNP.  A total of 4 
unique SNPs were identified that conferred resistance to STnc6030-mediated 
immunity. Interestingly, the 4 SNPs clustered within a 36 bp region corresponding to 
the 3’ end of the STnc6030 transcript, antisense to the putative DNA injection gene 
STMMW_03891 (Figure 6.10C). These results suggest that the 3’ end of STnc6030 
is a functionally active “seed” region of the RNA, which interacts with the antisense 
target (STMMW_03891). The 4 SNPs also represent non-synonymous amino acid 
substitutions to the STMMW_03891 protein (Figure 6.10C). It is possible that the 
substitution associated with SNP identified in escape phages 3 and 4 results in 
reduced function of the STMMW_03891, resulting in a less efficient infection process 
and the reduced plaque size observed. 
To confirm the biological role of the four nucleotides described in Figure 6.10B, in the 
future, complementary nucleotide substitutions should be constructed in the 
STMMW_03891 gene. 
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Figure 6.10 Isolation of STnc6030-escape mutants. A. A high titer BTP1 phage 
stock was used to identify naturally occurring BTP1 phage mutants that were immune 
to inhibition by STnc6030. Escape phages were estimated to occur at a frequency of 
approximately 4-9. B. Five escape phages of varying plaque morphologies were 
selected for sequencing. The sequence of the STnc6030 region of the escape phages 
identified SNPs. The position and substitution are shown. *S/nS = synonymous or 
non-synonymous with respect to the STMMW_03891 protein. C. The SNPs identified 
to confer immunity to STnc6030 interference were clustered within a 36bp region 
(shown) corresponding to the 3’ end of the STnc6030 transcript and the 3’ end of the 
STMMW_03891 gene. 
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6.4.4 The biological role of the STnc6030 asRNA remains unclear 
The data presented here suggest that STnc6030 effectively excludes BTP1 phage 
replication specifically by antisense inhibition of the putative DNA injection gene 
STMMW_03891. However, the significance of the STnc6030-STMMW_03891 
interaction for the biology of the BTP1 prophage is not clear. Over-expression of 
STnc6030 had no effect on the production of BTP1 phage via spontaneous induction, 
and yet expression of the RNA in a naïve host mediated total immunity to BTP1 
infection. How does the STnc6030 RNA differentiate between phage replication 
through induction and phage replication through infection? Further work is required to 
reveal the biological role of the STnc6030 RNA in the life history of the BTP1 
prophage. 
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6.5 Discussion 
To assess whether any of the highly-transcribed regions of the BTP1 or BTP5 
prophage contribute to the virulence of African ST313 strains, three assays of 
virulence-related phenotypes were conducted using full prophage knock-out strains. 
Motility is an essential part of Salmonella virulence, and functioning flagella have been 
implicated in adherence to and colonisation of the gut (Josenhans and Suerbaum, 
2002). Intracellular replication is a defining feature of Salmonella infection, and 
therefore replication within macrophages has been used as a model to explore 
Salmonella virulence (Srikumar et al., 2015). Lastly, infection of chickens is an in vivo 
infection model, and therefore a direct measure of virulence potential, that has 
previously been used to identify the enhanced virulence of African S. Typhimurium 
ST313 (Parsons et al., 2013). The whole prophage knock-out mutants of BTP1 and 
BTP5 did not show attenuated phenotypes compared to wild-type strains in motility or 
macrophage replication assays. In the chicken infection model, D23580 ΔBTP1::FRT 
showed a trend of slightly reduced colonisation of the spleen compared with D23850 
WT, however the results were not statistically significant. The number of chickens 
infected in the two groups was low (n=9), and therefore it is possible that with higher 
sample numbers and more statistical power, this difference may reflect a real 
biological effect. Further work will be required to define the contribution of the BTP1 
& BTP5 prophages in the chicken infection model.  
Though the results of all three virulence-related assays did not show statistically 
significant effects of deleting either prophage, it remains possible that the prophages 
contribute to niche adaption of African S. Typhimurium ST313. A recent analysis 
revealed that African S. Typhimurium ST313 strains show only subtle differences to 
non-African ST19 strains in a number of animal infection models (Ramachandran et 
al., 2017), suggesting that an accurate model of ST313-mediated iNTS disease has 
yet to be established. As a defining characteristic of iNTS disease is the association 
with immune-compromised populations, perhaps the true disease potential of iNTS-
associated ST313 strains will only be evident in an infection model which mimics the 
environment of an immune-compromised human host. 
Of course, the novel prophages BTP1 & BTP5 may not contribute to the virulence of 
African ST313 strains, but rather contribute to another, as yet unknown, element of 
their adaption to the sub-Saharan African human niche. 
An example of an accessory phage function that could contribute to the fitness of a 
bacterium in a specific environment is immunity to phage infection. Indeed, 
225 
 
superinfection immunity systems are commonly found in temperate prophages (Seed, 
2015). In this chapter, the ST313-td gene was found to mediate immunity to P22 
infection in the BTP1 lysogen. Though the mechanism of action remains unknown 
(except for the ruling-out adsorption interference) the presence of the ST313-td gene 
in the BTP1 prophage makes strain D23580 (and probably all African ST313 strains) 
highly resistant to P22 infection.  
Though the ST313-td gene was originally reported to have a virulence function, 
increasing systemic infection in a mouse model, the results presented in section 6.3 
suggest a more complex function. Perhaps ST313-td enhances virulence as well as 
conferring immunity to phage infection? Parallels could be drawn to the 
glycosyltransferase (Gtr) enzymes of P22-like phages, which modify the phage 
receptor of the lysogen to prevent the infection of self-phages and heterologous 
phages that utilise the same receptor (Davies et al., 2013). The mechanism of Gtr-
mediated superinfection immunity is glycosylation of the bacterial O-antigen (the 
phage receptor). Whilst Gtr systems undeniably serve a phage-function by conferring 
immunity, there is increasing evidence that the modification by Gtr enzymes represent 
an essential component of bacterial surface modification for immune evasion (Kintz 
et al., 2017). Further, a number of core-genome encoded Gtr enzymes are thought to 
have been co-opted by the bacterial host from once functional prophages (Davies et 
al., 2013). In light of this, the mechanism by ST313-td confers immunity to phage 
infection may be the same by which it contributes to virulence. The adsorption-
independent mechanism of the ST313-td remains to be described, and further work 
is required to understand the contribution of the ST313-td protein to the biology of 
African S. Typhimurium ST313 strains. 
Like the ST313-td gene, the asRNA STnc6030 also conferred an immunity phenotype 
on the BTP1 lysogen. The ~ 500 nt transcript is located antisense to the 3’ end of the 
putative DNA-injection gene STMMW_03891 and 5’ end of the tailspike gene 
STMMW_03901. Over-expression of STnc6030 completely abolished susceptibility to 
infection by BTP1, but not the related phage P22. The spontaneously induced titer of 
BTP1 phage was not affected when the STnc6030 transcript was overexpressed, 
suggesting that the asRNA does not interfere with spontaneously induced BTP1 
replication. The data suggest that the functionally-active region of the asRNA is the 3’ 
end (corresponding to antisense of STMMW_03891), as naturally occurring mutants 
of BTP1 phage that were immune to the action of STnc6030 had single nucleotide 
substitutions in a 3’-located 36 bp region. asRNAs in bacteria (also known as cis-
encoded RNAs, are usually found antisense to annotated coding genes and thus 
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share extensive genetic complementarity with the corresponding transcripts 
(Gottesman and Storz, 2011). asRNAs can affect the stability of complementary 
mRNA transcripts by base-pair interactions. Native endoribonucleases such as 
RNase III and RNase E target double-stranded RNA complexes formed by base 
pairing of asRNA and target mRNAs (Thomason and Storz, 2010). As double-
stranded RNA molecules are substrates for endoribonucleases, the effect of asRNA 
targeting is to increase the degradation of an mRNA transcript and so reduce levels 
of the gene product. Alternatively, base-pairing of two RNA species can block an 
RNase recognition site, leading to increased stability of the target mRNA (Thomason 
and Storz, 2010). If the mechanism of the STnc6030 asRNA is a base-pairing 
interaction with the DNA-injection gene STMMW_03891, that decreases the stability 
of the mRNA, how is the effect on phage immunity mediated? The consequence of 
this interaction would likely be the formation of BTP1 phage particles that lack the 
DNA-injection protein required for successful infection of a new host. In this scenario, 
the initial infected cell (e.g. D23580 ΔΦ pPLSTnc6030) would be lysed as a result of 
the termination of lytic replication, but the resulting phages would not be infective, 
raising the possibility that STnc6030 acts as an abortive infection (abi) system. 
However, as the asRNA is natively located within the BTP1 prophage, which contains 
other infection exclusion systems that prevent self-infection (the Gtr system), the 
biological role of the STnc6030 asRNA remains uncertain.  
In conclusion, phenotypes associated with virulence could not be convincingly 
assigned to either the BTP1 or BTP5 prophage. It remains possible that BTP1 or 
BTP5 contribute to virulence in a way not detectable in these models, or that lysogenic 
conversion by BTP1 and BTP5 does not relate to virulence. Indeed, investigation into 
the function of two highly expressed accessory elements of the BTP1 prophage, the 
ST313-td gene and the STnc6030 transcript both demonstrated immunity functions. 
ST313-td was convincingly shown to mediate immunity to the related lambdoid phage 
P22. Could the immunity function conferred by ST313-td explain the strong 
association between prophage BTP1 and the African S. Typhimurium ST313 
lineages? Though the ecology of phages in the natural environment is not well 
studied, it is logical to assume that lambdoid prophages are highly abundant due to 
the frequency at which they are isolated and studied. Perhaps the particular immunity 
conferred by the ST313-td gene provides a significant selective advantage in the sub-
Saharan African environment. Certainly, if the ST313-td protein is proven to confer 
immunity to a broad range of different phages, it would lend support to this hypothesis. 
Alternatively, the physiological phenotype of the ST313-td mediated immunity may 
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provide a selective advantage in a particular niche, which may or may not relate 
directly to infection of a human host. 
Some caution has been taken over the interpretation of the immunity phenotype of 
the STnc6030 asRNA. Though the heterologous expression of the RNA was shown 
to mediate complete immunity to BTP1 infection, it remains possible that these results 
are experimental artefacts. This is because the exact coordinates of the asRNA were 
predicted based on RNA-seq data, though the size of the largest transcript detected 
by Northern blot (~500 nt) is considerably shorter than the RNA predicted by RNA-
seq (789 nt). Consequently, the asRNA expressed from the pPL-STnc6030 construct 
is likely an extended version of the STnc6030 asRNA, and could be considered 
synthetic. In light of this, the possibility cannot be ruled out that the immunity 
phenotype conferred by the synthetic STnc6030 expression vector is simply an 
artefact of synthetic antisense silencing of the complementary mRNA sequence. An 
important aspect of further study will be the experimental identification of the 5’ and 
3’ ends of the STnc6030 RNA transcript(s) by 5’ rapid amplification of cDNA ends (5’ 
RACE). Once the extent of the STnc6030 has been defined, the immunity phenotype 
of the real STnc6030 RNA must be retested. However, evidence that STnc6030 
performs a genuine biological role was provided by the sequencing of escape phage 
mutants that could overcome infection interference by STnc6030; if the immunity 
phenotype was simply a synthetic antisense-silencing effect, mutations that 
destabilise the base pairing interaction would not necessary be localised to a 
particular part of the target region. In fact, all escape phage sequenced possessed 
mutations within a 36 bp region. The function of the STnc6030 RNA will be a topic for 
further study. 
The fact that the ST313-td gene, and perhaps the STnc6030 asRNA, mediate 
important phenotypes in terms of ST313 biology means that the BTP1 prophage does 
mediate lysogenic conversion of African S. Typhimurium ST313. 
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Chapter 7 
General discussion 
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7.1 The context of this thesis 
Salmonella enterica is an important pathogen that causes disease across the world. 
The diseases caused by Salmonella enterica isolates range from mild, self-limiting 
gastroenteritis, to fatal systemic infection. Typically in humans, ‘typhoidal’ S. enterica 
serovars including S. Typhi and S. Paratyphi A are associated with systemic disease, 
whilst ‘non-typhoidal’ serovars such as S. Typhimurium and S. Enteritidis are 
associated with gastrointestinal infections. However, in recent years this clinical 
distinction has weakened, as it has become increasingly appreciated that there are 
clades of traditionally non-typhoidal S. enterica serovars which are specifically 
associated with systemic disease in infant, malnourished or immunocompromised 
hosts (Feasey et al., 2016; Kingsley et al., 2009). The syndrome of systemic infection 
caused by non-typhoidal S. enterica serovars is known as invasive non-typhoidal 
Salmonella (iNTS) disease (Feasey et al., 2012). Whilst it was appreciated early on 
that iNTS-associated clades of S. enterica are strongly associated with multi-drug 
resistance, the genetic determinants mediating the enhanced propensity to cause 
systemic infection compared to closely-related non-typhoidal clades are unclear. This 
study set out to investigate whether or not novel prophages associated with iNTS-
causing clades of S. Typhimurium (ST313) effect the biology of the host in a way that 
could contribute to the niche adaption, whether through modulating virulence or other 
phenotypes. 
7.2 Summary of findings 
In Chapter 3, I showed that the African ST313 representative strain D23580 contains 
5 full length prophages. Prophage BTP1 and BTP5 are undescribed, novel prophages 
specific to African ST313 strains, whilst the remainder; Gifsy-2, ST64B and Gifsy-1 
have been previously described and are found in other strains of S. Typhimurium. Of 
the five prophages, only BTP1 and BTP5 showed evidence for functional phage 
production, and mutations inactivating Gifsy-2, ST64B and Gifsy-1 were identified. 
The BTP1 prophage spontaneously induced at a high rate, estimated to cause the 
phage-mediated lysis of approximately 0.2% of the lysogenic population. A GFP 
reporter system was developed to visualise the spontaneous induction of the BTP1 
prophage at the single-cell level.  Though the BTP5 phage could not be studied using 
traditional plaque assay methodology, there was evidence that the BTP5 prophage 
was capable of forming viable BTP5 phage that could lysogenise naïve hosts. 
In Chapter 4, I analysed the genomes of S. Typhimurium ST313 genomes from the 
UK, and found that in fact, ST313 in the UK represents a distinct population of 
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antibiotic susceptible strains associated with gastrointestinal infection. The discovery 
of the UK-ST313 population revolutionised our understanding of the evolution of the 
two African ST313 lineages, because UK-strains shared more recent common 
ancestry to each of the two African lineages than the African lineages share with each 
other. Additionally the UK-ST313 strains lacked the BTP1 and BTP5 prophages. 
Together these results indicated that the BTP1 and BTP5 prophages were acquired 
independently by the two African ST313 lineages, showing convergent evolution to 
acquire and conserve the BTP1 and BTP5 prophages. 
In light of this, in the remaining two chapters I explored the potential functional 
contribution of the BTP1 and BTP5 prophages that could drive their conservation in 
African ST313. In Chapter 5, I presented evidence that the prophages, in particular 
BTP5, affect the global gene expression of representative strain D23580 based on 
the results of a transcriptomic ‘target hunt’ experiment. Finally, in Chapter 6, I showed 
that the ST313-td gene of BTP1 mediates lysogenic conversion by functioning as a 
superinfection immunity factor against infection by Salmonella phage P22. 
An overall model illustrating the prophage evolution and functional contribution to 
ST313 lineages described in this thesis is summarised in Figure 7.1.
231 
 
 
Figure 7.1 Model summarising the evolution of the S. Typhimurium ST313 prophage repertoire and its putative functional 
contribution.
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7.3 Implications of this work 
My findings highlight the importance of characterising prophages beyond the genomic 
level. Putative prophages identified in genome sequencing studies are frequently 
disregarded, despite the overwhelming evidence that prophages contribute greatly to 
bacterial biology and pathogenesis. Characterising novel prophages is challenging, 
particularly in bacterial systems that are not genetically tractable or where no related 
phages or prophages have been characterised. Studying the prophages of D23580 
at the functional level revealed the surprising discovery that the BTP1 prophage yields 
the highest spontaneously induced phage-titer so far described in the literature for 
any prophage.  
Though spontaneous prophage induction is not well studied and the novelty of this 
finding is not entirely clear, the spontaneously induced phage titer produced by the 
BTP1 lysogen is surprising given that a predicted 0.2% of the cellular population are 
lysed as a result. The transcriptomic data presented in Chapter 5 suggest that BTP1 
spontaneous induction occurs in all growth conditions, including intracellular growth 
inside murine macrophages. Spontaneous cell lysis during infection of mammalian 
hosts could hypothetically lead to increased LPS (endotoxin) release and  therefore 
an enhanced inflammatory response (Zivot and Hoffman, 1995). Whether or not 
BTP1-mediated spontaneous induction and cell lysis interacts with the human 
immune response to infection by S. Typhimurium ST313 is beyond the scope of this 
study, but remains an important topic for future investigation. Indeed, Salmonella are 
known to exploit gut inflammation by utilising tetrathionate produced by oxidation of 
thiosulphate in the presence of reactive oxygen species during infection of the gut 
(ROS) (Chirullo et al., 2015; Winter et al., 2010), so a heightened inflammatory 
response could plausibly modulate Salmonella pathogenesis. How exactly the host 
pathologies associated with iNTS such as AIDS, malnutrition and malaria coinfection 
may affect the host response to BTP1-mediated cell lysis should also be considered. 
The mechanism behind the high frequency spontaneous induction of the BTP1 
prophage is another question that remains unanswered. As induction of a prophage 
is generally the result of repressor inactivation or repressor titration (Campbell, 2006), 
two hypotheses arise. Firstly, the BTP1 CI repressor protein may have a higher 
turnover rate, and be intrinsically less stable than the repressor of P22 or Lambda. 
Secondly, the BTP1 CI repressor may be intrinsically less abundant in the cell. 
Assuming there is activation of the SOS response in a fraction of the cellular 
population, as has been demonstrated in other bacteria (Nanda et al., 2014), both 
these eventualities would result in the balance between induction and maintenance 
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of lysogeny more readily swinging towards the former. Future experiments involving 
functional exchange of the BTP1 and P22 repressor proteins may provide evidence 
for the role of the repressor protein in BTP1 spontaneous induction. 
There are a number of examples in the literature where spontaneous prophage 
induction has been demonstrated to directly contribute to the disease potential of a 
bacterial pathogen. Most notably, in the case of Shiga toxin producing E. coli (STEC). 
The Shiga toxin, Stx, is carried by a number of different lambdoid prophages which, 
upon infection of susceptible E. coli, lysogenically convert the strain to cause fatal 
renal pathology due to the synthesis of the Stx toxin (Allison, 2007). However, no 
secretion system has been identified for the Stx toxin, and therefore synthesis and 
release of Stx toxin (encoded by a gene located in the prophage early lytic gene 
operon) depends entirely on prophage induction and cell lysis (Livny and Friedman, 
2004). As spontaneous prophage induction in essential for the function of the Stx 
toxin, it is likely that a heightened sensitivity of the Stx-prophage to induction signals 
would significantly affect STEC infection and disease progression. Increased 
spontaneous induction has been observed in Stx-phage lysogens compared to 
lysogens of non-Stx encoding prophages, suggesting that increased prophage 
induction is a phenotype that may be selected for when phage-mediated lysis is 
necessary for release of a cellular product (Livny and Friedman, 2004). However, no 
phenotype for the BTP1 lysogen has yet been detected that would be consistent with 
a role for spontaneous cell lysis as a release of a cellular product. 
Furthermore, there are numerous examples of prophages which contribute to 
virulence in animal models without a known mechanism, highlighting the challenge of 
identifying prophage virulence factors. For example, the SPC-P1 prophage is required 
for virulence of Salmonella Paratyphi C, as judged by the attenuation of a strain 
lacking the prophage, but no virulence factors have been identified (Zou et al., 2010). 
Similarly, the Salmonella Enteritidis prophage element ΦSE12 is required for 
virulence in mice though the mechanism by which the prophage promotes virulence 
is unknown (Araya et al., 2010). Clearly, further functional studies are required to 
understand the relationship between temperate phage and bacterial pathogens. 
Overall, whilst this study clearly showed the strong association between novel 
prophages BTP1 and BTP5 and the African S. Typhimurium ST313 lineages, no 
evidence was found that the prophages contribute to pathogenicity. Furthermore the 
implication of the functional inactivation of the three common S. Typhimurium 
prophages Gifsy-2, ST64B and Gifsy-1 in ST313 isolates remains unclear. On the 
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other hand, I have presented clear evidence that prophage BTP1 mediates a 
superinfection immunity function against other phages via the function of the ST313-
td potein, as well as data that suggests both prophages BTP1 and BTP5 modulate 
global gene expression of the lysogen. These results suggest that the role of 
prophages in the evolution of bacterial pathogens is diverse and complex, and may 
not be as simple as the addition of a single virulence factor.  
In conclusion, this thorough exploration of the prophage repertoire of S. Typhimurium 
ST313 poses interesting questions about the potential fitness costs and benefits of 
novel prophages in epidemic S. Typhimurium ST313. The phenotypic contributions of 
the prophages represents novel biology in this clinically important sequence type, and 
it remains to be seen how prophages modulate the behaviour of the pathogen in terms 
of ecological niche, host range or invasiveness in humans. 
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Appendix i 
Accession numbers and metadata for the 99 genome sequences used in this thesis. Where multiple isolates were collected from the same 
patient, a single representative isolate was chosen. This table includes information about the publicly available African genomes which were 
included in the analysis for context as well as Public Health England strains. Empty cells or the text N/A indicate no available data or not 
applicable (in the case of reference genomes that were not isolated by PHE). 
ID 
Accession 
number 
Lineage 
PHE centre (if 
UK) 
Travel to sSA 
country 
associated 
with 
travel info 
available 
Sample Type Isolate source Report Date 
AMR genes or plasmid 
replicons detected in genome 
Antimicrobial resistance 
phenotype 
DT2B ERR024398 UK #N/A  UK #N/A  Faeces #N/A #N/A N/A 
U10 SRR1965263 UK 
Yorkshire and 
Humber 
N UK Y Human Faeces 03/06/2014 FII-S1;FIB-17 $ 
U11 SRR1965387 UK West Midlands N UK Y Human Faeces 05/06/2014 FII-S1;FIB-17 $ 
U12 SRR1967419 UK London N UK Y Human N/A 19/06/2014 FII-S1;FIB-17 $ 
U14 SRR1966418 UK East of England N UK Y Human Blood 26/08/2014 FII-S1;FIB-17 $ 
U15 SRR1645388 UK East Midlands  UK N Human Faeces 24/05/2012 FII-S1;FIB-17;gyrA_SET[83:S-F] SUL256,NAL16,CIP 
U16 SRR1645171 UK 
Yorkshire and 
Humber 
 UK N Human Faeces 15/06/2012 FII-S1;FIB-17 $ 
U2 SRR1646230 UK East of England N UK Y Human Faeces 02/11/2012 FII-S1;FIB-17 $ 
U22 SRR3048892 UK South East  UK N Human Faeces 18/06/2014 #N/A $ 
U23 SRR1969854 UK South East N UK Y Human Faeces 10/10/2014 FII-S1;FIB-17 $ 
U24 SRR1967447 UK London N UK Y Human Faeces 23/10/2014 FII-S1;FIB-17 $ 
U25 SRR1958036 UK London  UK N Human Faeces 10/11/2014 FII-S1;FIB-17 $ 
U27 SRR1958303 UK London Y Uganda Y Human Faeces 07/11/2014 FII-S1;FIB-17 $ 
U28 SRR1960363 UK None  UK N Human Faeces 10/12/2014 FII-S1;FIB-17 $ 
U29 SRR1968084 UK London  UK N Human Faeces 26/01/2015 None found $ 
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U3 SRR1646238 UK East of England  UK N Human Faeces 10/12/2012 FII-S1;FIB-17 $ 
U30 SRR1968221 UK #N/A  UK N Food Raw Produce 24/02/2015 FII-S1;FIB-17 $ 
U31 SRR1967938 UK London  UK N Human Faeces 18/02/2015 FII-S1;FIB-17 $ 
U32 SRR1969492 UK London  UK N Human Blood 25/02/2015 FII-S1;FIB-17 $ 
U34 SRR1966635 UK West Midlands N UK Y Human Faeces 05/03/2015 FII-S1;FIB-17 $ 
U36 SRR1966593 UK London N UK Y Human Faeces 05/03/2015 FII-S1;FIB-17 N/A 
U37 SRR1968962 UK East of England N UK Y Human Faeces 12/03/2015 FII-S1;FIB-17 $ 
U38 SRR1967438 UK 
Yorkshire and 
Humber 
N UK Y Human Faeces 17/03/2015 FII-S1;FIB-17 $ 
U4 SRR1645545 UK West Midlands N UK Y Human Faeces 20/12/2012 FII-S1;FIB-17 $ 
U40 SRR1968061 UK London  UK N Human Faeces 18/03/2015 FII-S1;FIB-17 $ 
U43 SRR5451258 UK 
Yorkshire and 
Humber 
 UK N Human Faeces 10/06/2015 #N/A $ 
U44 SRR5451287 UK London N Pakistan Y Human Faeces 26/05/2015 FII-S1;FIB-17 $ 
U46 SRR5451286 UK London N UK Y Human Faeces 12/06/2015 FII-S1;FIB-17 $ 
U47 SRR5451276 UK South West N UK Y Human Faeces 16/06/2015 FII-S1;FIB-17 $ 
U48 SRR5451252 UK 
Yorkshire and 
Humber 
N UK Y Human Faeces 29/06/2015 FII-S1;FIB-17 $ 
U49 SRR5451278 UK London  UK N Human Faeces 30/06/2015 FII-S1;FIB-17 $ 
U5 SRR1645768 UK Wales  UK N Human Faeces 21/12/2012 FII-S1;FIB-17 $ 
U50 SRR5451285 UK London  UK N Human Faeces 02/07/2015 FII-S1;FIB-17 $ 
U51 SRR3323011 UK London N UK Y Human Faeces 06/08/2015 FII-S1;FIB-17 $ 
U52 SRR3284779 UK London N UK Y Human Faeces 06/08/2015 FII-S1;FIB-17 $ 
U53 SRR3285477 UK East of England  UK N Human Faeces 07/08/2015 FII-S1;FIB-17 $ 
U54 SRR5193685 UK South East N UK Y Human Faeces 10/08/2015 None found AMP8,SUL256,STR16,TET8 
U55 SRR3322345 UK North West N UK Y Human Faeces 08/09/2015 FII-S1;FIB-17 $ 
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U56 SRR5451268 UK 
Yorkshire and 
Humber 
N Pakistan Y Human Faeces 12/10/2015 FII-S1;FIB-17 $ 
U57 SRR5451279 UK London N UK Y Human Faeces 25/09/2015 FII-S1;FIB-17 AMP8 
U58 SRR5451270 UK South West N UK Y Human Faeces 01/10/2015 FII-S1;FIB-17;I1 $ 
U59 SRR5451254 UK East of England  UK N Human Faeces 19/10/2015 FII-S1;FIB-17 $ 
U61 SRR5451275 UK South East N UK Y Human Faeces 27/10/2015 FII-S1;FIB-17 $ 
U62 SRR5451283 UK East of England  UK N Human Faeces 19/10/2015 FII-S1;FIB-17 $ 
U63 SRR5451281 UK London  UK N Human Blood 22/10/2015 FII-S1;FIB-17 $ 
U64 SRR5451266 UK London N UK Y Human Faeces 27/10/2015 FII-S1;FIB-17 $ 
U65 SRR5451255 UK London N Portugal Y Human Faeces 28/10/2015 FII-S1;FIB-17;FII-2 $ 
U66 SRR3322379 UK London  UK N Human Faeces 03/11/2015 FII-S1;FIB-17 $ 
U69 SRR5451261 UK #N/A  UK N Dog Dog 22/12/2015 FII-S1;FIB-17 $ 
U7 SRR1966408 UK East of England N UK Y Human Faeces 14/05/2014 FII-S1;FIB-17 $ 
U70 SRR5451259 UK London  UK N Human Faeces 04/01/2016 FII-S1;FIB-17 $ 
U74 SRR5451280 UK North West N Cape verde Y Human Faeces 03/02/2016 FII-S1;FIB-17 $ 
U75 SRR5451257 UK East of England N Belize Y Human Faeces 26/02/2016 FII-S1;FIB-17 $ 
U76 SRR5451251 UK South East N India Y Human Faeces 02/03/2016 FII-S1;FIB-17 
AMP8,CHL8,CHL16,SUL256
,STR16,NAL16,CIP0.64,CIP
0.5 
U77 SRR5451260 UK East of England N UK Y Human Faeces 29/02/2016 FII-S1;FIB-17 $ 
U78 SRR5451265 UK West Midlands N India Y Human Faeces 11/03/2016 FII-S1;FIB-17 $ 
U8 SRR1966656 UK London N UK Y Human Faeces 29/05/2014 FII-S1;FIB-17 $ 
U80 SRR5451253 UK East of England N UK Y Human Faeces 21/03/2016 FII-S1;FIB-17 $ 
U81 SRR5215816 UK East of England N UK Y Human Faeces 29/03/2016 FII-S1;FIB-17 $ 
U82 SRR5451272 UK London N UK Y Human Faeces 04/04/2016 FII-S1;FIB-17 $ 
U83 SRR5451267 UK South East N UK Y Human Faeces 22/04/2016 FII-S1;FIB-17 $ 
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U84 SRR5451256 UK East of England N UK Y Human Faeces 22/04/2016 FII-S1;FIB-17 $ 
U86 SRR5451274 UK South East N UK Y Human Faeces 26/05/2016 None $ 
U87 SRR5451262 UK North West N India Y Human Faeces 26/05/2016 FII-S1;FIB-17 $ 
U9 SRR1968363 UK East of England N UK Y Human N/A 30/05/2014 FII-S1;FIB-17 $ 
U26 SRR1968109 Unknown London  UK N Human Faeces 03/12/2014 #N/A AMP8,TET8 
6325U ERR024780 II #N/A  Uganda N/A  Blood #N/A #N/A N/A 
A082 ERR023770 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
A13198 ERR023769 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
A16083 ERR023784 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
A357 ERR023771 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
A38589 ERR023782 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
A39051 ERR023797 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
C13184 ERR023796 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
C2110 ERR023777 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
D11578 ERR023783 II #N/A  Malawi N/A  Blood #N/A #N/A N/A 
I32 ERR023810 II #N/A  Mali N/A  Blood #N/A #N/A N/A 
I7 ERR023812 II #N/A  Mali N/A  Blood #N/A #N/A N/A 
J17 ERR023794 II #N/A  Mali N/A  Blood #N/A #N/A N/A 
J20 ERR023805 II #N/A  Mali N/A  Blood #N/A #N/A N/A 
J27 ERR023795 II #N/A  Mali N/A  Blood #N/A #N/A N/A 
J3 ERR023793 II #N/A  Mali N/A  Blood #N/A #N/A N/A 
M1111568 ERR024769 II #N/A  Mozambique N/A  Faeces #N/A #N/A N/A 
M1605206 ERR024424 II #N/A  Mozambique N/A  Blood #N/A #N/A N/A 
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M2907772 ERR024420 II #N/A  Mozambique N/A  Blood #N/A #N/A N/A 
P51 ERR023803 II #N/A  Mali N/A  Blood #N/A #N/A N/A 
P73 ERR023802 II #N/A  Mali N/A  Blood #N/A #N/A N/A 
U1 SRR1646227 II London Y Ghana Y Human Blood 28/08/2012 
FII-S1;FIB-17;TEM-
1;strB,strA;dfrA-1;sul-2;sul-
1;catA-1;gyrA_SET[83:S-Y] 
AMP8,CHL8,SU256L,STR16
,TMP2,NAL16,CIP 
U13 SRR1966509 II London Y Nigeria Y Human Blood 21/07/2014 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-1;sul-
2;catA-1 
AMP8,CHL8,CHL16,SUL256
,STR16,TMP2 
U17 SRR1967883 II London Y 
African 
continent (?) 
Y Human Blood 07/05/2014 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-2;sul-
1;catA-1 
AMP8,CHL8,CHL16,SUL256
,STR16,TMP2 
U35 SRR1966023 II London Y Nigeria Y Human Blood 04/03/2015 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-1;sul-
2;catA-1 
AMP8,CHL8,CHL16,SUL256
,STR16,TMP2 
U42 SRR3285401 II London  
UK (African 
name) 
N Human Blood 27/05/2015 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-2;sul-
1;catA-1 
AMP8,CHL8,CHL16,SUL256
,STR16,TMP2 
U45 SRR5451277 II London  UK (STD clinic) N Human Blood 17/07/2015 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-2;sul-1 
AMP8,SUL256,STR16,TMP2 
U60 SRR5451282 II London Y Kenya Y Human Blood 08/10/2015 
FII-S1;FIB-17;HI2;CTX-M-
15;OXA-1;TEM-1;strA;strB;dfrA-
1;dfrA-14;sul-2;sul-1;catA-
1;tet(A)-1;terF;terE;terD;terC;terB 
AMP8,CHL8,CHL16,SUL256
,TOB2,NAL16,CIP0.064,CIP
0.5,CTX0.5,CTX1 
U67 SRR3323046 II East Midlands Y Nigeria Y Human Blood 23/11/2015 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-2;sul-
1;catA-1 
AMP8,CHL8,CHL16,SUL256
,STR16,TMP2 
U68 SRR5451264 II London  
UK (African 
name) 
N Human Pus 10/12/2015 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-1;sul-
2;catA-1 
AMP8,CHL8,CHL16,SUL256
,STR16,TMP2 
U72 SRR5451284 II London N UK Y Human N/A 03/02/2016 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-2;sul-
1;catA-1 
AMP8,CHL8,CHL16,SUL256
,STR16,TMP2 
U73 SRR5451273 II London N 
UK (African 
name, African 
markets) 
Y Human Blood 03/02/2016 FII-S1;FIB-17;TEM-1 AMP8 
U85 SRR5451269 II London Y Ghana Y Human Faeces 09/05/2016 
FII-S1;FIB-17;TEM-
1;strA;strB;dfrA-1;sul-1;sul-
2;catA-1 
AMP8,CHL8,CHL16,SUL256
,STR16,TMP2 
 
